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Abstract 
The synthesis of 5-membered heterocyclic rings that bear both amine and carboxylic acid 
functional groups has been investigated using a 1,3-dipolar cycloaddition reaction strategy. 
These molecules, on incorporation into a chain of amino acids, have the potential to restrict 
the conformational freedom of the peptide. 
Cycloaddition of a nitrile oxide, derived from a Boc-protected naturally-occurring a-amino 
acid, with a pyrrolidine en amine led to a Boc-protected 3-aminoalkylisoxazole amino acid 
ester. The nitrogen and carbon termini of this isoxazole were coupled to other a-amino 
acids. Analysis of the dipeptide from coupling to (S)-alanine indicated that the integrity of 
the chiral centre of the isoxazole had been retained during the synthesis. Molecular 
modelling of a tripeptide unit incorporating the isoxazole showed that the presence of the 
ring had, as intended, restricted the conformational freedom of the molecule. 
Analogous cycloadditions using azomethine imines as the dipole yielded the corresponding 
tetrahydropyrazoles (pyrazolidines). These dipoles were generated by reaction of an 
aldehyde with a 1,2-disubstituted hydrazine, followed by elimination of the elements of 
water from the resulting aminol. Reaction with a dipolarophile bearing an electron-
withdrawing substituent gave predominantly the 4-substituted pyrazolidine. A study of the 
scope of the reaction found that, although the required carboxylic acid group could easily 
be incorporated by use of methyl acrylate as the dipolarophile, it proved impossible to 
attach an amine group to the ring using this methodology. However, by using one of the 
nitrogen atoms in the ring as the N-terminus, two pyrazolidines with protected amine and 
carboxylic acid groups were prepared, and these can be thought of as conformationally 
restricted ~-amino acids. 
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Abbreviations 
General Terms 
Ac 
Alloc 
AMPA 
ag. 
Bn 
Boc 
b.p. 
Bu 
CCK 
CI 
COSY 
CTP 
DBU 
DCC 
DCM 
DEAD 
DIBAL 
DCU 
DMAP 
DMSO 
D-S 
Acetyl 
Allyloxycarbonyl 
2-Amino-3-(3-hydroxy-S-methylisoxazol-4-yl)propionic acid 
aqueous 
Benzyl 
tert-Butoxycarbonyl 
boiling point 
n-Butyl 
tert-Butyl 
Cholecystokinin 
Chemical Ionisation 
IH_IH correlation spectroscopy 
D-Phe-Crs-Tyr-D-Trp-Lys-Thr-P,n-Thr-NH2 
1 ,8-Diazabicyclo[S.4.0]undec-7 -ene 
Dicyclo hexy lcarbodiimide 
Dichloromethane 
Diethyl azodicarboxylate 
Diisobutylaluminium hydride 
DicYclohexylurea 
4-Dimethylarninopyridine 
Dimethyl sulfoxide 
Dean and Stark 
EDCI 
EI 
ES 
Et 
FAB 
FMO 
HOMO 
HPLC 
i.d. 
1m 
LG 
LH-RH 
LUMO 
Me 
MO 
m.p. 
NCS 
NMDA 
NMR 
nOe 
PG 
Ph 
ppm 
iPr 
RGDS 
TBDMS 
1-(3-Dimethy laminopropyl)-3-ethylcarbodiimide hydrochloride 
Electron Impact 
Electrospray 
Ethyl 
Fast Atom Bombardment 
Frontier Molecular Orbital 
Highest Occupied Molecular Orbital 
High Performance Liquid Chromatography 
internal diameter 
Imidazole 
Leaving Group 
Luteinising Hormone-Releasing Hormone 
Lowest Unoccupied Molecular Orbital 
Methyl 
Molecular Orbital 
melting point 
N-Chlorosuccinimide 
N-Methyl-D-aspartic acid 
Nuclear Magnetic Resonance 
Nuclear Overhauser Effect 
Protecting Group 
Phenyl 
parts per million 
iso-Propyl 
Arg-Gly-Asp-Ser 
tert-Butyldimethylsilyl 
ii 
TCTP D-Tic-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 
I I 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
Tic Tetrahydroisoquinoline-3-carboxylic acid 
TLC Thin Layer Chromatography 
TMS Tetramethy lsilane 
p-tolyl para-methylphenyl 
pTs para-toluenesulfony I 
Z benzyloxycarbonyl 
Amino Acid Nomenclature 
Amino acids are given three letter codes as abbreviations. In peptides the abbreviation of 
each residue is separated by a hyphen, which can be formally considered as the amide 
bond. For example, an alanine molecule bonded to the N-terminus of glycine is 
abbreviated to Ala-Gly. Protecting groups that may be attached are also indicated, e.g. 
alanine with a Z protecting group on nitrogen is represented as Z-Ala. Side chain 
protecting groups are written in brackets, e.g. Tyr(Me) for a tyrosine residue with the OH 
group of the phenyl ring protected as the methyl ether. 
Below are listed the three letter codes for the 20 amino acids commonly found in peptides 
and proteins. Also included are the abbreviations of other amino acids (both naturally-
occurring and synthetic) that will be encountered in this work. Unless stated, all amino 
acids have S stereochemistry (except cysteine which is R) as this is the naturally-occurring 
enant io mer. 
iii 
Name Abbreviation ~-R 
Alanine Ala ~-CH3 
Arginine Arg NH ~-(CH2h'N)lNH 
H 2 
Asparagine Asn 0 
)l ~-CH2 NH2 
Aspartic Acid Asp ~-CH2C02H 
Cysteine Cys ~-CH2SH 
Glutamic Acid Glu ~-CH2CH2C02H 
pyroGlutamic Acid2 <Glu ~C02H 
NH 
0 
Glutamine GIn 0 ~-CH2'C)l NH 
H2 2 
Glycine Gly ~-H 
Histidine His )[~ ~-CH2 N 
H 
Isoleucine Ile ~-CH(CH3)CH2CH3 
Leucine Leu ~-CH2CH(CHs)2 
iv 
Name Abbreviation ~-R 
Lysine Lys ~-(CH2)4NH2 
Methionine Met ~-CH2CH2SCH3 
1 . I Noreucme Nle ~-CH2CH2CH2CH3 
Penicillamine Pen CH3 ~-?-SH 
CH3 
Phenylalanine Phe ~-CH20 I~ 
r 2 Pro me Pro ~co,H 
H 
. 2 Sarcosme Sar ....-..... CH3NH C02H 
Serine Ser ~-CH20H 
Threonine Thr ~-CH(OH)CH3 
Tryptophan Trp ~-CH2u:9 
N 
H 
Tyrosine Tyr j-CH2~ 
~ OH 
Valine Val ~-CH(CH3)2 
1. Not a naturally-occurring amino acid 
2. Full structure shown for clarity 
v 
Chapter 1: 
Introduction 
1.1 Background 
Peptides are chains of up to 50 amino adds linked head-to-tail by amide bonds (Scheme 
1.1) (longer sequences are usually referred to as proteins). They are of great importance in 
nature, as they playa key role in many biological processes such as digestion, respiration 
and the immune system. Examples include insulin, synthesised in the pancreas and 
responsible for lowering blood sugar levels, angiotensin and Substance P, both of which 
control blood pressure, and thyrotropin, present in the thyroid gland. 
Scheme 1.1 
Being so commonplace in living systems, peptides would appear to be an ideal choice for 
use as potential pharmaceutical agents and pesticides. However, naturally-occurring 
peptides suffer from a number of limitations that prevent their use in such applications. 
These include poor absorption into the bloodstream, rapid degradation in the gastro-
intestinal tract due to proteolysis of the amide bond and a lack of specificity of activity 
caused by conformational flexibility. 
To overcome these problems, chemists began to explore the possibility of modifying 
natural peptides in an attempt to eliminate the problems associated with their stability 
whilst retaining the biological activity. Such analogues can function by either mimicking 
the naturally-occurring molecule - an agonist - or by blocking a receptor site, rendering it 
inactive, an antagonist. Molecules that contain a peptide backbone which has been 
modified are known as pseudopeptides 1 or peptidomimetics.2 These are defined as 
2 
substances that possess a similar secondary structure to a natural peptide and can therefore 
act in the same manner. The secondary structure of a peptide refers to the arrangement of 
the backbone in regular patterns, thus controlling the orientation of the side chains. This is 
critical for recognition of the molecule at a receptor site, and therefore peptidomimetics 
can not only act as stable, biologically active compounds, but can also provide some 
insight into the conformation a molecule must adopt if it is to exhibit such activity. 
The fIrst laboratory synthesis of a peptide hormone was carried out by Du Vigneaui in 
1953 who successfully prepared oxytocin, a cyclic peptide comprising eight amino acids 
that is responsible for uterine muscle contraction during labour. Further studies 
4 
revealed 
that removal of the N-terminal amino group - to give desamino-oxytocin - resulted in the 
biological activity of the molecule being doubled, an observation attributed to an increased 
stability towards enzymatic degradation. 
Desamino-oxytocin was the fIrst example of a peptidomimetic, and further research soon 
followed. Early work concentrated on the addition or deletion of amino acids or the 
exchange of one residue for another. This field of chemistry has since become a more 
sophisticated science with specifically designed non-peptidic units being incorporated into 
chains of amino acids. These units usually replace two amino acids as the amide bond 
which links two residues in the parent molecule is replaced by some other functional 
5 
group. Examples of amide bond replacements include C=C double bonds 1.1, 
hydroxyethylene groups 1.2,6 ketomethylene groups 1.37 and reduced amides l.l (Fig. 
1.1). 
3 
OH R2 
H2N~OH 
R1 0 
1.2 
R2 
H2N'('~~OH 
R1 0 
1.4 
Fig. 1.1 
A number of reviews of peptidomimetics has been published,2. 9-19 and the field of 
peptidomimetic research is now so vast that an exhaustive review is unrealistic_ Therefore 
only peptidomimetics containing a heterocyclic ring system will be considered here, and 
even these will be limited to selected examples. 
A simple, straight-chain peptide backbone consists of three types of single bond (Fig. 1.2), 
each with a dihedral angle associated with it; the a.-carbon-carbonyl carbon bond (",), the 
amide bond (00) and the a.-carbon-nitrogen bond (<1». Rotation is possible about all of these 
(although the amide bond has a degree of double bond character, restricting it somewhat) 
giving rise to a number of possible conformations. 
Fig. 1.2 
4 
Introducing a ring system can limit or prevent rotation about one or more of these bonds, 
reducing the range of conformations that the molecule can adopt. The ring arises by either 
tethering two points on the peptide backbone, usually involving extension of the side 
chain, or by replacing an entire section of the backbone with a cyclic molecule. The 
presence of a ring in a peptidomimetic usually serves one of two functions. It can stabilise 
the conformation of the molecule by increasing its rigidity, or it can act as a mimic for a 
structural feature such as a turn or helix. In nature, structural features such as turns are 
usually induced by the insertion of a proline residue (Fig. 1.3), which possesses a bridge 
between the nitrogen and a-carbon atoms. 
1.2 Features of Secondary Structure 
It is appropriate at this point to consider the features of secondary structure to which we 
• 20 21 
have already alluded. The four main structural features are a-helIces, ~-pleated sheets, 
~-turns and y-turns. Due to the complex and extended structure of a-helices and ~-pleated 
sheets, only a few examples of molecules which can mimic them or initiate their formation 
are known.22-24 The comparatively straightforward structure of reverse turns, and the fact 
that they often occur at points in peptides which are significant with regard to the 
molecule's biological activity, means that they are the focus of the majority of secondary 
structure mimetics. The difference betwe~n the two kinds of turn is described below. 
5 
~-Turns 
The presence of a ~-turn causes the peptide backbone to go back upon itself. Any 
sequence of four amino acid units in a non-helical region of the peptide where the a-C 
atoms of the first and fourth residues are <7A apart is defined as a ~-turn (Fig. 1.4).25 This 
rather broad definition means that many different types of ~-turn are known (called Type I, 
Type II etc.), though they will not be detailed here. Another feature worth noting is the 
hydrogen bonding that takes place between the carbonyl oxygen of the first residue and the 
N-H of the fourth. 
R 0 R HY~JyO 
FO",I\'H-N, 
aC(1) aC(4) 
Fig. 1.4 
,,(-Turns 
A y-turn performs a similar task to a ~-turn. However, whereas a ~-turn comprises 4 
. 26 
amino acid residues, a ,,(-turn is made up of only 3 (FIg. 1.5). These are less common than 
~-turns although they are still an important structural feature. 
6 
1.3 Analogues of Single Amino Acids 
One of the simplest amino acids with a heterocycle as part of the backbone is a 
tetrahydroisoquinoline carboxylic acid (Tic) (Fig. 1.6). It results from insertion of a 
methylene bridge between the amine and the 2-position of the side chain phenyl ring of a 
phenylalanine molecule. 
Phe Tic 
Fig. 1.6 
An example of the effect that this restraint can have on the biological activity of a 
compound can be demonstrated by the work of Kazmierski and Hruby.27 Previously, they 
had designed a potent opioid receptor antagonist called CTP (Fig. 1.7). By replacing the 
N-terminal D-Phe residue with its more restricted Tic analogue, TCTP was synthesised, a 
molecule with a much higher level of selectivity than CTP for one type of receptor over 
another (>9000 fold for the Jl receptor against the 8 receptor). 
H-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 CTP 
I I 
H-D-Tic-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 TCTP 
I I 
Fig. 1.7 
Other examples of conformationally restrK,ted analogues of single amino acids include the 
tryptophan mimetics 1.528 (Fig. 1.8) and an azaTic phenylalanine derivative 1.6.29 
7 
n = 0,1 
1.5 1.6 
Fig. 1.8 
1.4 Lactams 
Attachment of an amino acid side-chain to the nitrogen atom of an adjacent residue, to 
form a pseudodipeptide, results in a lactam. Many cyclic peptidomimetics contain a 
lactam of some description as it allows retention of the amide bond. As mentioned earlier, 
the hydrogen bonding abilities of the amide bond are important in terms of the secondary 
structure of the molecule. Keeping the amide bond prevents disruption of these hydrogen 
bonds. 
o 
<Glu-His-Trp-Ser-Tyr, ~~~ 
N = Arg-Pro-Gly-NH2 H :: o -y 
Fig. 1.9 
Freidinger and colleagues have carried out extensive research into simple lactams 
including the synthesis of an analogue of Luteinising Hormone-Releasing Hormone (Fig. 
1.9).30 This involved the replacement of the Gly-Leu dipeptide unit with the y-Iactam 1.7 
(Scheme 1.2) synthesised by cyclisation of 1.8, the methyl sulfonium salt of Boc-Met-Leu-
OMe. Biological tests showed LH-RH mimic 1.9 to be 2.4 times as potent as the parent 
8 
hormone. The enhanced activity of 1.9 suggests that the bioactive conformation contains a 
~-turn. 
BocHN 
o y 
1.8 1.7 
i, NaH 
o 
<Glu-His-Trp-Ser-Tyr, ,yN-J-lA P GI NH N = rg- ro- y- 2 H :: oy 
1.9 
Scheme 1.2 
1.5 Rings Containing More Than One Heteroatom 
1.10 
Fig. 1.10 
9 
Horwell and colleagues, having designed 1.10 (Fig. 1.10), an antagonist for the NK1 
neuropeptide receptor, then prepared a conformationally restricted analogue 1.11 (Scheme 
1.3) containing a piperazinone ring,31 which is effectively an open chain peptide containing 
an ethylene bridge between the nitrogen atoms of the two amide bonds. The synthesis of 
1.11 involved a Mitsunobu cyclisation of 1.12 to form the heterocyclic intermediate 1.13 
(Scheme 1.3). 
.. 
1.12 1.13 
i, DEAD, PPh3 
1.11 
Scheme 1.3 
On testing the ability of 1.11 to bind to the NKJ receptor, it was found that the cyclic 
analogue was 104 times less potent than the acyclic compound 1.10. A comparison of the 
10 
crystal structures of 1.10 and 1.11 revealed that although the backbone of the piperazinone 
mimetic has a similar conformation to the acyclic compound, the orientation of the side 
chains is significantly altered. It is this that is presumed to be responsible for the decrease 
in biological activity. 
RODS 
Fig. 1.11 
The tetrapeptide sequence Arg-Oly-Asp-Ser (RODS) (Fig. 1.11) of fibrinogen is crucial in 
its binding to a glycoprotein called OP IIb/lIIa. This results in platelet aggregation, which 
can lead to thrombosis, therefore any molecule which can mimic RODS and block the 
receptor site has potential for use in the treatment of this condition. Stilz, Beck, Jablonka 
and Just designed and synthesised a heterocyclic peptidomimetic 1.14 (Scheme 1.4) which 
features a carbonyl bridge between the a-nitrogen atoms of the arginine and glycine 
residues, giving rise to a dioxotetrahydroimidazole (a hydantoin), as well as a phenyl ring 
as a rigid analogue of the arginine side-chain. 32 The cyclisation occurred via the acid 
catalysed intramolecular attack at a carbonyl group by a urea nitrogen atom to give the 
hydantoin 1.15, which was then converted to the mimic 1.14. 
11 
Br 
1.15 
i, Hel 
o ~» 
N~ . 
HNi 0 ~C02H 
1.14 
Scheme 1.4 
1.6 Peptidomimetics With Altered Backbones 
In the peptidomimetics highlighted so far, the peptide backbone has been left intact. Some 
mimics though, replace the peptide backbone with a different structural unit (see Fig. 1.1). 
In these cases, the side chains are frequently conserved, as they are the portions of the 
molecule that are important for binding to a receptor site. Peptidomimetics of this type 
often have enhanced stability towards proteolytic degradation as the readily hydrolysed 
amide bond is no longer present. However, such compounds may no longer be able to 
form the crucial intramolecular hydrogen bonds that are present in the parent peptide. For 
this reason, many peptidornimetics display only subtle changes in order that they retain 
many of the bonding properties of the original peptide. 
12 
Falorni, Dettori and Giacomelli have carried out enantiospecific syntheses of amino acids 
1.16 containing an oxazole ring (Scheme 1.5).33 Although this does not possess an amide 
bond, the ring does contain both a nitrogen and an oxygen atom which have the same 
positioning as an amide relative to the rest of the peptide backbone (Fig. 1.12). Although 
the lack of an N-H group will prevent hydrogen bonding to another carbonyl group, it is 
still possible for the oxygen atom to act as a hydrogen bond acceptor. 
o R 
YlNJy 
H 
amide oxazole 
Fig. 1.12 
The ring was prepared by a rhodium-catalysed reaction of amide 1.17 (derived from an N-
protected a-amino acid) and diazocompound 1.18 (Scheme 1.5). The resulting ~-carbonyl 
amide 1.19 then underwent dehydrative cyclisation to the oxazole . 
.. 
1.17 1.18 
Scheme 1.5 
13 
By selecting appropriate functionality at Rl, the oxazole ring-containing fragment 1.16 can 
either be attached to the side chain (Rl= C02Bn, R2= Boc) or form part of the backbone 
(Rl= Ph, R2= Z) of a pseudopeptide. 
Thiazoles can be employed similarly, sulfur having similar chemical properties to oxygen. 
These ring systems have been found to be present in a number of cytotoxic cyclic peptides 
. 1 d fr . . I As 'd' I 'd 34 P II 'd A 35 B36 d 36 ISO ate om mar me amma s, ego Cl lacyc amI e, ate amI e, an C, and 
Ulithiacyclamide.37, 38 Shioiri and colleagues devised a synthesis for optically pure amino 
acids containing a thiazole ring from an a-amino aldehyde 1.20 and the methyl ester of 
cysteine 1.21, a naturally-occurring amino acid (Scheme 1.6).39 After attack of the 
aldehyde carbonyl group by the cysteine nitrogen, the same carbon atom was attacked by 
the sulfur atom of the cysteine side chain. Loss of the elements of water gave the 
thiazolidine 1.22 as a racemic mixture that upon oxidation with manganese dioxide yielded 
the product 1.23. The stereochemistry at the chiral centre of the a-amino aIde hyde was 
retained during the cyclisation. 
+ 
SH yC02CHa 
NH2 
1.21 
1.22 1.23 
Scheme 1.6 
14 
Analogue 1.24 (Scheme 1.7), which was designed as an HIV protease inhibitor, contains 
an imidazole ring in place of an amide bond.4o Retention of the NH group in the backbone 
is desirable for hydrogen-bonding to the carbonyl of a glycine residue in the receptor site, 
whilst the lone pair of electrons on the other ring nitrogen atom offers further hydrogen 
bonding via a water molecule to another site on the receptor. The molecule also contains 
an acyclic amide bond replacement, a hydroxyethylene group (Fig. 1.1). The imidazole 
ring was synthesised by cleavage of the isoxazole in 1.25 by hydrogenation to form 1.26 
(Scheme 1.7). Base-catalysed intramolecular attack on the amide carbonyl by the free 
amine and elimination of the elements of water formed 1.27, which was then converted to 
the inhibitor 1.24. 
~Ph j0N o ::;...-- \o ::---BocHN . . N 
= ~ H 
TBDMSO "-Ph 
(Ph R ~NH2 ~I 
BocHN . . N 0 
= .: H 
TBDMSO, H 
Ph 
1.25 1.26 
Ph £J~ 'Pro 
Z-Val-NH : : .. ~/ I( 
6H ~ H 0 
'Ph 
Ph 
• ~~H BocHN . . N 
. . H 
TBDMS6 ~ 0 
Ph 
1.24 1.27 
i, H2, Pd-C; ii, NaOH; 
Scheme 1.7 
Peptidomimetic 1.24 and a number of analogues were tested for their inhibition of HIV-l 
protease.41 Also tested were the analogous triazole and thiazole containing mimics 1.28 
and 1.29 (cf. 1.24), both derived from the protected hydroxyethylene pseudodipeptide 1.30 
15 
(Scheme 1.8).42.43 The triazole 1.28 was prepared by condensation of the amide 1.30 with 
N,N-dimethylformamide dimethyl acetal to form 1.31. Nucleophilic attack by hydrazine in 
the presence of acid then generated the triazole ring. The thiazole was synthesised by 
reacting the amide 1.30 with Lawesson's reagent to give thioamide 1.32, which was 
condensed with N,N-dimethylformamide dimethyl acetal as before. S-Alkylation of the 
product with 1-bromo-2-butanone was followed by spontaneous cyclisation to form the 
thiazole. All three ring systems were found to be effective replacements for an amide 
bond, however 1.24 was found to be significantly more potent than 1.28 and 1.29 as an 
inhibitor of HIV -1 protease. This was attributed to the imidazole ring being a better 
hydrogen bond acceptor than the thiazole or triazole. 
(Ph R (Ph ~ 
~ __ .-.. ~ 'lCHN(CH3b BoeHN .: ; NH2 BoeHN ~ .: N 
- - - -
OAe 
1.30 
Ph BOCHN~NH2 
OAe , 
Ph 
1.32 
ji,V,iii 
Ph BOCHN~)yEt 
OH = 0 
"Ph 
1.29 
OAe 
'--Ph 
1.31 
j ii, iii 
(Ph N-N 
~;> BoeHN . . N 
=. ~ H OH = 
'--Ph 
1.28 
i, (<=H3)2N<:H(~H3)2; 
ii, H2NNH2.H20; iii, aq. NaOH; 
iv, Lawesson's reagent; v, BrCH2COEt 
Scheme 1.8 
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The structural similarity between oxazoles, thiazoles and imidazoles was utilised by Singh, 
Gordon, Morgan and colleagues, who prepared peptidomimetics containing each of these 
three ring systems from the same ~-oxodipeptide unit 1.33 (Scheme 1.9).44.45 To form the 
thiazole 1.34, Lawesson's reagent was used to thionate the carbonyl group. Cyc1isation 
occurred spontaneously with none of the intermediate thioamide being isolated. The best 
yields of the imidazole 1.35 were obtained with ammonia when the water generated during 
ring formation was removed azeotropically. The oxazole 1.36 meanwhile, was formed by 
the action of triphenylphosphine and a base, the elements of water being eliminated in the 
ring-forming process. 
NH NH 
• 
H 
ZHN NXC02CH3 ZHN 
0 o Ph 
1.33 1.34 
iii 
ZHN ZHN 
1.36 1.35 
i, Lawesson's reagent; ii, NH40H, AcOH; iii, Ph3P, DBU. 
Scheme 1.9 
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All three peptidomimetics were used as replacements for the Trp and Phe residues of the 
neurokinin antagonist H-Pro-Trp-Phe-Trp-Leu-Phe-NHz 1.37, the amide bond between the 
two residues effectively being substituted by a 5-membered azole ring.46 In each case an 
increase in biological activity was observed; however, the thiazole-containing peptide 
derived from 1.34 was found to be the most potent, with a lO-fold increase over 1.37. 
cf 
cis trans 
Fig. 1.13 
Johnson and Yu synthesised a series of peptidomimetics containing a tetrazole ring to act 
as a replacement for a cis amide bond (Fig. 1.13).47 Although not as common as the trans 
configuration, the cis amide plays an important part in peptide folding. The ring-forming 
step in the synthesis of peptidomimetic 1.38 involved conversion of a simple dipeptide 
ester 1.39 to the imidoyl chloride 1.40 using phosphorus pentachloride, followed by 
treatment with hydrogen azide to give the tetrazole 1.38 (Scheme 1.10). 
i, pels; ii, HN3 
... 
Scheme 1.10 
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Unfortunately, epimerisation at the chiral centre of the N-terminal amino acid occurred 
during the cyclisation. However, further research found that this could be suppressed by 
the addition of quinoline during the formation of 1.40.48 Epimerisation, this time at the 
chiral centre of the C-terminal amino acid, also took place if the tetrazole dipeptide was 
subjected to treatment with base. Therefore, although Johnson and Yu had found that the 
best yields were obtained when a phthaloyl group was used to protect the N-terminal 
amine,47 this proved to be impractical as its cleavage required basic conditions. Zabrocki 
and co-workers, in their preparation of bradykinin analogues containing the tetrazole amide 
49 . bond replacement, employed a Z group - cleaved by hydrogenation - to protect the N-
terminus and a benzyl ester - removed under acidic conditions - to protect the C-terminus, 
thus retaining the stereochemical purity of the molecule. 
The conformationally restricted ammo acid 1.41, which contains a pyrrole ring, was 
50 
synthesised by Abell, Hoult and Jamieson, also as a surrogate for a cis amide bond. 
Formation of the ring was brought about by reaction of the hydrochloride salt of an amino 
acid methyl ester 1.42 with 1,4-dimethoxytetrahydrofuran 1.43 (Scheme 1.11). 
Formylation of the resulting pyrrole 1.44 with trimethyl orthoformate followed by 
reductive amination with ammonium acetate and sodium cyanoborohydride then 
introduced the amine function to give the mimetic 1.41. N- and C-Terminal protecting 
groups can then be attached as required making 1.41 a more versatile cis amide bond 
mimetic than the tetrazole 1.38 described earlier. 
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1.42 
Scheme 1.11 
1.7 Cycloadditions 
1.44 
R 
~~C02H 
NH2 
1.41 
Cycloadditions are frequently used to construct carbocyclic and heterocyclic rings as they 
usually allow a high degree of stereocontrol to be exercised over the final product. The 
field of peptidomimetic research includes a number of cases of heterocycles that have been 
constructed using a cycloaddition reaction; some examples synthesised by Diels-Alder 
reactions and 1,3-dipolar cycloadditions will now be considered. 
1.7.1 Peptidomimetics Constructed Using a Diels-Alder Reaction 
The Diels-Alder reaction involves reaction of a diene (containing two double bonds) and a 
dienophile (which possesses just one) (Scheme 1.12) resulting in the formation of a 6-
membered ring. 
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Scheme 1.12 
HSJyN9 
o C02H 
Fig. 1.14 
Captopril (Fig. 1.14) is a peptidomimetic used to control high blood pressure.51 As part of 
the effort to discover even more potent mimetics to treat this condition, Hassall and co-
workers used a Diels-Alder reaction between triazole 1.45 or 1.46 and the diene 1.47 as a 
key step in the synthesis of the tetrahydrotriazolopyridazinediones 1.48 and 1.49 (Scheme 
1.13), which are conformationally restricted analogues of captopri1.52 
n = 1,1.45 
n = 2,1.46 
1.47 
Scheme 1.13 
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The di-substituted azanorbornane 1.50 (Scheme 1.14) is a ~-tum mimic designed to model 
the Trp-Phe sequence of a cyclic peptide that exhibits a high affinity for a neuropeptide 
receptor (NK_2).53 As well as imitating the side chain orientation of Trp and Phe, the 
dipole moment of 1.50 also closely matches that of the hexapeptide it is designed to 
replace. Whilst 1.50 does not display the same affinity for the NK-2 receptor, it does 
display the same affinity for the NK-l receptor as the hexapeptide, suggesting that the Trp-
Phe section of the molecule is responsible for binding to this site. The synthesis of the 
azanorbornane 1.50 involved an aza-Diels-Alder reaction of cyc10pentadiene with the 
dienophile 1.51 (Scheme 1.14), which is derived from the condensation of benzylamine 
. 54 
WIth phenylglyoxall.52. 
o 
H 
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1.7.2 Peptidomimetics Constructed Using a 1,3·Dipolar Cycloaddition 
1,3-Dipolar cycloadditions are used in the synthesis of 5-membered rings containing one or 
more hetero-atorns (see Section 1.10). The perhydroisoindol-4-one 1.53 (Scheme 1.15) is 
a non-peptidic antagonist of Substance P. A key step in its synthesis was a 1,3-dipolar 
cycloaddition involving the azomethine ylid 1.54 and cyclohex-2-enone 1.55 to produce 
the perhydroisoindol-4-one 1.56 in 84% yield.55 As the dipole is C2-symmetrical, only one 
regioisomer can arise from the reaction. 
Ph Ph Ph 
H C-2 , 
/N\ .. N\ 
H2C Ph Ph + 
0 0 
1.55 1.54 1.56 
1 j
Ph 
OCH3 
o 
1.53 
Scheme 1.15 
Harwood and co-workers have carried out research into the enantioselective synthesis of 
proline derivatives from a-amino acids, again by the 1,3-dipolar cycloaddition of an 
56 
azomethine ylid (Scheme 1.16). (S)-Valine 1.57 was converted to the morpholinone 
template 1.58 in which the original chiralIty has been used to generate a new chiral centre. 
On formation of the azomethine ylid 1.59, by reaction with formaldehyde, the chiral centre 
23 
at C-3 derived from the valine was destroyed; however, the presence of the second chiral 
centre allowed stereocontrol at C-3 during cyc1oaddition. Hydrogenation of the resulting 
cyc10adduct 1.60 gave the proline derivative 1.61, which possesses the same 
stereochemistry at C-2 as the starting amino acid 1.57. 
1.57 
H . 
__ 1,_11_. Ph'CNxP' 
o 0 
1.58 
1.61 
II . 
iii • Ph'C~x'P' 
o 0 
1.59 
1.60 
i, PhCOCH2Br; ii, reduction; iii, (HCHO)n; iv, N-phenylmaleimide; v, H2, Pd(OHh-C 
Scheme 1.16 
Further research has investigated the use of other aldehydes to introduce functionality at 
the 5-position of the proline ring,57 as well as intramolecular cycloadditions with a tethered 
dipolarophile to exert greater stereocontrol over the reaction.58 Cycloadditions have also 
been carried out using a morpholinone template bearing a phenyl group at C-3 instead of 
59 
iso-propyl, which had the effect of increasing both the yield and the diastereocontrol. 
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Scheme 1.17 
The orthogonally protected spirocyclic pseudodipeptide 1.64 was designed as a scaffold for 
60 
combinatorial libraries. One of the intermediates in its preparation is the tricyclic 
pyrazoline 1.63, formed by the intramolecular dipolar cycloaddition of an azomethine 
imine 1.62 (Scheme 1.17). By having the dipolarophile tethered to the dipole, a high 
degree of regiocontrol was observed. This is because the twisting of the intermediate 1.62 
that would be required to form the other regioisomer would raise the energy of the 
transition state to a prohibitive level. 
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1.65 
1.67 
Ph3CO 
1.69 
1.68 
i, CHOC02
tBu; ii, CH2=CH2; iii, HCI, Na2C03 
Scheme 1.18 
Isoxazolidines have been used as proline analogues by Vasella and Voeffray.61 They 
devised an asymmetric synthesis of the (3S)-enantiomer of the 5-oxaproline 1.67 by means 
of the 1,3-dipolar cycloaddition of ethylene to the N-glycosylnitrone 1.66 derived from the 
oxime of D-mannose 1.65 and tert-butyl glyoxylate (Scheme 1.18). By using the oxime of 
D-ribose 1.68, the (3R)-5-oxaproline 1.69 can also be prepared. 
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Fig. 1.15 
NMDA 1.71, AMPA 1.72 and kainic acid 1.73 all mimic glutamic acid 1.70 (Fig. 1.15). 
The hydroxyisoxazolinylprolines (±)1.74 and (±)1.75 were prepared as conformationally 
restricted analogues of these compounds (1.74 being regarded as a mimic of NMDA and 
1.75 of AMPA and kainic acid, the spacing between the backbone carboxylic acid group 
and the side-chain OH functionality being similar).62 Their syntheses involved the 1,3-
dipolar cycloaddition of bromonitrile oxide 1.76 (derived from the oxime 1.77) to the 
unsaturated proline derivative 1.78 (Scheme 1.19). The resultant fused bicyclic products 
1.79, 1.80 and 1.81, which are simply regio- and stereoisomers from the cycloaddition (the 
diastereoisomer of 1.79 was not detected), were then treated with sodium hydroxide to 
hydrolyse the ester and to convert the bromine substituent to a hydroxyl group. 
Trifluoroacetic acid (TFA) removed the Boc group to realise the peptidornimetics 1.74 and 
1.75. The action of sodium hydroxide also altered the stereochemistry of 1.81, pOSitioning 
the ester group on to the opposite face of the pyrrolidine ring to the isoxazole, meaning that 
both 1.80 and 1.81 gave rise to the final product 1.75. 
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An isoxazoline ring, constructed by the 1,3-dipolar cycloaddition of nitrile oxide 1.82 
(Scheme 1.20), has also been used as a conformationally constrained version of Val-Pro. 63 
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Cycloaddition of 1.82 with methyl acrylate produced syn and anti diastereoisomers of 1.83, 
although these were separable by recrystallisation after coupling to the methyl ester of 
methionine. The methionine-coupled product was then incorporated into a series of tetra-
and hexapeptides to produce analogues of known immunomodulating peptides. Similarly, 
a stereoselective method for synthesising the isoxazoline 1.84 using an N-acryloyl 
derivative of Oppolzer' s camphor sultam has been reported. 64 
1.8 Previous Research· Imidazolines 
Previous research in the group carried out at Nottingham 65-69 has focussed on the 
construction of imidazolines 1.85 (Fig. 1.16) for insertion into peptide backbones. An 
imidazoline can be regarded as a cyclic version of an amidine 1.86, which bears a close 
structural relationship to an amide 1.87. 
0~ H 
1.85 
Fig. 1.16 
This was thought to be a suitable replacement for an amide bond as it features a similar 
arrangement of hetero-atoms and double bonds as well as similar hydrogen bonding 
capabilities. In addition to the conformational constraints introduced by the ring, the 
replacement of the amide bond with a more basic functional group should increase the 
resistance of the molecules to proteolytic hydrolysis. 
The initial strategy for preparing peptidomimetics with the imidazoline ring was to use a 
65 
convergent approach, the ring being assembled as the final stage of the synthesis. 
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Several peptidomimetics were formed m this way, including 1.88, an analogue of 
enkephalin (H-Tyr-Gly-Gly-Phe-Leu-OH) with the imidazoline ring replacing the amide 
bond between the two glycine residues (Scheme 1.21). 
j i 
/~J~ Phe-Leu-OMe 
z-Tyr(Bn) ~/ n 
H 0 
1.88 
i, MeOH, 65°C. 
Scheme 1.21 
Further work involved ring construction as the initial stage followed by coupling to other 
69 
amino acids in a divergent approach. Amino acid side chains were introduced by use of 
appropriately substituted diamines. Cycli~ation to form the imidazoline 1.89 was carried 
out by reaction of the S-methylthioimidate 1.90 with the diamine 1.91 (Scheme 1.22). 
Using standard peptide coupling reactions, the imidazoline 1.89 (a conformationally 
restricted replacement for Trp-Nle) was incorporated into a mimic of the CCK-4 analogue 
H -Trp-Nle-Asp-Phe-NH2. 
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Scheme 1.22 
Racemisation occurred at the chiral centre of the thioimidate during ring formation. 
However, separation of the Boc-protected imidazolines 1.92 allowed preparation and 
isolation of both diastereoisomers of the CCK analogue 1.93 as trifluoroacetate salts. 
1.9 Aims and Targets 
This project aims to extend this area of research by synthesising other 5-membered 
heterocyclic rings bearing amine and carboxylic acid functional groups. These molecules 
can then be incorporated into peptides in order to restrict their conformational freedom. 
The ring systems that will be studied are isoxazoles 1.94 (Fig. 1.17) and 
tetrahydropyrazoles 1.95. Isoxazoles are fully unsaturated, hetero-aromatic derivatives of 
the isoxazolines studied by Kim et al. that were discussed earlier. 
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Fig. 1.17 
Apart from the absence of any double bonds, tetrahydropyrazoles are structurally similar to 
isoxazoles, having two adjacent nitrogen atoms instead of a nitrogen atom and an oxygen 
atom. The presence of amine and carboxylic acid ring substituents gives target molecules 
with a general structure of 1.95 or 1.96 (Fig.I.I8). 
N-X N-X H2NyZ)yOH 
R 0 
H2Nti 
o OH 
1.97 1.96 
o R 
H2N0~Arr°H 
R 0 
1.98 
Fig. 1.18 
Target 1.96 has a substitution pattern in which the amine and acid functions are arranged in 
a similar manner to the natural dipeptide 1.98. In the second general target 1.97, the amine 
and carboxylic acid groups have one less atom between them than in the natural dipeptide 
1.98. For this reason, molecules of this type might be expected to have a more pronounced 
effect on peptide backbone conformation than those of type 1.96. Comparison of the 
intended targets with the generic dipeptide 1.98 also shows that the amide bond has been 
replaced. This should increase the stability towards proteolytic degradation. 
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1.10 Synthetic Strategy 
The strategy for forming the 5-membered heterocyclic rings will employ a 1,3-dipolar 
cycloaddition reaction. This comprises a three-atom component, the dipole, and a 
dipolarophile which contributes two atoms to the ring (Scheme 1.23). Such reactions have 
found widespread use in organic synthesis as they provide an easy and controlled route to 
70 5-membered heterocycles. 
Scheme 1.23 
• 
The dipole, as its name suggests, bears both a positive and a negative charge, although it is 
charge neutral overall. In reaction schemes the dipole is usually drawn so that the 
constituent atoms each have a full octet in their valence shell. This resonance structure 
does not highlight the 1,3-reactivity of the species as the charges are on adjacent atoms. 
This reactivity is best represented by the sextet resonance structure shown in Fig. 1.19 . 
.. 
•• /c b 
I 
+a 
Fig. 1.19 
For this resonance to occur, the central atom (b) in the dipole must carry a lone pair of 
electrons to stabilise the dipole. Carbon cannot fulfil this requirement and so the dipole 
must contain a hetero-atom such as nitrogen at this position. Many dipoles contain more 
than one atom which is not carbon. 
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A necessity of the dipolarophile is that it contains a mUltiple bond, as a pair of 1t-electrons 
is required to form a bond to the dipole. If the dipolarophile contains a triple bond (two 
pairs of 1t-electrons), then the cyclic product will contain a double bond between atom d 
and e (Scheme 1.23). 
The mechanism of cycloaddition is generally believed to be a concerted process, as 
d . 71 propose by HUlsgen. Other mechanisms, such as the formation of diradical 
72 intermediates have been postulated, but these do not readily account for the 
stereospecificity observed in such reactions. 
The regiochemistry of 1,3-dipolar cycloadditions is best explained by frontier molecular 
orbital (FMO) theory. It is the relative energy levels of these molecular orbitals (MOs) and 
the size of their coefficients that control the reactivity and regioselectivity of the dipolar 
cycloaddition. Three classifications of 1,3-dipolar cycloaddition have been identified, as 
shown in Fig. 1.20.73 
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Fig. 1.20 
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If the highest occupied molecular orbital (HOMO) of the dipole and the lowest unoccupied 
molecular orbital (LUMO) of the dipolarophile are the two MOs closest in energy, then 
this will be the dominant interaction and the cycloaddition is said to be HOMO controlled 
(Type I). Alternatively, if the two closest energy levels are the LUMO of the dipole and 
the HOMO of the dipolarophile, then the reaction is said to be LUMO controlled (Type 
III). A third class of cycloaddition occurs when the difference between the energy levels is 
the same or comparable and the reaction is under the control of both HOMO and LUMO 
(Type II). 
The regioselectivity is often determined by the size of the orbital coefficients at the termini 
of the two closest FMOs (i.e. the ones which are said to control the reaction). The dipole 
and dipolarophile react in such a way that the larger (terminal) coefficients of the two 
components align. This maximises the orbital overlap, which gives rise to the lower 
energy transition state (Fig. 1.21a). Sho!.lld the dipole and dipolarophile react the other 
way around, less overlap occurs and a higher energy transition state forms (Fig. 1.21b). If 
the terminal coefficients of the PMOs of a component are similar in magnitude, then one 
transition state is not significantly favoured over the other and little or no regioselectivity is 
observed. 
Dipole ~\ .~ Dipolarophiie 
Dipole 
Dipolarophile 
a b 
Fig. 1.21 
The magnitude of the coefficients is dependent on the constituent atoms at the reaction 
centre and the nature of their substituents (e.g. electron-withdrawing). Houk and co-
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workers have applied perturbation theory to calculate the co-efficients of the HOMOs and 
LUMOs of a variety of dipoles and dipolarophiles allowing predictions to be made on the 
regioselectivity of a particular cycloaddition.74• 75 
The goals of the project have now been outlined and the general structure of the target 
molecules identified. A strategy for the synthesis of these target molecules is also in place. 
Identification of the exact targets and discussion of the efforts made to synthesise them will 
be presented in the following chapters. 
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Chapter 2: 
Results and 
Discussion -
Isoxazoles 
2.1 Introduction 
The isoxazole ring system 2.1 was initially chosen for incorporation into a non-
proteinogenic amino acid. This heterocycle can be formed by the 1,3-dipolar cycloaddition 
of a nitrile oxide 2.2 and a dipolarophile 2.3 containing a triple bond, or its equivalent 
(Scheme 2.1). 
2.1 2.2 2.3 
Scheme 2.1 
Nitrile oxides are widely used in organic synthesis,76 as they are the most common way to 
prepare isoxazoles and isoxazolines. These compounds are of great synthetic importance 
as they can be converted, using a range of reductive sequences, into a variety of functional 
77 78 
groups, for example ~-hydroxy ketones 2.4, y-amino-alcohols 2.5 and c:x.,~-unsaturated 
ketones 2.6 (Scheme 2.2).79 By gaining access through a ring system, the functionality is 
masked but can be uncovered subsequently as required. 
0 OH 
R1~R2 2.4 N-O ~ R1~R2 
-------
NH2 OH 
R1~R2 2.5 
N-O 0 
R1~R2 .. R1~R2 2.6 
Scheme 2.2 
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Previous experience in our group with the synthesis of heterocyclic triones, such as the 3-
acyltetramic acid and 3-acyl-4-hydroxypyridone groups of natural products,80-82 led us to 
choose isoxazoles as the first target ring system. The ~,W-tricarbonyl moiety 2.7 (Fig. 2.1) 
found in the heterocyclic triones (drawn here in the enol form) is extremely polar and 
reactive, but can be masked by means of an isoxazole ring, as in 2.S. This permits other 
reactions to be carried out on the molecule without affecting the trione system. 
2.7 
n = 0,1; X = NR, 0 
Fig. 2.1 
2.S 
Nitrile oxides are usually generated in one of two ways. The first involves the loss of 
water from a primary nitro-compound (Scheme 2.3). 
-H20 
Scheme 2.3 
A number of dehydrating agents has been used, the classical example being the 
83 
Mukaiyama and Hoshino method, which employs phenyl isocyanate (Scheme 2.4). 
However this has the disadvantage of creating diphenylurea 2.9 as a by-product which can 
often prove difficult to remove. Other reagents that accomplish this dehydration include 
para-toluenesulfonic acid,84 ethyl chloroformate,8S and di-tert-butyl dicarbonate (BOC20 ) 
86 
with 4-dimethylaminopyridine (DMAP). 
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A second method for generating nitrile oxides employs the oxidation of an aldoxime using, 
for example, manganese dioxide.
87 
Alternatively, the oxime can be halogenated at the 
oxime carbon atom by reagents such as chlorine gas, sodium hypochlorite,88 Chloramine 
T89 or an N-halosuccinimide.
90 
Treatment with base results in dehydrohalogenation, 
forming the dipole (Scheme 2.5). 
[0] 
.. 
"x~ ~se / (~~) 
Scheme 2.5 
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Since nitrile oxides bear two charged atoms they are extremely reactive, and as such are 
not stable enough to be isolated. Even when stored in the absence of other reagents they 
will readily undergo an irreversible dimerisation, and for this reason they are usually 
generated in situ, for example by the addition of a base to a solution of a chlorinated 
aldoxime in the presence of a dipolarophile. 
2.2 Disconnection 
> 
2.10 
I 
+ ...... 0 
~N 
NHBoc 
2.11 
Scheme 2.6 
2.12 
The Boc-protected 3-aminoalkylisoxazole amino acid ester 2.10 was selected as the target 
molecule and a possible disconnection is shown in Scheme 2.6. It can be viewed as a 
conformationally constrained replacement for a dipeptide unit containing an alanine 
residue (Fig. 2.2). In addition to the absence of an amide bond (improving stability 
towards hydrolytic cleavage of the molecule), the isoxazole has one less atom between the 
N- and C-terrnini, a feature that will further restrict the flexibility of the backbone. 
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Fig. 2.2 
The selection of an acid-labile group at the N-terminus of 2.10, and a base-sensitive one at 
the C-terminus was made to allow the two ends of the amino acid to be deprotected 
orthogonally. The third major class of protecting group, those that are removed by 
hydrogenation, are of little value here as the conditions required for their removal will 
result in the isoxazole ring being destroyed by reductive N-O bond cleavage.91 
The presence of a substituent (here a methyl group) at the 5-position of the target isoxazole 
2.10 will be a key factor in directing the ester to the desired 4-position on the ring. 
Without this substituent, the required dipolarophile would be a mono-substituted alkynoate 
ester. Such monosubstituted alkynes are known, almost without exception, to result 
exclusively or predominantly in the alkyne substituent occupying the 5-position of the 
resultant isoxazole ring upon reaction with nitrile oxides.
92 
The amine functionality is located on the 2-position of an alkyl chain because, as will be 
seen, this is ultimately derived from a naturally-occurring a-amino acid. In this case the 
amino acid chosen was S-alanine, the simplest natural example that contains a chiral 
centre. 
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The fITst of the two components required for the cycloaddition is thus the dipole 2.11 
(shown in Scheme 2.6 as both a 1,3-charged species and as the more stable octet resonance 
structure), which would be generated by the loss of Hel from the hydroximoyl chloride 
2.13. This process will be effected by treatment with base as mentioned previously. An 
alternative way of viewing hydroximoyl chlorides is as C-chlorooximes, which are readily 
prepared from standard oximes, in this case 2.14. The oxime could be prepared from an 0.-
amino aldehyde 2.15. These are widely used as intermediates in a range of reactions
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and 
a great number of methods for their preparation is known. The aldehyde can be accessed 
by reduction of the ester 2.16, which is a di-protected amino acid (here, S-alanine 2.17). 
Q 
° Q +/ (( -~ rA > + Et02C/ C02Et H 
C02Et 
2.12 2.18 2.19 2.20 
Scheme 2.8 
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The other fragment of the target molecule 2.10, represented by the double-bonded synthon 
2.12, will be derived from the pyrrolidine enarnine 2.18 (Scheme 2.8). Reaction of 2.18 
with the dipole 2.11 will result in a 2-isoxazoline which will eliminate a pyrrolidine 
molecule across the bond between the 4 and 5 positions to give the desired product,94 This 
sequence will be discussed in more detail later. 
This enamine is a more useful synthetic equivalent than the simple alkyne due to the 
enhanced regioselectivity it offers. Reaction of the nitrile oxide 2.11 with ethyl but-2-
ynoate 2.21 (Scheme 2.9) should result in predominantly the required product 2.10, 
however some of the undesired regioisomer 2.22 would also be expected to be formed. 95 
* NH C02Et Boc 
2.10 
2.11 
2.22 
Scheme 2.9 
Attaching an electron-donating group (here, the enamine nitrogen atom) to the opposite 
end of the double bond to the electron-withdrawing group (the carboxylate ester), results in 
94, 96, 97 0 I dd" . h formation of the 4-carboxyisoxazole as the major product. n cyc oa Ihon, It as 
been found that the electron-donating substituent will prefer to be located at the 5-position 
of the product heterocycle, which enhances the lesser preference of an electron-
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withdrawing group for location at the 4-position of the ring. This can be attributed to the 
electron-donating group altering the coefficients of the FMOs of the dipolarophile. 
As previously mentioned, the cycloaddition of a nitrile oxide with 2.21 will give rise to 
two regioisomers (Scheme 2.9); the 4-carboxyisoxazole 2.10 formed as a result of the 
HOMO controlled reaction (see Chapter 1, Section 1.10), and the 5-carboxyisoxazole 2.22 
from the LUMO controlled cycloaddition (Fig. 2.3). (The relative magnitudes and signs of 
the FMOs of nitrile oxides and dipolarophiles bearing an electron-withdrawing group have 
previously been determined by Houk and colleagues).74 
+ 
R-C=N-O 
LUMO R~ 
HOMO R~-
2.21 
- H3C~C02Et HOMO 
Fig. 2.3 
Attaching an electron-donating group to the multiple bond of the dipolarophile will alter 
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the coefficients of both the HOMO and LUMO in the manner shown in Fig. 2.4. 
Although the difference in magnitude of the two coefficients of the LUMO has increased, 
they will still react with the HOMO of the dipole to give the same product as before, the 4-
carboxyisoxazole. However in the HOMO of the dipolarophile, the larger of the two 
coefficients is now at the same end of the multiple bond as the ester group (previously it 
was at the opposite end), and so the LUMO controlled cycloaddition will now also give the 
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4-carboxyisoxazole. Therefore, both the HOMO and LUMO controlled reactions yield the 
same product. 
+ 
R-C=N-O 
LUMO R~ 
HOMO R~-
Fig. 2.4 
Following cycloaddition, elimination across the 4,5-bond of an initially formed isoxazoline 
results in the isoxazole (Scheme 2.10). If the eliminated molecule is stable enough then 
this process can occur spontaneously, driven by the stability of the aromatic ring that is 
formed. 
j 
Scheme 2.10 
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The strategy of using a doubly-bonded "push-pull" dipolarophile, which then undergoes 
elimination, was fIrst reported by Stork and McMurry,94 who used pyrrolidine enarnines of 
~-keto esters to synthesise 4-carboxyisoxazoles. Since then, it has been adopted a number 
of times to obtain isoxazoles with electron-withdrawing substituents at the 4-position, such 
. '1 99 d . 100 h as mtn e an mtro groups (Sc emes 2.11 & 2.12). 
CI 
Q f'Ph 
CN 
Scheme 2.11 
Scheme 2.12 
Ph 
CI 
o 
Species other than enarnines have been used to direct electron-withdrawing groups, e.g. 
triphenylphosphonium salts96 (Scheme 2.l3); however, studies have shown that the best 
yields and regioselectivities are obtained by using enamines, such as those of pyrrolidine or 
. 101 
morpholme. 
+ 
+ -CH3PPh3 Br 
Scheme 2.13 
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The planned synthesis of the enamine 2.18 was via the dehydrative addition of an amine to 
a p-keto ester. The required p-keto ester in this case is ethyl acetoacetate 2.19, which is 
commercially available, and although this will react with any secondary amine, pyrrolidine 
2.20 was selected due to its well-publicised success in such applications. 
2.3 Synthesis of the Hydroximoyl Chloride 
0 0 0 YOH YOMe ii YOMe .. .. 
NH2 +NH3CI- NHBoc 
2.17 2.23 2.16 
N/OH /OH 
1 ui 
N 0 YCI v yH iv YH .. .. 
NHBoc NHBoc NHBoc 
2.13 2.14 2.15 
i, AcCI, MeOH, aoc, 72h; ii, Et3N, Boc20; iii, DIBAL, -78°C; 
iv, NH20H.HCI, NaOAc; v, tBuOCI 
Scheme 2.14 
S-Alanine 2.17 was converted into its methyl ester 2.23 (Scheme 2.14) in order to create a 
good leaving group for the subsequent reduction to the corresponding aldehyde. 
Esterification was accomplished using anhydrous methanol as both the solvent and the 
source of the methoxy nucleophile. Acetyl chloride was also present, which, upon reaction 
with methanol, generated hydrochloric acid as catalyst for the reaction. The acetyl 
chloride was added dropwise to methanol that had been cooled to aoc, before addition of 
the amino acid in one portion and stirring of the solution at a°c. Despite the presence of 4 
equivalents of acetyl chloride, the reaction proceeded sluggishly, taking 72-96h to reach 
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completion. Even so, this method was found to be more successful than dissolving the 
amino acid in methanol, cooling to O°C for the addition of acetyl chloride, then heating at 
reflux. In both cases the acetyl chloride had to be added very slowly, or fumes of HCI gas 
would begin to escape from the reaction flask. The desired ester was obtained in a 
virtually quantitative yield as the hydrochloride salt, with no purification required other 
than removal of the solvent. 
N-Protection of the amino ester was achieved by treatment with triethylamine and Boc20 
(Scheme 2.14). On dissolving the ester hydrochloride 2.23 in dichloromethane (DCM) (in 
which it was only sparingly soluble) and cooling to O°C, two equivalents of base were 
added dropwise, one to neutralise the hydrochloride and give the free amine, the second to 
remove a proton from the nitrogen atom at a later stage of the reaction. Boc20 (as a 
solution in DCM) was then added dropwise, and the solution stirred for 16h at room 
temperature, by which time the reaction had reached completion. Only a very slight excess 
of Boc20 was used, as removing unreacted material at the end of the reaction proved 
difficult. Repeated washing with a 1M solution of citric acid was required in order to 
eliminate all traces of BOC20. Despite the volatile nature of the reaction solvent, on its 
removal under reduced pressure the product 2.16 was usually obtained as an oil, which 
would only crystallise after standing for several days, presumably due to traces of trapped 
tert-butanoI. 
The N-protected ester 2.16 was reduced to the aldehyde 2.15 by means of 
diisobutylaluminium hydride (DIBAL) using a procedure developed by Rich and co-
workers. 102 DIBAL (1M solution in toluene) was added to a solution of the ester in dry 
toluene at -78°C. Care was needed to prevent the desired aldehyde from being further 
reduced to the corresponding alcohol; consequently the reaction was carefully monitored 
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by thin layer chromatography (TLC). As soon as all of the starting material had been 
consumed (approximately 45min after hj1dride addition had been completed), the excess 
hydride was quenched with methanol. A saturated solution of sodium potassium tartrate 
(Rochelle salt) was used in the reaction work up, the tartrate anion forming a complex with 
the aluminium ion to ensure that it remained in the aqueous layer. On adding the reaction 
mixture to the Rochelle salt solution, a thick emulsion formed which gradually dissipated 
on stirring vigorously for 2h. This was presumably due to the aluminium ion complexing 
to the tartrate whilst still dissolved in the organic phase, and subsequently partitioning to 
the aqueous phase. 
A IH NMR spectrum of the crude aldehyde showed that it was virtually pure, although 
there were small traces of impurities, the major of which was assumed to be the alcohol. 
However, it was decided that purification would not be practical, since a-amino aldehydes 
are unstable towards racemisation. This loss of chirality occurs via keto-enol tautomerism 
(Scheme 2.15), a process studied by Ito and co-workers who found that racemisation is 
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accelerated when the aldehyde is subjected to column chromatography. This was 
attributed to the acidic nature of silica gel and an acid-catalysed mechanism for the 
tautomerism was postulated. 
Scheme 2.15 
In order to minimise this problem the crude aldehyde 2.15 was immediately converted to 
the oxime 2.14 (Scheme 2.14). The aldehyde, dissolved in ethanol, was added to an excess 
of hydroxylamine hydrochloride and sodiJ!TI acetate in water. After heating at 60-70°C for 
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10min the reaction mixture was left to cool overnight, during which time the oxime 
crystallised from the solution. Purification of the oxime by recrystallisation from aqueous 
ethanol, a common solvent for such procedures, proved awkward due to the extreme 
solubility of the oxime in ethanol. In addition, the purified product retained significant 
amounts of moisture and, since anhydrous conditions were required for the subsequent 
cycloaddition, prolonged drying over phosphorus pentoxide in a vacuum dessicator was 
necessary. An attempt was also made to recrystallise the oxime from chloroform and 
hexane. This yielded a white crystalline solid as before but this time no drying was 
required. Combustion analysis showed a higher degree of purity than the earlier samples, 
however the melting point was found to be considerably lower than that of material 
crystallised from ethanol and water (125°C compared to 136°C). 
Thus the oxime 2.14 was obtained as a white solid which is thought to be more stable 
towards racemisation than its aldehyde precursor. This was attributed to the fact that it can 
be purified by recrystallisation, thus avoiding the need for contact with any acidic or basic 
substances, such as silica or alumina, which may cause racemisation (see Scheme 2.15). 
This oxime exists as a 2: 1 mixture of E and Z isomers (calculated from the ratio of the 
integrals of the IH NMR spectrum), though it was not possible to determine which of these 
was the major product. NMR studies showed that, even on heating to 70°C, there was no 
alteration in the E:Z ratio. Presumably, the lone pair of electrons on the nitrogen atom 
presents a significant energy barrier to rotation about the double bond (Scheme 2.16). 
However, the presence of E:Z isomers proved not to be a problem, as both isomers are able 
to undergo transformation to the nitrile oxide dipole. 
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Scheme 2.16 
HO ,Q 
'NC" yH 
NHBoc 
To chlorinate 2.14 at the carbon of the C=N double bond, a source of Cl+ was required. 
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Larsen and Torssell have reported N-chlorosuccinimde (NCS) for chlorination of oximes 
as a convenient alternative to chlorine gas, obtaining good yields by reaction at room 
temperature in the presence of a trace of pyridine. Since the addition of base may lead to 
dehydrochlorination of the chlorinated product and generate the dipole before it is needed, 
the reaction was attempted in the absence of pyridine. On heating at reflux with NCS in 
dry chloroform for 2h, it was found that whilst one of the two starting materials visible by 
TLC (presumed to be the two geometric isomers of the oxime) was readily converted, the 
other was significantly less reactive, some remaining even after heating for 16h. Other 
workers have found one isomer of an oxime significantly more reactive than the other 
towards N-halogenated succinimides. In trying to brorninate an oxime with N-
64 bromosuccinirnide, Kim and colleagues found one isomer to be completely unreactive. 
As an alternative, tert-butyl hypochlorite,97 synthesised from household bleach (effectively 
a solution of sodium hypochlorite), acetic acid and tert_butanol,105 was selected. On 
dissolving the oxime in chloroform and cooling to <5°C, the tert-butyl hypochlorite was 
added, turning the solution a deep blue. After 45min the colour had turned to green and 
TLC analysis showed that both E and Z oximes had reacted and no starting material 
remained. The resulting hydroximoyl chloride 2.13 was not isolated, but used directly in 
the cycloaddition reaction. 
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2.4 Synthesis of the Enaminoester Dipolarophile 
° Q Q ~ + .. ~ (-H2O) C02Et H 
C02Et 
2.19 2.20 2.18 
i, toluene, reflux 
Scheme 2.17 
The required dipolarophile, ethyl 3-pyrrolidinobut-2-enoate 2.18 (arbitrarily drawn as the 
E-isomer), was synthesised by dissolving ethyl acetoacetate 2.19 and pyrrolidine 2.20 in 
toluene and heating at reflux in a flask fitted with a Dean and Stark trap (Scheme 2.17). 
When no further water separated, the solvent was removed under reduced pressure to give 
the enamine 2.18 in quantitative yield. A slight excess of pyrrolidine was used to ensure 
that all of the ~-keto ester was consumed, thus avoiding the problem of having to remove it 
at the end of the reaction (b. p. 181°C). Care was needed when storing the product as, 
when left in air, it slowly hydrolyses back to the starting materials. However, the product 
could be kept for many months without noticeable decomposition, if stored in a freezer in a 
flask flushed with nitrogen. 
2.5 Cycloaddition to form Isoxazole 2.10 
Due to the anticipated high reactivity of the nitrile oxide 2.11, it was generated in situ. 
Having formed the hydroximoyl chloride 2.13 in chloroform solution, 2-3 equivalents of 
the dipolarophile 2.18 were added to the reaction mixture and the solution heated to reflux. 
Triethylamine was added slowly, causing the loss of HCI from 2.13 and forming the dipole 
2.11 (Scheme 2.18). Since the desired isoxazole 2.10 was the product isolated, the dipole 
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2.11 must then have attacked the enamine, presumably to form an intermediate 2-
isoxazoline 2.24 that underwent the anticipated spontaneous elimination of a pyrrolidine 
molecule. However, no direct evidence for the postulated intermediate 2-isoxazoline 2.24 
was obtained. 
/OH 
+/0 - 0 N YCI yN N .. + ~ NHBoc NHBoc C02Et 
2.13 2.11 2.18 
J 
2.10 2.24 
Scheme 2.18 
Since nitrile oxides are known to dimerise readily, steps were taken to minimise the 
possibility of this unwanted reaction occurring. By having an excess of the enamine 
present, the chances of the dipole reacting with it (rather than another molecule of dipole) 
were enhanced. The slow addition of base meant that only a small amount of the dipole 
was present in the flask at anyone time, again improving the statistical probability of 
reaction occurring with the enamine. By adding triethylamine over a period of 
approximately 4-5h, a yield of 65% (from the oxime) has been attained. A slower rate of 
addition was found not to improve the efficiency of the reaction, whilst adding the base in 
one portion caused a drop in the yield to around 30-35%. 
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Only one cycloaddition product was isolated from the reaction, demonstrating the high 
regioselectivity of the reaction with the enaminoester dipolarophile. This is believed to be 
the 4-carboxyisoxazole 2.10, based on reported precedent,94 and on previous research in 
the group involving the synthesis of pyrroloisoxazolone 2.25 (Fig. 2.5), the structure of 
h · h h be 80, 81 W IC as en confirmed by X-ray crystallography. 
2.25 
Fig. 2.5 
A successful synthesis of a ring-containing amino acid derivative had now been completed. 
However, in order to be of potential use in peptides, it was necessary to see whether it was 
possible to selectively couple the isoxazole to other amino acids to construct 
pseudopeptides. 
2.6 Coupling to other Amino Acids 
In order to couple two amino acids, protecting groups are needed so that unwanted side 
reactions do not occur. For example, in Scheme 2.19, coupling the two unprotected amino 
acids could result in four different dipeptides, as the amino group of 2.26 is just as likely to 
react with the carboxylic acid function of 2.27 as vice versa. Alternatively, either 2.26 or 
2.27 could react with another molecule of the same type to form homodimers. 
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2.26 2.27 
4 possible products: X=R I, Y =R 2 
X=R2, Y=R1 
X=R1, Y=R1 
X=R2, Y=R2 
Scheme 2.19 
By protecting the amine function of one amino acid and the carboxylic acid group of the 
other, a clean reaction is ensured with only one possible product (Scheme 2.20) . 
• 
PG=Protecting Group 
Scheme 2.20 
In addition to suitable protecting groups on the amino acids to be coupled, a so-called 
"coupling reagent" is required to transform the hydroxyl function into a better leaving 
group. The classic coupling reagent is dicyclohexylcarbodiimide (DCC) 2.28 which 
converts the acid into a type of activated ester 2.29 (Scheme 2.21). A disadvantage of 
Dec is that dicyclohexylurea (DCU) 2.30 is formed as a by-product, which can prove 
difficult to remove at the end of the reaction. 
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R\, Jl 
'( 'OH 
NHPG 
+ Q-N=C=N-Q 
2.28 
Scheme 2.21 
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2.29 
To circumvent this problem, a variant of Dee was chosen, 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (EDe or EDeI) (Fig. 2.6). This has a similar mode of 
action to Dee, however the by-product formed is water-soluble and so can simply be 
washed out on work-up. 
Fig. 2.6 
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2.7 Coupling at the N-Terminus 
2.10 2.31 
R 
i, TFA; ii, HCl; iii, EDCI, Et3N, BOCHN~OH 
o 
R = H, 2.32 
R = CH31 2.33 
Scheme 2.22 
N-O 
... R ,AA 
111 T Y " B~CHN~NH C02Et 
o 
R = H, 2.34 
R = CH31 2.35 
Before attachment of an amino acid to the nitrogen terminus of the isoxazole 2.10 was 
possible, the Boc protecting group had to be removed. This was accomplished using a 
solution oftrifluoroacetic acid (TFA) in DCM (1:10 v/v) (Scheme 2.22). After stirring for 
2h at room temperature, no starting material was visible on analysis by TLC. Having 
removed the solvent, the oily product was dissolved and stirred in a solution of 2M 
hydrochloric acid for 30min. This converted the trifluoroacetate salt into the more easily 
handled hydrochloride salt 2.31, an off-white solid. 
The first coupling reaction attempted was to an N-protected glycine derivative. N-Boc-
glycine 2.32 was prepared by reaction of glycine with BOC20 and a base. The reaction was 
carried out by dissolving glycine in a mixture of l,4-dioxane, water and 1M aqueous 
sodium hydroxide, cooling the solution to DoC then adding BOC20. After stirring for 
90min at DoC and 30min at room temperature, the reaction was worked up with citric acid. 
Extraction with ethyl acetate gave the crude product, which was purified by 
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recrystallisation from a mixture of hexane and ethyl acetate, resulting in a 47% yield of the 
protected amino acid 2.32. This reaction was performed once; thus yields have not been 
optimised. 
The N-protected glycine 2.32 and EDCI were dissolved in anhydrous diethyl ether along 
with the hydrochloride salt of the deprotected isoxazole 2.31, which remained as a 
suspension (Scheme 2.22). On cooling to O°C, triethylamine was added to the reaction 
mixture to generate the free amine and the mixture was stirred for 16h at room 
temperature. By the end of the reaction, a white suspension was still present, the isoxazole 
salt being replaced by triethylamine hydrochloride and the urea by-product from EDCI, 
both of which are insoluble in ether. Following addition of water to remove the amine 
hydrochloride and urea by-products, and purification by column chromatography, the 
dipeptide 2.34 was obtained as a colourless gum in a somewhat disappointing 39% yield; 
however several repetitions of the reaction gave similar results. A slightly different 
procedure was adopted involving reaction of the deprotected isoxazole 2.31 and 
triethylamine in DCM for IOmin. Addition of water and separation of the organic phase 
yielded the free amine. This was added (as a solution in anhydrous DCM) to a solution of 
N-Boc-glycine and EDCI in anhydrous DCM, which had previously been stirring for 
10min. This mixture was stirred for 16h and worked up as in the original procedure. The 
result was an improvement in the yield to a moderate 57%, still lower than might be 
expected for this type of reaction. 
In order to check whether the stereochemical integrity of the isoxazole had been retained 
during its synthesis, a coupling to alanine was attempted. Since the isoxazole and its 
glycine-coupled derivative contain only one chiral centre, any racemisation during the 
synthetic sequence will produce two enantiomers, which have identical chemical and 
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physical properties (apart from the sign of their optical rotation) and are indistinguishable 
by NMR spectroscopy. By introducing a second chiral centre, the possibility arises of 
different diastereoisomers with different chemical and physical properties. If 
enantiomerically pure alanine is used, then the presence of diastereoisomers would 
necessarily be due to a loss of chirality in the isoxazole amino acid unit. 
Coupling to form 2.35 was carried out in a similar manner to the synthesis of 2.34, by the 
slow addition of triethylamine to a mixture of the N-protected amino acid (in this case (S)-
N-Boc-alanine 2.33), EDCI and the ethyl ester hydrochloride of the isoxazole 2.31 in 
anhydrous DCM (Scheme 2.22). Like the protected glycine derivative, 2.33 was prepared 
by the addition of Boc20 to an ice-cooled solution of (S)-alanine in l,4-dioxane, water and 
1M aqueous sodium hydroxide. After stirring at O°C for 90min and room temperature for 
30min, the mixture was treated with a solution of potassium hydrogen sulfate. This 
resulted in a yield of 2.33 of 37%, lower than that obtained in synthesis of the glycine 
derivative, which employed a citric acid work up. However, as with the synthesis of N-
Boc-glycine, the reaction was performed once and is unoptimised. 
Reaction of (S)-N-Boc-alanine 2.33, EDCI and the deprotected isoxazole 2.31, followed by 
treatment with water and purification by column chromatography, realised the product 2.35 
as a white solid in 74% yield. Only one product arising from a coupling reaction was 
obtained from the column chromatography, and analysis by IH and I3C NMR spectroscopy 
showed it to be made up of only one compound (Figs. 2.7 and 2.8). 
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As diastereoisomers can have very similar NMR spectra, the dipeptide was also analysed 
by reverse-phase high performance liquid chromatography (HPLC) (Fig. 2.9). In addition 
it was analysed on a Hypercarb column designed for the separation of diastereoisomers. In 
both cases, there was no sign of more than one product being present, indicating that 
synthesis of the isoxazole amino acid derivative 2.31 had been completed with no loss of 
optical activity at any stage. 
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2.8 Coupling at the C-Terminus 
To attach amino acids to the carboxyl terminus of the isoxazole 2.10, it was first necessary 
to hydrolyse the ethyl ester to give the carboxylic acid 2.36 (Scheme 2.23). Having 
experienced problems with incomplete conversion and low yields when using lithium 
hydroxide, the conditions used to effect hydrolysis were to dissolve both the ester 2.10 and 
potassium hydroxide in ethanol and heat the solution to reflux for 16h. This was followed 
by addition of citric acid and extraction with DCM, to give the carboxylic acid 2.36 in 97% 
yield. 
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2.10 2.36 
R 
N~CORI H 2 
R = H, R' = Et, 2.39 
R = CH3, R' = CH3, 2.40 
i, KOH or LiOH; ii, citric acid; iii, EDCI, Et3N, 
R 
H3~~C02R' 
CI-
R = H, R' = Et, 2.37 
R = CH3, H = CH3, 2.38 
Scheme 2.23 
Coupling to a C-protected alanine derivative (to probe the stereochemical purity as 
previously described) was carried out by the slow addition of triethylamine to an ice-
cooled solution of carboxylic acid 2.36, EDCI and (S)-alanine methyl ester hydrochloride 
2.38 in anhydrous DCM. Following addition of water and extraction with ethyl acetate, 
purification by column chromatography yielded what appeared to be a single product on 
analysis by TLC. However the IH NMR spectrum (Fig. 2.10), whilst corresponding to the 
desired product 2.40, appeared to show that the product was a mixture of diastereoisomers. 
In addition to the signals at ()H 4.7, 5.2 and 5.4ppm, which are due to the CH protons 
attached to the 2 chiral centres and the NH next to the Boc group, respectively, there are 
similar shaped signals at 4.9, 5.1 and 5.8ppm suggesting a compound of similar structure. 
These signals are unlikely to be caused by one of the unreacted starting materials being 
present, as the signals for the 5-methyl group of the isoxazole ring and the methyl ester 
have the same integral value, showing them to be present in a 1: 1 ratio. Measurement of 
the integrals in the NMR spectrum shows that the two diastereoisomers are present in a 
ratio of approximately 5: 1. Other impurities are also present, which were not removable 
by column chromatography. 
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The presence of a mixture of diastereoisomers was attributed to the conditions employed 
for the ester hydrolysis being too severe and racemisation of the isoxazole amino acid 
occurring. Lithium hydroxide in a waterrrHF/ethanol solution (1: 1: 1 v/v/v) was used as a 
milder alternative, the reaction mixture being stirred at room temperature rather than 
heated at reflux. The reaction proceeded extremely slowly, and after stirring for 16h 
approximately one sixth of the starting material remained (as measured by the ratio of 
integrals of the two 5-CH3 signals in the IH NMR spectrum). As a prolonged reaction time 
did not achieve complete conversion, the coupling reaction with (S)-alanine methyl ester 
hydrochloride 2.38 (Scheme 2.23) was carried out using the crude carboxylic acid 2.36. 
This was accomplished by generating the free amine of alanine methyl ester from the 
hydrochloride salt using triethylamine, then adding this (as a solution in anhydrous DCM) 
to an ice-cooled solution prepared by stirring carboxylic acid 2.36 and EDCI in anhydrous 
DCM for tOmin. Only one product, with IH and J3C NMR spectra corresponding to the 
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desired dipeptide 2.40, was isolated from column chromatography, in a yield of 24%. 
Analysis of the IH and \3C spectra (Figs. 2.11 & 2.12) showed that only one 
diastereoisomer of 2.40 had been formed, as there are no additional signals in the IH NMR 
spectrum (ef. Fig. 2.10) and the \3C NMR spectrum does not indicate the presence of 
another product. The purity of 2.40 was confIrmed when only one peak was observed on 
analysis by reverse phase HPLC and on passage through a column of Hypercarb. 
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Coupling to glycine ethyl ester hydrochloride 2.37, to give the dipeptide 2.39 (Scheme 
2.23), was also attempted. This was initially carried out by the slow addition of 
triethylamine to an ice-cooled mixture of the carboxylic acid 2.36, EDCI and glycine ethyl 
ester hydrochloride 2.37 in anhydrous ether. The method of generating glycine ethyl ester 
as the free base by treatment of the hydrochloride salt 2.37 with triethylamine, then adding 
it to a solution prepared by stirring 2.36 and EDCI for lOmin in anhydrous DCM was also 
tried. Both methods resulted in yields of the final product 2.39 of approximately 40%. 
The moderate yields for these reactions suggest that both the amine and acid functions of 
the isoxazole suffer from a degree of steric hindrance making attack at these centres 
slightly more difficult than in ordinary amino acids. Since one reason for synthesising 
these molecules is to inhibit the conformational freedom of the acid and amine groups, this 
is perhaps not unexpected. In addition, the carboxy group of the isoxazole-4-carboxylates 
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is deactivated by conjugation to the oxygen atom of the ring; esters for example, may 
alternatively be regarded as vinylogous carbonates (Fig. 2.13) . 
.. 
Fig. 2.13 
2.9 Further Couplings 
In order to demonstrate that there are no limitations on couplings to the isoxazole, the 
tripeptide 2.41 was prepared by two different routes (Scheme 2.24), namely N-coupling 
followed by C-coupling (Route A) and C-coupling followed by N-coupling (Route B). 
To couple the dipeptide 2.34 to glycine ethyl ester hydrochloride 2.37 (Route A), the ester 
substituent on the isoxazole was first hydrolysed in a manner similar to that described 
previously, using lithium hydroxide in a waterrrHF/ethanol solution (1: 1: 1 v/v/v). 
Although one seventh of the starting material 2.34 remained, the crude carboxylic acid was 
reacted with EDCI in an ice-cooled solution of anhydrous DCM. To this solution was 
added glycine ethyl ester (as a solution in anhydrous DCM) formed by reaction of glycine 
ethyl ester hydrochloride 2.37 with triethylamine. The yield for the coupling reaction to 
produce 2.41 was rather low (28%), and again this was attributed to both the hindered 
environment of the carboxylic acid group and its deactivation. 
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NH C02Et Boc 
2.10 
~ BOCHN~NH C02Et 
o 
2.34 
~NH 
BocHN II ° 
o 
2.41 
i, LiOH, citric acid; ii, 2.37, EDCI, Et3N; iii, AcCl, EtOH; iv, 2.32, EDCI, Et3N. 
Scheme 2.24 
For Route B, removal of the Boc group from the amino group of 2.39 was required. 
Deprotection with TF A did not occur as smoothly as before, with significant loss of 
starting material through degradation. Therefore, a solution of acetyl chloride in ethanol 
was used to generate the necessary acidic conditions. Analysis by TLC showed that all of 
the starting material had reacted after 6h, and the hydrochloride salt of the amine was 
obtained in quantitative yield. The hydrochloride salt was converted to the free amine 
using triethylamine, and then added (as a solution in anhydrous DCM) to a solution of N-
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Boc-glycine 2.32 and EDCI which had been cooled to O°c. The product 2.41 was obtained 
in 10% yield, the low value being partly attributed to the small scale of the reaction and 
therefore mechanical loss of material during work up and purification. Analysis by TLC 
and 1 Hand l3C NMR spectroscopy showed the product to be identical to that obtained 
from reaction of 2.34 and glycine ethyl ester 2.37, described earlier (Route A). 
No X-ray crystal structure analysis of the tripeptide 2.41 was possible since attempts to 
recrystallise the product proved unsuccessful. In order to gain some idea of the possible 
conformations of the product, molecular modelling studies were undertaken using the 
modelling program Spartan 4.1, run on a Silicon Graphics Indy workstation. Fig. 2.14 
shows the minimum energy geometry obtained from a calculation using the AM 1 semi-
empirical method when the three amide bonds are locked in the trans conformation. (The 
alkoxy groups at either end have been replaced with methyl groups in order to simplify the 
calculation). Whilst not necessarily the lowest energy conformation that is possible, it was 
the lowest that could be found in these studies. It has a calculated standard enthalpy of 
formation of -517kJmor1, between 3 and 37kJmor i more stable than conformations 
located from calculations performed on the molecule when the starting geometry was 
altered (e.g. cis amide bonds). 
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The model indicates that the presence of the isoxazole ring has restricted confonnational 
flexibility in the peptide, the two ends of the molecule being forced much closer together 
than might reasonably be expected in a chain of four acyclic amino acids. The distance 
between the a-carbon atoms of the two glycine residues, wruch can be considered as the 
ftrst and fourth residues of the sequence (as the aminoalkylisoxazole unit is a dipeptide 
mimic), is S.4A. Since a ~-tum has been defmed as a tetrapeptide sequence in which the 
aC(WaC(4) distance is ~7 A,25 the tripeptide 2.41 does possesses some of the characteristics 
of a ~-turn. However, any hydrogen bonding between the fmt and fourth residues would 
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seem to be impossible in this conformation as the hydrogen atoms of the amido groups 
point away from the oxygen atoms of the carbonyl groups. For intramolecular hydrogen 
bonding to occur they would need to point inwards. Another feature of the molecule that is 
apparent from the model is the planar nature of the isoxazole ring, arising from its 
aromaticity. 
2.10 An Alternative Target 
2.42 
> 
Q 
~ 
NH C02Et Boc 
2.43 
Scheme 2.25 
+ 
2.44 
Attempts were also made to synthesise the 5-aminoalkylisoxazole 2.42, which carries the 
same substituents as 2.10 but with the groups at the 3- and 5-positions reversed. This 
effectively exchanges the nitrogen and oxygen atoms in the ring, which, it was speculated, 
may alter the charge density distribution around the ring. A retrosynthetic analysis using 
the cycloaddition of a nitrile oxide is shown in Scheme 2.25. 
The dipole for the proposed cycloaddition 2.44 was to be generated by the dehydration of 
nitroethane. A test reaction to form 2.45 (Scheme 2.26), which was carried out by slow 
addition of nitroethane (to minimise nitrile oxide dimerisation) to a solution of methyl 
acrylate, Boc20 and DMAP in hexane and acetonitrile (4: 1 v/v), resulted in an 86% yield 
of the desired product 2.45. This showed that the combination of DMAP and Boc20 as 
used by Basel and Hassner 86 was an effective dehydrating agent. 
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H3C02C~ + N1 CH 
'/ '-.../ 3 o + 
i, Boc20, DMAP 
Scheme 2.26 
.. 
O-N 
H3C02C~CH3 
2.45 
Previous work
lO6 
has found that enamines such as 2.43 cannot be synthesised by reaction 
of pyrrolidine with the corresponding ~-keto ester if the carbon atom adjacent to the ketone 
carbonyl group is a branch point, so a modified approach was required. The envisaged 
route to the dipolarophile was as depicted in Scheme 2.27. The pyrrolidine enamine 2.43 
would be prepared from the alkyne 2.46, a step taken to enhance the regioselectivity as 
mentioned earlier. The alkyne would be derived ultimately from the a-amino aldehyde 
2.15 used previously, and would be prepared via the dibrominated alkene 2.47 using the 
. 107 Corey-Fuchs reactIon. 
Q ~C02EI y=<Br ~ ~ > > Br NHBoc NHBoc 
NH C02Et Boc 
2.43 2.46 2.47 
~ 
0 
YH 
NHBoc 
2.15 
Scheme 2.27 
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2.11 Attempts to Synthesise the Dipolarophile 
° yC02Et YH ~Br ~ 11 .. Br .. 
NHBoc NHBoc NHBoc 
2.15 2.47 2.46 
1 iii 
O'-N Q ~ IV ~ .. NH C02Et Boc NH C02Et Boc 
2.42 2.43 
i, CBr4' PPh3, Zn; ii, BuLi, CIC02Et; iii, pyrrolidine; iv, EtN02, Boc20, DMAP. 
Scheme 2.28 
By adding the aldehyde 2.15 to an ice-cooled mixture of carbon tetrabromide, zinc and 
triphenylphosphine and stirring at room temperature for 24h, J08 the alkene 2.47 was 
produced in a 50% yield (Scheme 2.28). However, subsequent dehydrobromination and 
bromine-lithium exchange using butyl lithium, followed by acylation with ethyl 
chloroformate to form the alkyne 2.46, proved a somewhat capricious reaction despite 
reports in the literature of it being successfully carried out in excellent yields.
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On some 
occasions, yields of 58% were obtained, although 30-35% was more usual and quite often 
none of the alkyne at all was recovered. Attempts to add pyrrolidine across the triple bond 
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by heating the amine and alkyne 2.46 in ethanol also proved difficult with complete 
conversion to the enamine 2.43 proving elusive. Since no purification was possible, due to 
the susceptibility of the enamine to hydrolysis, the cyc1oaddition was attempted on the 
mixture of enamine and alkyne. This was carried out in a similar manner to the test 
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reaction, by addition of nitroethane to a solution of en amine 2.43, BOC20 and DMAP in 
hexane and acetonitrile (4: 1 v/v). Approximately 17% of the isoxazole 2.42 was isolated 
from the reaction mixture, however it contained significant impurities which could not be 
removed by column chromatography. 
Due to the problems encountered in forming the enamine 2.43, a cycloaddition between 
nitroethane and the alkyne 2.46 was attempted (Scheme 2.28), again by slow addition of 
nitroethane to a mixture of the alkyne, BOC20 and DMAP in a hexane/acetonitrile (4:1 v/v) 
solution. However, no cycloadduct was isolated. 
0 0 0 YOH .. yoA,m 
NHBoc NHBoc 
2.48 
+ 
0 
0 0 ii HO~OEt .. £? 
EtO 0" M9"'Br 
2.49 
2.50 
N~ ~ ~N-~ =Im 
i, (ImhC=O; ii iprMgBr; iii, NaH, TBDMSCI 
Scheme 2.29 
0 
.YI 
NH C02Et Boc 
2.51 
111 
~DMS 
NH C02Et Boc 
2.52 
As a more accessible alternative to the enamine 2.43, the tert-butyldimethylsilyl (TBDMS) 
enol ether 2.52 (arbitrarily drawn as the E-isomer) was prepared as shown in Scheme 2.29. 
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The ~-keto ester 2.51 was synthesised according to a procedure reported by Pollet and 
. III 112 
Gehn and used by a previous worker in the group. Ethyl hydrogen malonate 2.49 and 
iso-propylmagnesium bromide (formed by treatment of 2-bromopropane with magnesium 
in anhydrous THF) were stirred at room temperature for 90min, then at 40°C for 30min in 
anhydrous THF to give magnesium enolate 2.50. On cooling to O°C, a solution of the 
activated ester 2.48 in anhydrous THF, prepared by reaction between N-Boc-alanine and 
1,1 '-carbonyldiimidazole at room temperature in anhydrous THF, was added and the 
mixture stirred for 16h at room temperature. The resultant ~-keto ester 2.51 was converted 
to the silyl enol ether 2.52 with sodium hydride and TBDMS chloride. 113 However, the 
attempted cycloaddition, performed by the addition of nitroethane to a solution of silyl enol 
ether 2.52, BOC20 and DMAP in a hexane/acetonitrile (4: 1 v/v) failed, with 48% of the ~-
keto ester 2.51 being recovered. 
At this point, efforts to synthesise the 5-aminoalkylisoxazole 2.42 were abandoned. It was 
decided that the final product would be unlikely to have a significantly different overall 
shape or electron distribution to the 3-aminoalkyl isoxazole 2.10 already made, and to 
spend more time attempting to overcome the synthetic difficulties would not be 
worthwhile. 
2.12 Conclusions 
A protected amino acid containing a heterocyclic ring 2.10 has been successfully 
synthesised, no loss of optical activity in the substituent at the 3-position of the ring being 
observed. It has been shown that it is possible to selectively couple other amino acids at 
either the C- or N-terminus of the molecule, although the yields of these couplings are 
often low. This is presumably due to steric hindrance and, in coupling to the C-terminus, 
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deactivation of the acid group through conjugation with the ring. On attachment of an 
amino acid to either end of the heterocyclic molecule, a peptide chain was formed with the 
isoxazole ring incorporated into the peptide backbone. Molecular modelling suggested that 
the presence of the isoxazole ring significantly restricted the conformational flexibility of 
the backbone. 
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Chapter 3: 
Results and 
Discussion -
Tetrahydropyrazoles 
3.1 Introduction 
Based upon the work with isoxazoles, efforts were next concentrated towards the synthesis 
of an alternative heterocyclic ring system bearing amine and acid functions. Replacing the 
oxygen atom of the isoxazole ring with a nitrogen atom produces pyrazoles 3.1 (Fig. 3.1), 
the saturated derivatives of which are pyrazolidines (tetrahydropyrazoles) 3.2. It is with 
these saturated versions, which have the potential to bear three chiral centres, at the 3-, 4-
and 5- positions, that this work is concerned. 
R', /R N-N 3V5 
4 
3.1 3.2 
Fig. 3.1 
Like isoxazoles, pyrazolidines can be formed by a 1,3-dipolar cycloaddition. The required 
dipole for such a reaction is an azomethine imine 3.3, which adds to a multiply bonded 
molecule 3.4 (Scheme 3.1). Highly functionalised molecules can be constructed in this 
way, although many of the reported examples of azomethine imine cycloadditions have 
been intramolecular in order to gain some control over the stereo- and regiochemistry of 
114-116 
the product. 
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Scheme 3.1 
The approach that we adopted was the addition of a hydrazine 3.5 to an aldehyde 3.6, as 
II? 
developed by Oppolzer (Scheme 3.1). Reaction of the aldehyde 3.6 with the hydrazine 
3.5 in toluene heated to reflux in a flask fitted with a Dean-Stark trap, results in formation 
of an intermediate aminol 3.7, that loses the elements of water in a 1,3-eIimination to give 
the dipole 3.3 (Scheme 3.2). 
WTransfer 
+ II 
3.7 3.3 
Scheme 3.2 
Although virtually any aldehyde can be used in the reaction, certain restrictions are placed 
on the nature of the nitrogen substituents of the hydrazine. For example, R2 is usually an 
alkyl or aryl group; it cannot be a hydrogen atom otherwise elimination across the C-N 
bond to form a hydrazone will occur. R3, however, should be an electron-withdrawing 
group in order to stabilise the negative charge on the adjacent nitrogen atom. 
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3.2 Initial Work 
Before attempting to synthesise amino acids containing a tetrahydropyrazole ring, a test 
reaction was attempted to ensure the viability of the cyc1oaddition. Our initial target was 
3.8 (Scheme 3.3), to be formed by cyc1oaddition of the azomethine imine 3.9 with methyl 
acrylate. This dipolarophile was chosen because it contains the ester group required for the 
cyc1oadditions that will be tried later to form amino acid analogues. 
o 
He " 3 'N-N~CH 
H H 3 
3.10 
+ 
o 
'(lH 
Scheme 3.3 
The dipole was to be formed from reaction between 2-methylpropanal and NI-acetyl-N2-
methylhydrazine 3.10. This hydrazine has the simplest alkyl group possible (methyl) at 
one nitrogen atom, and acetyl, a simple electron-withdrawing group, at the other. The 
aldehyde 2-methylpropanal was chosen as it possesses a similar branched geometry at the 
a-carbon to the amino aldehyde 2.15 used in the isoxazole work. If this cyc1oaddition 
were found to be successful, then 2-methylpropanal could be replaced by aminoaldehyde 
2.15, and a pyrazolidine with both acid and amine functions could be synthesised. 
Though both the dipolarophile and aldehyde are commercially available, the accessibility 
of unsymmetrical 1,2-disubstituted hydrazines is more problematic. Simple targets, such 
as 3.10 can be prepared by reaction of methylhydrazine with an ester,118 giving 
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predominantly the 1,2-disubstituted product. Unfortunately the reaction suffers from a 
number of problems and limitations. The fIrst of these is that in addition to the 1,2-
disubstituted hydrazine 3.11, a significant amount of the 1, I-disubstituted product 3.12 is 
also formed (Scheme 3.4). 
He 0 0 
3 ..... N-NH )l )l H3C, N-NH 
H 2 + ----.. H3C ..... N_ N R + R LG R-{ 2 H H 
3.11 
Scheme 3.4 
o 
3.12 
If the source of the electron-withdrawing group is more reactive than an ester, then the 1,1-
disubstituted hydrazine is the exclusive product. This restricts the choice of groups that can 
be attached to the unsubstituted nitrogen centre using this reaction. This tendency for 
reaction to take place more readily at the substituted nitrogen atom is perhaps not 
surprising as the nitrogen centre to which the methyl group is attached is the more 
nucleophilic. 
Another problem is that the reaction is extremely slow, taking several days to go to 
completion. Despite these drawbacks, acetylation of methylhydrazine with ethyl acetate 
was chosen as the method to prepare 3.10 since it was the most convenient preparation 
available. The low yields returned were not considered to be especially significant due to 
the low cost of the starting materials. 
HC 
3 ..... N-NH2 H -EtOH 
i, ethanol, reflux, 72h 
Scheme 3.5 
.. 
o 
H3C ..... N_ N)lCH H H 3 
3.10 
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The reaction was performed in ethanol, heated to reflux for 72h under an atmosphere of 
nitrogen (Scheme 3.5). No effort was made to purify the ethyl acetate, as the most likely 
contaminants, namely ethanol, water and acetic acid, have all been found to catalyse the 
. 119 ft 
reactIon. A er heating, the solvent was removed under reduced pressure and the 
resultant viscous liquid purified by distillation to give a colourless oil which solidified 
when stored in a freezer. Analysis by NMR spectroscopy and comparison of the chemical 
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shifts obtained with published values showed the product to be predominantly the 
desired I,2-disubstituted hydrazine with traces of the I, I-product also present. On 
allowing the product to warm to room temperature, part of it melted and some remained as 
a solid. Removal of the liquid component of the mixture by filtration gave a white solid 
which proved to be pure N1-acetyl-N2 -methylhydrazine 3.10, formed in 49% yield. Care 
had to be taken at all stages of the purification to keep the product under an inert 
atmosphere, as contact with air for even a few minutes resulted in decomposition, 
noticeable by the product gradually turning yellow. 
o 
Hell 
3 'N-N~CH 
H H 3 
3.10 
+ 
ytH 3.9 
i, toluene, reflux, 2h; ii, ~C02CH3 
Scheme 3.6 
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With the hydrazine to hand, an attempt was made at the cycloaddition (Scheme 3.6). The 
aldehyde, 2-methylpropanal and NI-aceryl-N2 -methylhydrazine 3.10 were dissolved in 
toluene and heated together to reflux in a flask fitted with a Dean and Stark trap to remove 
the water released by dipole formation. After two hours, methyl acrylate was added and 
the solution heated at reflux for a further 16h. Initially, the dipolarophile was not added 
earlier in order to reduce the possibility of it reacting with the hydrazine in a competing 
Michael addition (Scheme 3.7). However, this proved to be an unnecessary precaution as a 
subsequent experiment where all 3 reagents were added at once produced virtually the 
same yields and ratios of products. 
o 
Hell + 
3 'N-N~CH H H 3 
3.10 
3.15 
Scheme 3.7 
On removal of the solvent, and purification by column chromatography, two products were 
obtained, whose IH and DC NMR spectra were both consistent with the desired 
cycloadducts. The first of these was a single compound, obtained in 25% yield, which, 
when studied using 2-dimensional NMR spectroscopy, was assigned as the 4-
methoxycarbonylpyrazolidine 3.13. This conclusion was based on the couplings between 
the protons attached to the ring. A I H_I3C correlation spectrum was used to ascertain that 
the protons with chemical shifts of 3.6 and 4.1 ppm were attached to the same carbon atom 
and hence were those of the methylene group (Fig. 3.2). 
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The protons at approximately 3.0 and 3.7ppm (the latter signal is in the same region as that 
of the ester methyl group and so determination of its exact chemical shift is difficult) were 
both bonded to carbon atoms that a DEPT spectrum showed to be tertiary. These protons 
are therefore those attached to the heterocyclic ring carbon atoms that carry the isopropyl 
and ester substituents. The IH_IH correlation (COSY) spectrum (Fig. 3.3) shows that these 
two protons couple to each other (although it was not possible to determine the coupling 
constant), something that would only be possible if they were on adjacent carbon atoms. 
This means that the isopropyl and ester substituents are also on adjacent carbon atoms, and 
the methyl ester can therefore be assigned to the 4-position of the ring, meaning that the 
structure of the cycloaddition product is 3.13. No coupling of the CH of the isopropyl 
group to the adjacent ring CH was observed in the COSY NMR spectrum. This is 
presumably due to the dihedral angle between the two protons being close to 90°, which, 
according to the Karplus relationship should result in no visible coupling. 
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The other cycloadduct was a mixture of two compounds in a 5:4 ratio - calculated from the 
integrals of the IH NMR spectrum - that together accounted for a further 25% yield. These 
were separated by normal-phase preparative HPLC, although significant amounts of the 
product were lost during purification. The major component, when analysed by NMR 
spectroscopy was also attributed as a 4-methoxycarbonyl product 3.13. A IH_13C 
correlation spectrum showed that the protons at 3.68 and 4.37ppm were those of the 
methylene group (Fig. 3.4). 
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Again the signals at 2.94 and 3.05ppm, the other two protons attached to the ring and 
found to be methine CHs, showed coupling to each other on analysis of the COSY NMR 
spectrum (Fig. 3.5). (The magnitude of the coupling constant could not be assigned, 
although the proton attached to the same carbon of the ring as the isopropyl group appears 
as a doublet of doublets with J values of 3.9 and 8.8Hz). 
The 4-substituted product is therefore present as 2 different stereoisomers, one having the 
alkyl group and methyl ester in a syn arrangement, the other as the anti. It was not possible 
to unambiguously determine the relative stereochemistries, however based on results found 
in later reactions with benzaldehyde (Section 3.6), the product which did not require 
purification beyond simple column chromatography will be tentatively assigned as the syn 
isomer 3.16 (Fig. 3.6) and the other, which was further purified by HPLC, as the anti 3.17. 
Fig. 3.6 
o 
He )l J2 CH. 
C02CH3 
3.17 
The minor isomer isolated from the preparative HPLC column was obtained in insufficient 
quantities to properly analyse by NMR spectroscopy, however IH and I3C NMR spectra 
were recorded along with a mass spectrum. This showed that the product had the same 
relative molecular mass as 3.16 and 3.17 and that the product was a mixture of 
diastereoisorners and/or rotational isomers which would arise from restricted rotation about 
the amide bond of the N-acetyl group. It was therefore tentatively assumed to be the 5-
methoxycarbonylpyrazolidine 3.14. 
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The observed preference for formation of the 4-carboxy pyrazolidines over the 5-
substituted product is a contrast to that reported by Oppolzer who, on reaction of ethyl 
acrylate with the 1,2-disubstituted hydrazine 3.18 and formaldehyde (Scheme 3.8), isolated 
65% of the 5-ethoxycarbonyl pyrazolidine 3.19 and 7.6% of the 4-substituted product 
3.20.
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o 
H3C, ~Ph N-N 
H H 
3.18 
+ .. 
o 
H3C, ~Ph Y 
C02Et 
3.20 
i, toluene, reflux; ii, ~C02Et , 2-4h. 
Scheme 3.8 
However, other reports of cycloadditions involving azomethine imines, where one nitrogen 
atom bears an alkyl group and the other an electron-withdrawing group, have found that 
they react with acrylate esters to give predominantly the 4-substituted product. Huisgen 
and co-workers found that reaction of the azomethine imine 3.21 with ethyl acrylate gave 
120 
the 4-carboxy product 3.22 in 85% yield (Scheme 3.9). 
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3.21 
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Scheme 3.9 
3.22 
More recently, Husson and colleagues used the cyclic hydrazine 3.23, which on 
undergoing a cYcloaddition with benzaldehyde and methyl acrylate resulted in a 74% yield 
of the 4-methoxycarbonylpyrazolidine 3.24 (Scheme 3.10).121 
+ Ph~>=O 
N-N 
+ Ph~ 
C02CH3 
3.24 
i, H20, heat, 48h. 
Scheme 3.10 
Also isolated from the reaction mixture was a product whose NMR and mass spectra 
correspond to the Michael addition product 3.15 mentioned earlier. This material 
accounted for a further 46% of the hydrazine used in the reaction. Interestingly, this value 
dropped to 9% when all three reagents were added at once, each of the two fractions 
containing cycloadducts stilI being obtained in yields of around 20%. 
89 
To summarise, the test reaction resulted in formation of both syn and anti diastereoisomers 
of the 4-methoxycarbonylpyrazolidine 3.13. One, believed to be the syn product 3.16, was 
obtained in 25% yield whilst the other, presumed to be the anti isomer 3.17, required 
purification by HPLC and was isolated in an 11 % yield. The 5-
methoxycarbonylpyrazolidine 3.14 was also isolated from the reaction mixture (1%), 
possibly as a mixture of syn and anti diastereoisomers. Most of the hydrazine that did not 
react to form a pyrazolidine was found to have undergone a Michael addition reaction with 
methyl acrylate to form 3.t5 (Scheme 3.7). 
3.3 Mechanism of Dipole Formation 
3.25 
+ 
o YCH 
.. 
i, toluene, 110°C, molecular sieve 
3.26 
Scheme 3.11 
o 
Ph~+ -A 
· 'l-N CH3 
3.27 
3.28 
In order to gain some understanding of the mechanism of the cycloaddition, or more 
specifically the dipole formation, the progress of the reaction was monitored by IH NMR 
spectroscopy. 2-Methylpropanal and NI-acetyl-N2-benzylhydrazine 3.25 (for synthesis see 
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section 3.10) were both dissolved in fully deuterated toluene and mixed in an NMR tube 
along with 4A molecular sieves (Scheme 3.11). A spectrum recorded approximately 5 
minutes after the two components were added to each other showed that in addition to the 
two starting materials. another product had been formed that corresponded to the aminol 
3.26. This was indicated by the presence of a second acetyl group CH3 resonance and the 
formation of two new doublets at chemical shifts of less than 1 ppm in addition to the 
doublet from the 2-methylpropanal (Fig. 3.7). 
3.81 
9 8 6 5 4 3 2 
Fig. 3.7 
These are caused by the methyl groups of the isopropyl substituent which, unlike in the 
starting aldehyde, are non-equivalent in the amino I 3.26 due to the presence of a chiral 
centre in the molecule. Finally, the signal from the methylene group of the hydrazine 
fragment, which is a singlet with a chemical shift of 3.81 ppm in the starting material 3.25, 
appears as two doublets at 3.57 and 4.0Ippm, since in the amino I the two protons are 
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diastereotopic. This is another feature arising from the presence of a chiral centre in the 
molecule. 
It is worth noting here that no signals corresponding to the enamine 3.28 were observed. 
This would be apparent by the methyl groups originating from the aldehyde appearing as 
two singlets and the appearance of a signal due to the proton attached to the C=N double 
bond. 
Following this initial analysis. the sealed NMR tube and its contents were then heated at 
110°C in an oil bath. At various intervals the tube was removed from the bath and a IH 
NMR spectrum again recorded. These spectra showed that even after heating for 72h the 
ratio of the starting materials to amino I did not change. 
A second experiment was carried out. this time with two equivalents of methyl acrylate 
added to the tube. Analysis by IH NMR spectroscopy immediately after addition of the 
reactants showed only a trace of the amino I in the mixture, the presence of the 
dipolarophile seeming to inhibit its formation (Fig. 3.8(a)). 
Again the sample was heated at 110°C and analysed at regular intervals. After 21h (Fig. 
3.8(b)) peaks at around 3.2ppm. that are characteristic of the cyclic product 3.29 (Scheme 
3.12). became evident. The disappearance of the singlet at 3.85ppm from the methylene 
group in the hydrazine indicated the progress of the reaction and after 72h of heating the 
reaction was adjudged to have gone to completion (Fig. 3.8(c)) as the integral underneath 
this singlet remained unchanged on further heating. 
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Scheme 3.12 
These two experiments suggest that the aldehyde and the hydrazine 3.25 exist in 
equilibrium with the aminol 3.26 (Scheme 3.12) and that this is itself in equilibrium with 
the dipole 3.27, with very little dipole present under normal circumstances. By removing 
the water that is formed and having a dipolarophile present that removes the dipole 3.27 
from the system, it is possible to force the equilibria towards the products. 
122 
This hypothesis is consistent with the work of Huisgen who also assumed the presence 
of an equilibrium between starting materials, an amino I and a dipole which could be 
intercepted by a dipolarophile (Scheme 3.13). 
94 
R..... .....R N-N 
H H 
+ 
R..... H 
N-N-R 
Ar~OH 
R=\~OCH3 
Ar=I-Q-CI 
Scheme 3.13 
3.4 Reactions with Functionalised Aldehydes 
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Having successfully carried out the test reaction, the next step was to try and introduce an 
amine function into the reactants in order to create an amino acid. The planned strategy for 
achieving this was to use an aldehyde bearing a nitrogen atom (Scheme 3.14), a suitable 
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example being the a-amino aldehyde 2.15 used in the isoxazole work. This would afford a 
3-(l-arninoalkyl)-4-carboxypyrazolidine 3.30. 
However, on heating the aldehyde 2.15, the hydrazine 3.10 and methyl acrylate to reflux in 
toluene with the removal of water, none of the desired product was obtained. Instead, two 
products were visible by TLC, one of which proved to be an inseparable mixture of 
products that we were unable to further identify. The other was a mixture of two 
compounds, probably either stereoisomers or rotational isomers caused by restricted 
rotation about the amide bond of the N-acetyl group. Purification by HPLC isolated one of 
the products from this mixture, and its IH NMR spectrum indicated that the product 
contained elements of both the aldehyde and hydrazine, but no methyl ester signal from the 
dipolarophile was apparent. In addition to signals for the N-methyl, N-acetyl and tert-butyl 
groups were a doublet and a multiplet with similar chemical shifts to the CH3CH fragment 
of the aldehyde 2.15, suggesting that this part of the molecule had remained intact. The 
only other signals were an NH (7.0ppm) and a broad signal (5.4ppm) caused by a CH. The 
oxazoline 3.31 is consistent with this spectrum and the EI mass spectrum contained a peak 
corresponding to the protonated molecular ion together with peaks corresponding to the 
loss of acetyl, tBu and tBuD fragments. The product was isolated in 27% yield, assuming 
that it is the oxazoline 3.31. 
o 
H3C ..... N_ N)lCH H H 3 
3.10 
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Scheme 3.15 
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The probable mechanism of formation of this product is shown in Scheme 3.15. The 
hydrazine 3.10 and aldehyde 2.15 react together to form an intermediate hydrazinium salt 
that, instead of deprotonating to form the dipole and reacting with the dipolarophile, loses 
the alternative carbamate NH proton and undergoes a cyclisation. Intramolecular reactions 
are generally faster than intermolecular ones, and the cycloaddition is known to proceed 
relatively slowly (Section 3.3), so the oxazoline 3.31 is formed apparently in preference to 
the desired pyrazolidine 3.30. To overcome this problem, an alternative protecting group 
was sought. The use of a benzyl group instead of Boc should prevent the cyclisation 
occurring since the carbonyl group that is necessary for the unwanted side-reaction is no 
longer present. Attaching two benzyl groups to the nitrogen atom means that the required 
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aldehyde is N,N-dibenzylalaninal 3.32, which has been synthesised previously, so its 
preparation was precedented (Scheme 3.16). 
0 0 YOH yosn ii ~~OH .. NBn2 
NH2 NBn2 
3.33 3.34 3.35 
j iii 
0 VI YH Bn = I h-
NBn2 
3.32 
Scheme 3.16 
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By converting the carboxylic acid group of S-alanine 3.33 to a benzyl ester, the desired 
protecting groups could be attached in one step. Tribenzylation was carried out using 
benzyl bromide and potassium carbonate, the reaction being performed in ethanol.
124 
As 
with the conversion of alanine to its methyl ester (Chapter 2), the reaction proceeded 
extremely slowly despite the use of an alkyl halide instead of an alcohol. After stirring for 
48h at 20°C, water was added to the reaction mixture and the solution extracted with ethyl 
acetate, the addition of sodium chloride being necessary to separate the aqueous and 
organic layers. The organic layers were washed with a 1M solution of sodium hydroxide 
and the crude product purified by column chromatography to give the N,N-diprotected 
benzyl ester 3.34 in 38% yield. Unreacted amino acid, which would have been lost in the 
aqueous layer during work up, partly explains this low yield. The reaction was not 
attempted again, so no efforts were made to secure an improvement on it. However, since 
protecting groups such as benzyl are usually attached and removed with high yields (it is 
for their ease of manipulation that they are chosen), a more efficient conversion should 
certainly be possible. 
The ester was then reduced to the alcohol 3.35 in anhydrous THF at -60°C using 15 molar 
equivalents of lithium aluminium hydride. After 1h, the reaction was quenched with a 
saturated solution of ammonium chloride in water and THF. Column chromatography 
realised the product in an unoptimised 65% yield. Oxidation of the alcohol 3.35 to the 
aldehyde was performed using DMSO, oxalyl chloride and triethylamine (the Swern 
reaction) 125 and resulted in an 83% yield of the aldehyde 3.32. Since this was found to 
decompose at room temperature within 4 days, it was used immediately in a cycloaddition 
reaction (Scheme 3.17). 
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Again the attempted cycloaddition was carried out by dissolving all three reactants in 
toluene and heating at reflux for 16h with a Dean and Stark trap for the removal of water. 
Once more, upon solvent removal and purification, none of the desired product 3.37 was 
isolated. The only isolable product, formed in 6.5% yield, had a 'H NMR spectrum 
consistent with the 2,3-dihydro-l ,3,4-oxadiazole 3.38. 
This is formed by a cyclisation similar to that shown in Scheme 3.15 that resulted in 
formation of the oxazoline 3.31. However, this time it is the N-acetyl group which loses a 
proton and attacks the C=N double bond. The fact that this type of cyclisation is not 
observed in cycloadditions with 2-methylpropanal (or benzaldehyde - see section 3.6) 
suggests that its occurrence is due to the presence of an electronegative group in a ~-
position to the carbon atom of the C=N double bond. This could destabilise the dipole 
sufficiently to cause reaction with the oxygen atom of the acetyl group, resulting in 
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formation of 3.38 via the mechanism shown in Scheme 3.17, in preference to a 
cycloaddition with methyl acrylate to give the pyrazolidine 3.37. 
The failure of the nitrogen-bearing aldehydes 2.15 and 3.32 led to cycloadditions being 
attempted with aldehydes bearing a functional group that could be converted subsequently 
to an amine (Scheme 3.18). Reactions of both 2-oxopropanal, 3.39, and ethyl glyoxalate, 
3.40, were tried with hydrazine 3.10 and methyl acrylate in toluene at reflux but did not 
yield any cycloaddition products. The only product we were able to identify in each case 
was the Michael addition product 3.15 (Scheme 3.7), isolated in yields of 18 and 10% 
respectively. 
o 
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Scheme 3.18 
2-Benzyloxypropanal 3.41 has an ether function (X.- to the aldehyde carbonyl group which 
has the potential to be converted to an amine. This aldehyde was formed in 36% yield 
(unoptirnised) by the O-benzylation of ethyl lactate 3.42 with sodium hydride and benzyl 
bromide. Subsequent reduction of the ethyl ester 3.43 using DIBAL at low temperature 
(-50°C) furnished the aldehyde 3.41 in 25% yield (unoptimised) (Scheme 3.19). 
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However, reaction with the hydrazine 3.10 and methyl acrylate in toluene heated to reflux 
failed to produce any of the desired cycloadduct 3.44. The only product that could be 
isolated from the reaction (in a yield of 11 %) had a IH NMR spectrum consistent with the 
2,3-dihydro-l,3,4-oxadiazole shown in Fig. 3.9, which has a structure analogous to 3.38. 
Fig. 3.9 
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3.5 A Different Approach to Dipole Formation 
An alternative way to generate 1,3-dipoles is via the thermally or chemically induced 1,2-
shift of a proton. This process is known as prototropy and has been used in a number of 
syntheses of heterocyclic molecules. 126 For example, the approach has been used by Grigg 
in the formation of azomethine imines from the hydrazones of aromatic aldehydes and 
ketones, tautomerisation taking place during heating of the hydrazone in xylene at 150°C 
127 (Scheme 3.20). 
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-N-N/ ====== 
Ph"""'-- H [ 
+ - /Ph] 
.......--N-N 
Ph H 
Ph o 
Scheme 3.20 
Attempts were made to carry out a cycloaddition with the hydrazone 3.45, derived from 2-
methylpropanal and acetyl hydrazide (Scheme 3.21). This should form the dipole 3.46 
analogous to 3.9 (Scheme 3.3), the only difference being the absence of the N-methyl 
group. Hydrazone 3.45 was synthesised by heating the two reactants in toluene at reflux in 
a flask fitted with a Dean and Stark trap to remove the water that is generated during the 
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reaction. After 2h, the solvent was removed to give the desired product in a quantitative 
yield. 
Jl +~OH H3C N-NH2 H 
3.45 
ii 
• 
3.46 
i, toluene, reflux, Dean and Stark trap, I6h; ii, xylene, reflux, 48h 
Scheme 3.21 
The hydrazone was then heated with methyl acrylate in degassed xylene at 150°C for 48h. 
However, on removal under reduced pressure of the solvent and any unreacted 
dipolarophile that remained, the only material that was recovered was the starting 
hydrazone 3.45. 
Work has also been carried out by Kanemasa, Tsuge and colleagues on the use of 
128 
hydrazones derived from aryl aldehydes as synthetic equivalents to azomethine imines. 
They found that on heating hydrazone 3.47 in toluene at reflux with methyl acrylate no 
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reaction took place. However, the use of N-(p-tolyl)maleimide as the dipolarophile 
resulted in a 39% yield of the cycloadduct 3.48 (Scheme 3.22). 
o 
Ph/ N-~)lOEl 
3.47 
p-tolyl = H3C-D-1 
Scheme 3.22 
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As this shows maleimide to be more reactive towards azomethine imines than acrylates, 
attempts were made to react a hydrazone with N-methylmaleimide. 
It should be mentioned that Kanemasa and Tsuge also carried out a cycloaddition with 
benzaldehyde, ethyl 3-benzyl carbazate 3.49 and N-(p-tolyl)maleimide in order to compare 
the different methods of dipole generation (Scheme 3.23). They found in this case that a 
quantitative yield of the dipole was generated and a 73:27 mixture of endo:exo isomers of 
3.50 was obtained. 
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In place of 2-methylpropanal acetylhydrazone 3.45, the experiment was attempted using 
the Ibutoxycarbonylhydrazone 3.51 (Scheme 3.24) since this bears closer resemblance to 
the hydrazone used by Kanemasa and Tsuge. This was prepared by the reaction of Ibutyl 
carbazate and 2-methylpropanal in toluene at reflux with the removal of water by means of 
a Dean and Stark trap. However, as before, heating the hydrazone 3.51 in xylene at reflux 
for 48h in the presence of N-methyl maleimide as dipolarophile did not yield any 
cycloadduct 3.52, the only identifiable products being the starting materials. 
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Scheme 3.24 
Clearly the generation of dipoles from hydrazones derived from aliphatic aldehydes is not 
possible by the action of heat alone. It has been found, again by Grigg and co-workers, 
that Lewis acids will assist the generation of the related azomethine ylide dipoles from 
arylidene imines of a-amino esters,129 due to the formation of a metallo-dipole 3.53 
(Scheme 3.25). 
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Further development of this methodology 130 led to the addition of a base as well as the 
Lewis acid which, as might be expected from the set of equilibria outlined in Scheme 3.25, 
promotes the conversion of 3.54 to 3.55. Silver acetate was found to give the highest 
yields of cycloadducts (lithium bromide predominantly giving rise to the product of 
Michael addition to the dipolarophile), whilst the base of choice was triethylamine. On 
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extending this approach to imines derived from aliphatic aldehydes, it was discovered 
that in addition to catalysing the cycloaddition process, the combination of silver acetate 
and triethylamine also suppresses the imine-enamine tautomerism (Scheme 3.26), which 
takes place in imines of aliphatic aldehydes bearing an a-hydrogen atom. 
Scheme 3.26 
It was hoped that this principle could be extended to the hydrazone 3.45, which would then 
also form a metallo-dipole 3.56, as shown in Scheme 3.27 (ef 3.53). 
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Thus 2-methylpropanal acetylhydrazone and methyl acrylate (2 equivalents) were heated, 
along with silver acetate (1.5 equivalents) and triethylamine (l equivalent) in dry toluene. 
The reaction was carried out at room temperature and at 80°C, but in neither case was any 
product of a cyc1oaddition observed, starting material 3.45 being recovered. Reactions 
using 2-methylpropanal tert-butoxycarbonylhydrazone 3.51 gave a similar result. 
3.6 Cycioadditions with Benzaldehyde 
Having thus far only completed a successful cyc1oaddition with 2-methylpropanal, the 
tolerance of the reaction to other non-functionalised aldehydes was tested. Benzaldehyde 
was chosen as a suitable example, as it has been used successfully in azomethine imine 
cycloadditions by others. On reaction of benzaldehyde with a molar equivalent of N1-
acetyl-N2 -methylhydrazine 3.10 and 1.5 equivalents of methyl acrylate in toluene, heated at 
reflux for 72h in a flask fitted with a Dean and Stark trap, several products were obtained 
(Scheme 3.28). 
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Of these, 3.57 is believed to arIse from dimerisation of the dipole to gIve the 
hexahydrotetrazine in 27% yield. The IH NMR spectrum contains peaks due to the N-
acetyl group, the N-methyl group, and the phenyl group. The only other peak, with the 
same chemical shift as two of the aromatic hydrogen atoms, was attributable to a CH 
group. An accurate mass measurement showed the molecular ion to have a mass 
consistent with that required for 3.57. The formation of such products is not unknown; 
Oppolzer has reported that reaction of formaldehyde and N I-methyl-N2-
phenylacetylhydrazine without a large excess of dipolarophile resulted in a significant 
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quantity (74%) of the dimer 3.61 (Scheme 3.29). 
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Scheme 3.29 
Dorn also reported isolating "thermal dimers" as by-products of cycloaddition in his study 
of reactions between highly polar species,I32 while Huisgen used the dimeric form of an 
azomethine imine as a means to store it, the molecule reverting to the dipole on gentle 
h . 122 eatmg. 
A second product, 3.15, (33%) can be attributed to a Michael addition between the 
hydrazine and methyl acrylate, as observed in the earlier reaction with 2-methylpropanal 
(Scheme 3.7). 
Finally, two products consistent with a cycloaddition reaction were isolated. One of these 
(22%) was itself a mixture of two compounds, present in approximately a 9:2 ratio as 
measured by the integrals of the 1 H NMR spectrum. Although apparently pure when 
analysed by TLC, an analytical-scale HPLC column confirmed the presence of two 
products. Some of the major isomer was isolated by preparative HPLC and assigned as a 
4-methoxycarbonylpyrazolidine isomer on the basis of the IH NMR and mass spectra. 
Unfortunately none of the minor product could be separated from the mixture. The 
regiochemistry was determined by 2-dimensional NMR studies. 
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spectroscopy showed that the ring protons with chemical shifts of 3.86 and 4.43ppm were 
part of the methylene group (Fig. 3.10). 
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Consequently, the protons at 3.45 and 4.47ppm must be attached to the carbon atoms in the 
ring that bear the substituents, a conclusion supported by a DEPT spectrum showing these 
carbon atoms to be tertiary. A COSY NMR spectrum (Fig. 3.11) showed that these two 
protons at the substituted positions on the ring couple to each other (J 5.9Hz). This means 
that they must be attached to adjacent ring carbon atoms and so the product carries the 
methyl ester substituent in the 4-position, giving rise to the possible structures 3.58 or 3.59. 
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In order to discover the relative stereochemistry of the product, a study of the nuclear 
Overhauser effects (n.O.e.s) in the NMR spectrum was carried out (Fig. 3.12). 
Fig. 3.12 
On irradiation of HB, no enhancement of the signal due to HA was apparent, only of that 
due to one of the protons of the methylene group, He, which had an n.O.e. of about 6%. 
This was reinforced by a 5% enhancement of the signal due to HB when the sample was 
irradiated at the frequency of He. Irradiation of proton HA did not give rise to any n.O.e. 
although irradiation of HD did result in an enhancement of HA of around 9%. There was 
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also an enhancement of HD when He was irradiated although this was not mirrored by 
irradiation of HD. Due to the close proximity in chemical shift of the signals due to HA and 
He, it is difficult to put exact values on the magnitudes of enhancement they undergo. 
However, it is the fact they are observable, rather than their magnitude, which is important 
here. 
The lack of any observable n.O.e. between HA and H8 suggests that they are on opposite 
faces of the ring, therefore the phenyl and ester groups must also be on opposing faces. 
This anti configuration suggests that the identity of the product is 3.58. The assignment of 
the relative stereochemistry was confmned by the structure obtained from an X-ray 
crystallographic study (Fig. 3.13). 
Fig. 3.13 
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This shows that in the solid state the dihedral angle between HA and HB, the two protons at 
the substituted positions on the ring, is 164.09°. The coupling constant between these two 
protons is 5.9Hz, significantly lower than might be expected from the Karplus relationship 
which predicts a J value of approximately 8.5Hz for a dihedral angle of 165°. This 
difference is due to the nitrogen atoms of the pyrazolidine ring. The presence of an 
electronegative substituent on the carbon atom bearing HA means that the magnitude of the 
coupling constant between HA and HB is less than that predicted by the Karplus 
1 · h' 133 re atlons lp. The methyl and acetyl groups attached to the two nitrogen atoms are also 
in an anti arrangement, the lone pair on each of the nitro gens in the ring causing them to 
act as tetrahedral centres in a similar manner to carbon atoms. Thus each of the 4 ring 
substituents is anti to the group adjacent to it. 
Also isolated from the mixture of products was a pure compound with both IH and I3C 
NMR spectra very similar to that of 3.58. Again analysis by 2-dimensional NMR 
spectroscopy showed that the two protons at 3.76 and 4.45ppm are attached to the same 
carbon atom (Fig. 3.14). 
Thus, the ring protons attached to the points of substitution must be those with chemical 
shifts of 3.94 and 4.35ppm. Once more this was confirmed by a DEPT spectrum which 
showed that the carbon atoms to which these hydrogen atoms are bonded are tertiary. A 
IH-IH correlation spectrum (Fig. 3.15) showed coupling between the two protons (J 7.7Hz) 
implying that this product must also carry the ester group in the 4-position. 
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As the anti product had already been isolated and characterised it could be reasonably 
assumed that this product was the syn isomer 3.59. The coupling constant between HA and 
HB, the two protons at the substituted positions on the ring, is larger than that of the anti 
product 3.58. According to the Karplus relationship, this means that the dihedral angle 
between these protons is either greater than 165° (the angle in 3.58) or it is close to 0°. As 
the syn isomer is unlikely to have a larger dihedral angle between HA and HB than the anti 
isomer, it can be assumed that the latter is true. Experiments to determine any 
enhancements due to the n.O.e. proved inconclusive and attempts to obtain a structural 
analysis by X-ray crystallography were also unsuccessful. However as the product had 
been shown to be a 4-methoxycarbonylpyrazolidine, and the chemical shifts in the IH 
NMR spectrum are different to those observed for the anti product 3.58, it will be assumed 
that the product is indeed the syn isomer 3.59. 
Since both of the 4-substituted pyrazolidine diastereoisomers have been isolated and 
identified, the minor isomer that eluted with 3.59 on purification by flash chromatography 
was assumed to be the 5-substituted product 3.60. This is based on analysis of the I H 
NMR spectrum of the mixture prior to purification by HPLC. An extra peak is visible in 
the region of the N-acetyl group (approximately 2.5ppm) and there is a multiplet at 
4.8ppm, a similar chemical shift to the proton attached to the ester substituted carbon atom 
in 3.14, the 5-methoxycarbonyl pyrazolidine formed in the test reaction (Section 3.2). In 
addition the ratio of integrals suggests that the minor product contains an aromatic ring, an 
N-methyl group and a methyl ester. 
To summarise, the cycloaddition with benzaldehyde yielded the anti 4-methoxycarbonyl 
pyrazolidine 3.58 in a yield of approximately 21 % (6% isolated yield following 
purification by HPLC) and a 17% yield of the syn 4-methoxycarbonyl pyrazolidine 3.59. 
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The 5-methoxycarbonyl pyrazolidine 3.60 was formed in trace amounts but could not be 
isolated. Also formed were the Michael addition product 3.15 in 33% yield and 3.57, 
formed in 27% yield by dimerisation of the azomethine imine dipole. The formation of a 
mixture of stereoisomers of the 4-methoxycarbonyltetrahydropyrazole, together with 
apparently only one 5-substituted product, is in agreement with the cyc1oaddition carried 
out using 2-methylpropanal (Scheme 3.6). Further supporting evidence for this analysis is 
. f .. 134 provIded by work on the elucidation of the structure 0 hydroxycotmme. 
3.63 
+ 
3.62 
+ 
3.65 
Scheme 3.30 
Nitrone 3.62 (Scheme 3.30) is analogous to the azomethine imine 3.66 formed by reaction 
between benzaldehyde and the hydrazine 3.10 (Scheme 3.31) 
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On reaction of the nitrone 3.62 with methyl acrylate (Scheme 3.30), three isoxazolidines 
were formed, the 5-substituted product 3.63 and the anti and syn isomers of the 4-
substituted regioisomer, 3.64 and 3.65, respectively. Whilst determining the relative 
stereochemistry of 3.64 and 3.65 it was noted in the IH NMR spectra that the peak: for the 
CH3 of the methyl ester appeared at 3.2ppm for the syn isomer and 3.7ppm for the anti. 
This compares favourably with values for the pyrazolidines 3.59 and 3.58 of 3.35ppm for 
the syn and 3.76ppm for the anti isomer. 
The formation of two diastereoisomers 3.58 and 3.59 of the 4-methoxycarbonyl 
pyrazolidines can be rationalised by considering two possible transition states for the 
cycloaddition, exo and endo. If the azomethine imine dipole 3.66, formed by reaction of 
benzaldehyde with N1-acetyl-N2-methylhydrazine 3.10, is assumed to adopt an E 
configuration, then an exo transition state, where the ester group of the dipolarophile points 
away from the dipole, will result in formation of the anti isomer 3.58 (Scheme 3.32). If the 
ester group is positioned beneath the dipole, the transition state is endo, and the product is 
the syn isomer 3.59 (Scheme 3.33). Should the dipole adopt a Z configuration then this 
will be reversed, 3.58 arising from an endo transition state and 3.59 from the exo. 
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From Schemes 3.32 and 3.33 the exo transition state appears to more favourable as there is 
less steric interaction between the methyl ester and the phenyl ring. However, the endo 
transition state is stabilised by a secondary 1t-orbital interaction between the central atom 
of the dipole and the double bond substituent of the dipolarophile (Fig. 3.16). The syn and 
anti isomers 3.58 and 3.59 are formed in approximately equal quantities, suggesting that 
the increased energy due to the steric hindrance of the endo transition state is offset by the 
stabilisation provided by the secondary orbital interactions, and that the two transition 
states are of roughly equal energy. 
, 
I 
I I I 
HOMO (dipole) 
~ LUMO (dipolarophile) 
Fig. 3.16 
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3.7 Optimisation of the CycIoaddition 
Having found that the cyc1oaddition would work with a second aldehyde, different 
conditions and ratios of reactants were tried to see if the yields of the tetrahydropyrazoles 
could be improved. 
Molar Ratio of Yields 
Entry Reaction Conditions Reactants 
PhCHO 3.10 Methyl 3.57 3.58 3.59 
Acrylate 
1 Toluene, reflux, D-S trap 1 1 1.5 27% 22% 17% 
2 Toluene, reflux, no trap 1 1 2 20% 5% 3% 
3 Toluene, reflux, leq water 1 1 2 20% 4% 2% 
4 Toluene, reflux, 3eq Et3N 1 1 1.5 18% a a 
5 Benzene, reflux, D-S trap 1 1 2 8% 18% 14% 
6 Toluene, 20°C, mol. sieve 1 1 2 5% <1% 0% 
7 Toluene, reflux, D-S trap 2 1 2 16% 26% 24% 
8 Toluene, reflux, D-S trap 1 2 2 b 25% 23% 
a Cyc10adducts isolated as mixture. Not separated as aim of reaction was to minimise dimer 
formation. b Product formed but not isolated. 
Despite the removal of water from the system seeming essential to drive forward the 
equilibrium between starting materials and dipole, cyc1oadditions of azomethine imines 
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have been reported where an equivalent of water has been added. The reaction between 
benzaldehyde, N1-acetyl-N2-methylhydrazine 3.10 and methyl acrylate was attempted in 
the absence of a Dean and Stark trap (Entry 2) so that the water formed as a by-product 
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was not removed from the reaction vessel, and also with a molar equivalent of water added 
to the mixture (again without a trap) (Entry 3). In both cases the yield of the cycloadducts 
fell significantly. The quantity of dipole dimer 3.57 was also reduced, although not to the 
same extent. As a consequence of the lower yields, over 40% of benzaldehyde was also 
retrieved. This compares with only a trace of unreacted aldehyde being recovered in the 
original reaction (Entry 1) (Scheme 3.28). 
In order to reduce the quantity of the unwanted hexahydrotetrazine 3.57, the cycloaddition 
was carried out with the addition of 3 equivalents of triethylamine (Entry 4). This device 
has found success in suppressing dimerisation during cycloadditions involving azomethine 
imines; 128 however, in this case it did not appear effective. Although the yield of pure 
material was slightly lower than previously, a mixture isolated following column 
chromatography contained more of the dimer, along with all three isomers of the 
pyrazolidine, 3.58, 3.59 and 3.60. 
In order to see if less severe conditions could increase the yield of the desired products (i.e. 
4-methoxycarbonyl isomers 3.58 and 3.59), the reaction was carried out in benzene (Entry 
5). This boils at 79°e (ef. 1OSoe for toluene) and, like toluene, forms a low-boiling 
azeotrope with water enabling a Dean and Stark trap to remain an effective way to remove 
the by-product water. The lower temperature resulted in a small drop in the cycloadduct 
yields, although the amount of dimer that formed was markedly reduced. A further 
lowering of the reaction temperature, to 20°C, this time using a 4A molecular sieve to 
remove water, gave only a trace of 3.58 and 3.59 and none of the S-substituted isomer 3.60 
(Entry 6). 
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The Michael addition that is in competition with the cycloaddition is a significant problem. 
To circumvent its formation, an extra molar equivalent of benzaldehyde was added. By 
having the aldehyde present in excess, the reaction between hydrazine and aldehyde, rather 
than hydrazine and dipolarophile, should be enhanced. However, only a slight increase in 
yield was recorded (Entry 7), being of the same order as for the initial synthesis (Scheme 
3.28). Further, a doubling of the quantity of the hydrazine, so that complete conversion of 
the aldehyde to dipole can take place, even allowing for Michael addition, produced a 
similar, marginal improvement (Entry 8). 
Overall, no significant gain in yield was achieved, though by having the hydrazine or 
aldehyde present in excess, a small improvement was noticed. Neither did the variation in 
conditions greatly affect the ratio of anti 4-methoxycarbonyl pyrazolidine 3.58 to its syn 
diastereoisomer 3.59. 
3.8 Reaction with Other Dipolarophiles 
As a further test of the reaction's versatility, a different dipolarophile was used in place of 
methyl acrylate. Acrylonitrile was selected, as, like methyl acrylate, it has a mono-
substituted double bond with an electron-withdrawing group attached. On reaction of 2 
molar equivalents with benzaldehyde and N1-acetyl-N2 -methylhydrazine 3.10 (l: 1) in 
toluene heated to reflux for 72h, two cycloaddition products were obtained, 3.67 and 3.68, 
in 10 and 15% yields respectively (Scheme 3.34). 
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The identity of each compound was assigned by analysis of the 2-dimensional NMR 
spectra and by comparison with the 4-alkoxycarbonyl pyrazolidines 3.58 and 3.59 (Scheme 
3.28). For the compound that was obtained as pure material after flash chromatography, 
the IH_13C correlation NMR spectrum showed that the protons with chemical shifts of 3.87 
and 4.41 ppm were those of the methylene group (Fig. 3.17). 
The protons with chemical shifts of 3.78 and 4.32ppm are therefore those attached to the 
substituted carbon atoms of the ring. As the COSY NMR spectrum shows that these 
protons couple (J 6.6Hz) to each other (Fig. 3.18), they must be attached to adjacent ring 
carbon atoms and, therefore, so must the phenyl and nitrile substituents. 
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The nitrile substituent is therefore at the 4-position of the ring, i.e. 3.67 or 3.68. Its relative 
stereochemistry will be discussed shortly. 
As in the case of the cycloaddition to methyl acrylate, the other cycloadduct was 
contaminated with traces of another product, which in this case proved inseparable by 
preparative HPLC. The IH_I3C NMR correlation spectrum shows the protons of the 
methylene group to be those with chemical shifts of 3.84 and 4.49ppm (Fig. 3.19). 
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The protons at 3.44 and 4.46ppm are therefore those attached to the same ring carbon 
atoms as the phenyl and nitrile substituents. A COSY NMR spectrum (Fig. 3.20) shows 
that these two protons couple to each other (J 6.0Hz), implying that they are attached to 
adjacent carbon atoms and that this product also bears the nitrile substituent at the 4-
position of the ring. 
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In order to determine the relative stereochemistry of these products their 1 H NMR spectra 
were compared with those of the 4-methoxycarbonyl pyrazolidines 3.58 and 3.59. The 
main difference between the syn and anti 4-substituted pyrazolidines appears to be the 
chemical shift of the proton attached to the 4-position of the ring which is approximately 
3.8-3.9 in the syn isomer but only 3.4-3.5ppm in the anti isomer. The IH NMR spectrum 
of the 4-cyano pyrazolidine obtained in pure form showed that the chemical shifts of the 
hydrogen atoms attached to the ring were almost identical to those of the syn 4-
methoxycarbonyl pyrazolidine 3.59 (Fig. 3.21). It was therefore assumed that the 4-cyano 
pyrazolidine also possessed syn relative stereochemistry, allowing it to be assigned the 
structure 3.68. The IH NMR spectrum of the impure 4-cyano pyrazolidine was very 
similar to that of the anti 4-methoxycarbonyl pyrazolidine 3.58 (Fig.3.22). It was therefore 
assigned as the anti pyrazolidine 3.67. 
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In addition, the coupling constant between HA and HB was found to be larger in the 4-
cyano pyrazolidine that was obtained in pure form than in the impure product (6.6Hz 
compared to 6.0Hz). In the case of the 4-methoxycarbonyl pyrazolidines the syn isomer 
3.59 had a larger coupling constant between the HA and HB than the anti isomer 3.58. This 
also suggests that the product isolated in pure form was the syn 4-cyano pyrazolidine 3.68, 
and the impure compound was the anti 4-cyano pyrazolidine 3.67. 
The impurity in 3.67 was assumed to be the 5-substituted pyrazolidine 3.69. This is based 
on the I H NMR spectrum; this shows extra peaks in the region of the N-acetyl group 
(approximately 2.5ppm) and there is also a multiplet at 4.8ppm, similar to peaks observed 
in the IH NMR spectra of the 5-substituted pyrazolidines 3.14 and 3.60 studied earlier. In 
addition, combustion analysis of the impure product showed good agreement with the 
calculated values, showing the impurity to have the same molecular formula as the desired 
product. 
------~. + 
+ 
3.70 
Scheme 3.35 
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To further investigate the scope of the reaction, cycloadditions with l,2-disubstituted 
dipolarophiles were attempted. Dimethyl maleate was initially chosen; on reaction with 
the azomethine imine 3.66 (formed from benzaldehyde and N I-acetyl-N2-methylhydrazine 
3.10) only one pure product 3.70 was isolated, in 11 % yield (Scheme 3.35). This proved to 
have an all-syn relationship between the phenyl group and the two ester substituents when 
n.O.e. experiments were performed (Fig. 3.23). 
Fig. 3.23 
Irradiation of the signal due to HA gave a 9% enhancement of the resonance for H8 and a 
2% enhancement of the signal due to He. Irradiation of the sample at the frequency of H8 
resulted in n.O.e. enhancements for HA and He of 9% and 10% respectively. Finally, 
applying radiation at the frequency of He saw a signal enhancement of 7% to H8 and just 
over 1 % for HA. Though the interaction between HA and He is weak, the strong n.O.e. 
witnessed to both on irradiation of H8 shows that all 3 protons are on the same side of the 
ring. 
An additional 22% of a mixture of cycloaddition products was also obtained, although 
further purification was not possible. Only two diastereoisomers (and their enantiomers, 
which will appear identical in NMR spectroscopy) can arise from concerted reaction of the 
azomethine imine and dimethyl maleate, namely the all-syn isomer 3.70 and the isomer 
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with both ester substituents anti to the phenyl substituent. However, since three different 
cyc10adducts were obtained, under the reaction conditions of prolonged heating at high 
temperatures, conversion of some of the dimethyl maleate into dimethyl fumarate (its 
thermodynamically more stable geometric isomer) may have occurred before 
cyc1oaddition. This would lead to the possibility of additional diastereoisomers with the 
ester groups anti to each other. 
To further address this issue, the reaction was repeated with dimethyl fumarate (Scheme 
3.36). This should also give only two diastereomeric products when observed by NMR 
spectroscopy, since the fumarate should not isomerise in the way that dimethyl maleate 
appears to do. 
o 
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3.71 
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On heating benzaldehyde, N'-acetyl-N2-methylhydrazine 3.10 and dimethyl fumarate in 
toluene at reflux for 72h in a flask fitted with a Dean and Stark trap. 38% of the product 
3.71, with the ester group in the 4-position anti to the phenyl substituent, was isolated. The 
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relative stereochemistry was again determined by a study of the nuclear Overhauser effects 
(Fig. 3.24). 
Fig. 3.24 
Irradiation of the signal due to HB showed no enhancement of the signals of either proton 
HA or He, only of the resonances for the protons on the aromatic ring. He was enhanced 
by nearly 3% on irradiation of HA, and this was matched by irradiating He to give an 
enhancement of HA of just over 3%. 
The anti, anti isomer 3.71 was also present as the major component of a further fraction 
that proved to be an inseparable mixture, the other component having an NMR spectrum 
consistent with the syn, anti diastereoisomer, 3.72. Assuming this to be the case, an extra 
21 % of 3.71 can be identified, along with 6% of 3.72. Since anti, anti isomer 3.71 is the 
least sterically hindered of the two possible products it might be expected to be the major 
product. 
Having uncovered a cycloaddition that formed one cycloadduct with a reasonable degree 
of efficiency, the same dipole was then reacted with N-phenylmaleimide. This is known to 
be an extremely reactive dipolarophile, and on formation of the bicyclic product 3.73 it 
should be possible to break open the imide ring and form an ester group (Scheme 3.37). 
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This would then have potential in terms of forming the carboxylic acid group of a 
heterocyclic amino acid. 
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Unfortunately, the reaction between N-phenylmaleimide and the azomethine imine 3.66, 
derived from benzaldehyde and NI-acetyl-N2-methylhydrazine 3.10, (Scheme 3.38) 
resulted in only a 4% yield of the cycloadduct 3.74, possibly due to steric effects. 
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The relative stereochemistry of the product was once more deduced by means of n.D.e. 
enhancements (Fig. 3.25). A through-space interaction between H8 and He is observed. 
Irradiation of the signal for HB results in a 3% enhancement of that of He whilst irradiation 
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at the frequency of He enhances the signal due to HB by 4%. HA is not affected in either 
case, nor does irradiation at its frequency cause any enhancements in HB or He. This 
suggests an anti relationship between the phenyl ring and the imide. 
o 
Fig. 3.25 
o 
An interesting feature of this molecule is that, in the I H NMR spectrum, the proton 
adjacent to the phenyl ring, HA , appears as a sharp singlet, exhibiting no spin-spin splitting 
due to a coupling with HB that might have been expected, This suggests that the angle 
between the two protons is very close to 90°, which, according to the Karplus relationship, 
should result in no visible coupling. HB appears as a doublet; however, on closer 
inspection is found to be a doublet of doublets, although the NMR instrument is not quite 
sensitive enough to accurately record the magnitude of the coupling to HA• The absence of 
any observable splitting of the signal due to HA is also presumably due to the limitations 
imposed by the resolution of the spectrometer. 
As the most efficient cycloaddition achieved so far was to dimethyl fumarate, the 
difference in reactivity of the two ester substituents in the cycloadduct 3.71 was examined. 
If, on treatment of 3.71 with an amine, one ester reacted preferentially over the other, this 
could be of use as the carbon terminus in an amino acid (Scheme 3.39). 
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A simple amine, methylamine, was chosen and one equivalent of a methanolic solution 
was reacted with the diester 3.71. Since the reaction of amines with non-activated esters 
can be extremely slow, a catalyst was used. Cyanide has been reported as an extremely 
efficient and mild catalyst for the aminolysis of esters,135 so 0.1 molar equivalents of 
sodium cyanide were also added to the reaction mixture. After heating in an oil bath at 50-
55°C for 16h, two new products were obtained. The IH NMR spectrum of the first product 
(Fig. 3.26(b», which was formed in 38% yield, revealed that one methyl ester peak had 
been lost when compared to the starting material (Fig. 3.26(a», and a new doublet was 
observed near 2.8ppm caused by the CH3 group of an N-methyl amide. Of the protons 
attached to the ring, only the doublet of doublets due to the proton in the 4-position had 
shifted significantly, from 4.03 to 4.78ppm, suggesting that reaction has occurred at the 4-
position, to give the amide ester 3.75. The other product, formed in 33% yield, contained 
no methyl ester signals in the IH NMR spectrum and two doublets near 2.8ppm (Fig. 
3.26(c». 
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The chemical shifts of the protons attached to the pyrazolidine ring were all different from 
the starting material (Fig. 3.26(a)). That of the proton attached to the same carbon as the 
phenyl ring had increased, from 4.58 to 4.75ppm, as had that of the proton at the 4-
position, from 4.03 to 4.38ppm. The chemical shift of the proton attached to the carbon at 
the 5-position had dropped however, from 5.16 to 4.86pm. This product was assigned as 
the diamide 3.76. (The amine was in fact present in very slight excess, accounting for the 
total amount of methylamine found in the products being over 100%). 
The fact that these two products were formed in almost equal yields indicates that there is 
little difference in reactivity between the esters and therefore the diester 3.71, despite being 
formed in relatively high yields, has limited use as the basis for a peptide mimetic. 
3.9 An Alternative Nitrogen Terminus 
-------
-------
PG = Protecting Group 
Scheme 3.40 
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I 
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Due to the lack of success in our attempts to incorporate a nitrogen-containing functional 
group that would become the N-terminus of the proposed heterocyclic amino acid, a 
slightly different strategy was adopted. It was decided to use one of the nitrogen atoms in 
the ring as the amine terminus of the amino acid (Scheme 3.40). 
Tetrahydropyrazoles have been used before in peptide chemistry, with full use made of the 
ring nitrogens. Dutta and Morley136 incorporated the di-protected pyrazolidine 3.77 into a 
chain of amino acids to represent an aza-proline unit where the a-CH of proline has been 
replaced by a nitrogen atom (Scheme 3.41). 
z..... ",Boc N-N ----.. 
H H 
z..... ",Boc 
N-N 
V 
3.77 
i, Br(CH2hBr, NaH 
Scheme 3.41 
More recently, Carreira has synthesised aza-prolines by a 1,3-dipolar cycloaddition 
between trimethylsilyldiazomethane 3.78 and a dipolarophile 3.79 bearing a camphor-
137 h d based chiral auxiliary (Scheme 3.42). With the diprotected pyrazolidine 3.80 in an, 
peptide couplings were carried out. 
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In order to use one of the nitrogen atoms in the pyrazolidine ring as an N-terminus, it is 
necessary to replace either the methyl or acetyl group with a standard amino acid 
protecting group that can be easily removed. For this approach, different 1,2-disubstituted 
hydrazines are required. 
3.10 Benzyl Group to Protect Nitrogen 
Substituting the methyl group for benzyl defines N1-acetyl-N2-benzylhydrazine 3.25 as a 
target. Rather than using a low-yielding reaction to try and selectively acetylate 
benzylhydrazine, which is itself very expensive, it was decided to synthesise 3.25 via 
hydrazone formation and subsequent reduction of the double bond (Scheme 3.43). 
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To prepare the hydrazone 3.81, benzaldehyde and acetylhydrazine were dissolved in 
toluene and heated to reflux in a flask fitted with a Dean and Stark trap. After 16h, the 
reaction was stopped and, following removal of the solvent and unreacted benzaldehyde on 
a rotary evaporator, the pure product was obtained in 64% yield after column 
chromatography. 
Attempts to reduce the C=N double bond of 3.81 with 1.5 molar equivalents of sodium 
cyanoborohydride (NaBH3CN) and an excess of glacial acetic acid were unsuccessful, with 
only trace amounts of the required product being recovered. The reaction was attempted in 
acetonitrile at room temperature and by using acetic acid as the solvent. Increasing the 
amount of NaBH3CN to 6 equivalents and heating the acetonitrile to reflux produced a 
similar result. A successful conversion was achieved by using para-toluenesulfonic acid 
(PTsOH) in place of acetic acid. The reaction was performed in tetrahydrofuran (THF) 
140 
with 4 equivalents of both reducing agent and acid. 138 The pH of the reaction was 
controlled with bromocresol green. This indicator is blue at high pH levels but changes to 
a yellow-brown colour when a pH of around 3.5 is reached. This is the optimum level of 
acidity for reductions with NaBH3CN and was maintained by the addition of a solution of 
pTsOH using a syringe. On completion of the reaction, the sodium salt of the acid, which 
had precipitated from the reaction mixture, was removed by filtration and the solution 
extracted with ethyl acetate. This yielded the cyanoborate salt 3.82, which was purified by 
I 139 co umn chromatography and subsequently converted to the free hydrazine 3.25 using a 
1M solution of sodium hydroxide and heating to 60°C for Ih.
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When the cycloaddition reaction between 2-rnethylpropanal, the benzylhydrazine 3.25 and 
methyl acrylate was attempted (Scheme 3.44), heating at reflux in toluene for 16h did not 
give the desired product. This was attributed to NJ-acetyl-N2-benzylhydrazine 3.25 being 
less reactive than NJ-acetyl-N2 -methylhydrazine 3.10. Indeed, the NMR experiments 
described in Section 3.3 revealed that a reaction time of 72h was required. Since the 
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temperature at which the reaction was performed was higher than the boiling points of both 
2-methylpropanal and methyl acrylate, the reaction was carried out in a sealed tube. In 
place of a Dean and Stark trap, 4A molecular sieves were used to remove the water. These 
reaction conditions yielded the desired product 3.29 as one stereoisomer, but the yield was 
extremely low (4%). Based on previously described cycloadditions (Schemes 3.6 and 
3.28) this was assumed to be a 4-substituted isomer. The IH NMR spectrum of 3.29 shows 
that a signal at approximately 3.1 ppm is due to two of the protons attached to the ring (Fig. 
3.27). 
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A IH_ J3C correlation spectrum shows that one of these protons is attached to the carbon 
bearing the isopropyl group (HA) and the other is bound to the carbon atom carrying the 
ester substituent (Ha) (Fig. 3.28). 
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Fig. 3.28 
As these protons are indistinguishable by NMR spectroscopy it is not possible to ascertain 
the regiochemistry of the product by a COSY experiment. Coupling is observed between 
the signal at 3.1ppm and both protons of the methylene group (He & Ho), however it is not 
possible to deduce whether the coupling from He and Ho is to HB alone, which would 
indicate the product was the 4-isomer, or t'J both HA and HB, suggesting the 5-isomer. 
Even assuming cycloadduct 3.29 is the 4-substituted product, no assumptions can be made 
about the relative stereochemistry as studies of the n.O.e. will suffer from similar problems 
to 2-dimensional NMR spectroscopy. An enhancement of the peak at 3.1 ppm could be due 
to interaction with either both or just one of HA and HB• making it impossible to determine 
whether they are on the same face of the ring or not. Also, unlike the pyrazolidines 3.58 
and 3.59 with a phenyl group at the 3-position. which had different chemical shifts of the 
methyl ester depending on whether the product was syn or anti, the esters of both isopropyl 
derivatives 3.16 and 3.17 had chemical shifts of around 3.8ppm (as does 3.29). 
3.11 Nitrogen Protection with a Boc Group 
N1-tert-Butoxycarbonyl-N2-methylhydrazine 3.83, like N1-acetyl-N2-methylhydrazine 3.10, 
possesses the ability to stabilise the negative charge of the azomethine imine dipole, but it 
has the advantage over 3.10 in that it should be possible to cleave the Boc group on 
treatment with acid. 
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It was not possible to prepare the N-Boc-hydrazine 3.83 in a manner analogous to the 
acetylated hydrazine 3.10 (Scheme 3.45), i.e. nucleophilic attack on a butoxycarbonyl 
derivative by methylhydrazine and elimination of a leaving group, since the required 
reagent would be BOC20. Acid anhydrides are more reactive than esters and so the 1,1-
disubstituted product 3.84 would result as discussed in Section 3.2.
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A solution to this problem was found in the approach employed by Gani and colleagues 
141 (Scheme 3.46). The substituted nitrogen of methylhydrazine is blocked by a 
benzyloxycarbonyl, or Z, group, a nitrogen protecting group requiring different conditions 
to Boc for deprotection. On reaction with BOC20, the Boc group can only react with the 
unsubstituted nitrogen atom. The Z group is then removed to give the desired 
asymmetrically disubstituted hydrazine, N I-tert-butoxycarbonyl-N2-methylhydrazine 3.83. 
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Although a three-step synthesis, each of the steps in the sequence is a standard protection 
or deprotection reaction that should proceed in high yield. 
3.83 
He 
3 'N-NH H 2 
.. 
iii 
3.85 
ii 
Q H3C, Jl 1/ ~ I 0 N-N O~ 
/( H 
o 
3.86 
Scheme 3.46 
N1-Benzyloxycarbonyl-NI-methylhydrazine 3.85 was prepared by treating 
methylhydrazine in chloroform at O°C with triethylamine followed by benzyl 
chloroformate. After stirring the mixture at 20°C for 16h the product was purified by 
distillation to give a colourless liquid in 57% yield. IH NMR spectroscopy showed that the 
chemical shifts for the methyl group at 3.lOppm and for the N-H protons at 4. 15ppm were 
. 85 142 . 2 In good agreement with published values for 3.. By way of comparIson, in the 1, -
disubstituted product the N-methyl group has a chemical shift of 2.63ppm and the NH 
142 
protons appear between 5.0 and 6.0ppm. 
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Addition of a solution of Boc20 in dichloromethane to the 1, I-disubstituted hydrazine 3.85 
(dissolved in propan-2-0l) resulted in reaction at the unsubstituted nitrogen atom, which, 
following recrystallisation, gave the trisubstituted hydrazine 3.86 as a white solid in 53% 
yield. In the 'H NMR spectrum of 3.86, the signals for the protons in the Boc methyl 
groups, the N-methyl group and the benzyl methylene group appear as broad singlets when 
the spectrum is recorded using deuterated chloroform as a solvent. On changing the 
solvent to fully deuterated dimethyl sulfoxide these signals each appear as two peaks 
indicating the presence of rotational isomers, caused by restricted rotation about the amide 
bond of the N-Boc group. (This phenomenon is not apparent in the 'H NMR spectrum of 
3.85 and so is presumably not due to the amide bond of the N-Z group). The Z protecting 
group was then removed by stirring a methanolic solution of 3.86 in the presence of a 
charcoal-supported palladium catalyst under an atmosphere of hydrogen to give the 
required disubstituted hydrazine 3.83. Although TLC analysis indicated that all of the 
starting material had reacted to form a single product, only 35% of 3.83 was isolated. This 
low yield is unoptimised as the reaction was only performed once, and is probably due to 
inadequate washing of the catalyst, resulting in some of the product being left in the slurry 
containing the catalyst and its support. 
H3C'N_NJlOX 
H H 
3.83 
+ 
• 
i, toluene, 72h, Dean and Stark trap 
Scheme 3.47 
3.87 
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Reaction of this hydrazine with an equimolar amount of benzaldehyde and 2 equivalents of 
methyl acrylate, heated to reflux in toluene for 72h, yielded the cycloaddition product 3.87 
in an 18% yield (Scheme 3.47). 
As with the N-benzylated pyrazolidine 3.29, exact determination of the regio- and 
stereochemistry of the product was not possible due to an overlap of signals in the IH 
NMR spectrum (Fig. 3.29). (The 4-methoxycarbonyl isomer 3.87 is drawn merely from 
analogy with earlier results). 
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A IH_ 13C correlation spectrum shows that the two signals at 3.75ppm are due to HB and 
either He or Ho (Fig. 3.30). 
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Fig. 3.30 
As these two protons cannot be distinguished, COSY NMR and n.O.e. studies do not 
provide any useful information about the regiochemical structure of the product. 
The N-Boc pyrazolidine 3.87 is presumed to be the 4-substituted product based on the 
results obtained from reactions with the N-methylhydrazine 3.10 (Scheme 3.28). In the syn 
and anti products from that reaction, 3.59 and 3.58, different chemical shifts for the methyl 
ester (3.2 and 3.7ppm respectively) were observed in the IH NMR spectrum. A value of 
3.4ppm in 3.87 is not sufficiently close to either of these to allow any speculation on the 
relative stereochemistry of the product. 
3.12 Conclusions 
The 1,3-dipolar cycloadditions of azomethine imine dipoles that have been described 
demonstrate that the reaction is subject to a number of restrictions. Although it has been 
shown that a variety of mono- and 1,2-disubstituted dipolarophiles can be used, the 
cycloaddition appears to be more sensitive to structural variations in the hydrazine and 
aldehyde. Exchanging the N-acetyl group for a N-tert-butoxycarbonyl group (effectively 
swapping a methyl group for O-tert-butyl) has little effect on the reaction, however 
replacing the N-methyl group with N-benzyl, which has considerably more steric bulk, 
resulted in a significant drop in yield, even with a longer reaction time. Whilst the reaction 
proceeded with 2-methylpropanal or benzaldehyde, no cycloadditions took place with an 
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aldehyde bearing a heteroatom functional group. Thus, it appears that the only 
pyrazolidines that can be synthesised using this approach are those bearing an alkyl or aryl 
substituent at the 3-position. 
The pyrazolidines 3.29 and 3.87 both have nitrogen substituents that, in principle, are easy 
to remove independently of the methyl ester group protecting the carboxylic acid function. 
There is, therefore, potential for these compounds to be coupled to other amino acids, and 
to create a peptide chain with a pyrazolidine ring incorporated. Both of these molecules 
can be thought of as conformationally restricted ~-amino acids, as there are two carbon 
atoms between the N-terminus nitrogen and the C-terminus carbon atom (Fig. 3.31). 
~-Amino Acid 
R3 R4 
RsJ} 
C02CH3 
R3=Bn, R4=COCH3, R5=(CH3hCH; 3.29 
R3=CH3, R
4
=C02C(CH3)3' R5=Ph; 3.87 
Fig. 3.31 
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Chapter 4: 
Experimental 
Melting points were determined using a Kofler hot-stage apparatus and are uncorrected. 
Optical rotations were measured on a JASCO DIP-I000 digital polarimeter using a cell 
with a path length of IOmm. Combustion analyses were performed by MEDAC Ltd. 
(Englefield Green, Surrey). Accurate mass measurements were carried out by the EPSRC 
National Mass Spectrometry Service Centre (University of Wales, Swansea). Infrared 
spectra were recorded using a Perkin-Elmer 1710 Ff-IR spectrometer. IH NMR spectra 
were obtained at 400MHz on a lEOL lNM-EX400 or at 300MHz on a JEOL JNM-LA300. 
13C NMR spectra were recorded at 100MHz on a JEOL JNM-EX400 or at 75MHz on a 
JEOL JNM-LA300. Chemical shifts are reported in parts per million (ppm) from 
tetramethylsilane (TMS) to two decimal places. Multiplicities are given as s-singlet, d-
doublet, t-triplet, q-quartet, dd-doublet of doublets, ddd- doublet of doublet of doublets, m-
multiplet and br.-broad signal. Coupling constants (1) are quoted in Hz to one decimal 
place. Low resolution mass spectra were recorded on a VG Micromass VG20-250 
spectrometer or by the EPSRC National Mass Spectrometry Service Centre (University of 
Wales, Swansea) by electron impact (EI), chemical ionisation (CI), fast atom bombardment 
(FAB) or electrospray (ES). Crystallographic measurements were carried out by the 
EPSRC X-Ray Crystallography Service (University of Southampton). 
All reagents were purified by distillation or recrystallisation where appropriate. Methanol 
and ethanol were dried using magnesium and iodine, THF and ether were dried over 
sodium wire or potassium lumps, and DCM was dried using sodium hydride, all according 
to the procedures described in "Purification of Laboratory Chemicals" by Perrin and 
143 b . d . II Armarego. Anhydrous toluene was 0 tame commerCIa y. 
Column chromatography was carried out using Fluka Silica Gel 60 (220-440 mesh). TLC 
analysis was performed using Machery-Nagel Polygram SIL GlUV254 plates with 
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fluorescent indicator and visualised by ultraviolet light or aqueous potassium 
permanganate. 
Analytical HPLC analysis was carried out on a Waters W600 fitted with a Phenomenex 
Luna CIS (2) column (25cm x 4.6mm i.d.) at 30°C and an ultraviolet detector set to 220nm. 
A solvent system of water:acetonitrile was employed, with an initial ratio of 85: 15 v/v 
rising to 45:55 v/v after 21min. Preparative HPLC was performed using a Waters Delta 
Prep 3000 fitted with a Jones Apex 2 silica column (5 micron, 25cm x 21mm i.d.). 
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(S)-Alanine methyl ester hydrochloride (2.23) 
Acetyl chloride (1 1 1.50g, 1.42mol) was added dropwise to anhydrous methanol (200cm3) 
at O°c. Alanine (30.12g, 338.07mmol) was added and the solution was stirred for 72h at 
this temperature. The solvent was evaporated under reduced pressure to give the ester 
(45.68g, 97%) as a white solid, m.p. 105-107°C (lit.,144 Ill-112°C); BH [400MHz; 
(CD3hSO] 1.44 (3H. d, J 7.3Hz, CH3CH), 3.74 (3H, s, C02CH3), 4.05 (1H, q, J 7.3Hz, 
CHCH3) and 8.77 (3H, s, NH/); Be [IOOMHz; (CD3)zSO] 15.53 (CH3CH), 47.79 (CH), 
52.65 (C02CH3) and 170.24 (C=O); mlz (EI) 104 (M+-CI, 5%), 88, and 44 (100). 
(S)-N-tert-Butoxycarbonylalanine methyl ester (2.16) 
(S)-Alanine methyl ester hydrochloride (lO.Olg, 71.72mmol) was dissolved in DCM 
(300cm3) in a flask fitted with a calcium chloride drying tube. The solution was cooled to 
O°C and triethylamine (l4.52g. 143.49mmol) was added dropwise. Di-tert-butyl 
dicarbonate (l7.27g, 79.13mmol) dissolved in DCM (15cm3) was added in a similar 
manner, then the solution allowed to warm to room temperature and stirred for 16h. The 
solution was washed with citric acid solution (lM; 3xI5Ocm3), dried (MgS04) and the 
solvent removed under reduced pressure to yield the title compound as a white solid 
145 68 (1O.57g, 73%), m.p. 31-33°C (lit., 33-34°C); BH (400MHz; CDCh) 1.38 (3H, d, J . 
153 
Hz, CH3CH), 1.45 [9H, s, (CH3hc], 3.74 (3H, s, C02CH3), 4.32 (IH, m, CHCH3) and 5.08 
(lH, In, NH); Oc (lOOMHz; CDCh) 18.67 (CH3CH), 28.33 [(CH3hc], 49.18 (CH), 52.30 
(C02Gh), 79.85 [C(CH3h], 155.13 (CONH) and 173.88 (C02CH3); m/z (El) 203 (M+, 
0.1%),144,130,102,88,59,57 (100), 44 (100) and 29. 
(8)-N-tert -Butoxycarbony lalaninal (2.15) 
o o yOCH3 
-·YH 
NHBoc NHBoc 
(S)-N-tert-Butoxycarbonylalanine methyl ester (6.75g, 33.21mmol) was dissolved in 
anhydrous toluene (lOOcm3) under an atmosphere of nitrogen and cooled to -78°C. 
Diisobutylaluminium hydride (1M solution in toluene, 83cm3, 83.00mmol) was added over 
90min. After addition was completed the solution was stirred for a further Ih then the 
reaction quenched with methanol (6cm\ The mixture was then poured into a saturated 
solution of potassium sodium tartrate (200g) in water (600cm3) and stirred vigorously at 
room temperature for 90min. The aqueous phase was separated and extracted with diethyl 
ether (3x75cm\ The organic extracts were combined, dried (MgS04) and the solvent was 
removed under reduced pressure to give the crude aldehyde as a white solid (4.58g, 80%), 
which was immediately converted to the oxime; OH (400MHz; CDCh) 1.34 (3H, d, J 
7.3Hz, CH3CH), 1.46 [9H, s, (CH3hC], 4.23 (lH, m, CHCH3), 5.14 (lH, br.s. NH) and 
9.57 (lH. s, CHO); Oc (lOOMHz; CDCh) 14.87 (CH3CH), 28.29 [(CH3)3C]. 55.54 (CH), 
80.14 [C(CH3h], 155.36 (CONH) and 199.80 (CHO). 
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(S)-2-tert-Butoxycarbonylaminopropanaldoxime (2.14) 
• ~: 
NHBoc 
A solution of (S)-N-tert-butoxycarbonylalaninal (4.58g, 26.44mmol) in ethanol (lOcm3) 
was added to a solution of hydroxylamine hydrochloride (1O.59g, 152.40mmol) and 
sodium acetate (20.72g, 252.59mmol) in water (50cm3). Ethanol was added to dissolve the 
resulting precipitate, then the solution was warmed to approximately 60°C for IOmin. The 
solution was allowed to cool to room temperature then placed in a refrigerator for 16h. 
The resulting white precipitate was collected by filtration and recrystallised from water and 
ethanol to give a mixture of syn and anti geometric isomers of the oxime as a white solid 
(3.93g, 63% from the ester), m.p. 136-138°C (lit.,64 145-146°C); [a]D25 33.0° (c 0.44, 
CH30H); Found: MNH/, 206.1505. CgHI6N203 requires MN~, 206.1505; Umax 
(KBr)/cm-1 3346,3221, 2982, 1684, 1531, 1446, 1328, 1164, 1052 and 896; Major isomer: 
~ [300MHz; (CD3hSO] 1.11 (3H, d, J 6.9Hz, CH3CH), 1.38 [9H, s, (CH3hC], 4.61 (lH, 
m, CHCH3), 6.55 (JH, d, 1 5.9Hz, CH=N), 7.09 (lH, d, 1 7.5Hz, NH) and 10.89 (IH, s, 
OH); Oc [75MHz; (CD3hSO] 17.37 (CH3CH), 28.19 [(CH3hCl, 41.90 (CHCH3), 77.87 
[C(CH3h], 152.65 (CH=N) and 154.86 (C=O); Minor isomer: ~ [300MHz; (CD3hSO] 
1.35 (3H, d, 17.0Hz, CH3CH), 1.38 [9H, s, (CH3hCl, 4.13 (lH, In, CHCH3), 7.03 (lH, d, J 
8.4Hz, NH), 7.19 OH, d, J 5.3Hz, CH=N) and 10.63 (lH, s, OH); ac [75MHz; (CD3hSO] 
18.63 (CH3CH), 28.19 [(CH3hCl, 45.49 (CHCH3), 77.87 [C(CH3)3], 150.59 (CH=N) and 
154.86 (C=O); m/z (EI) 189 (MH+, 4%), 173, 132, 115,88,72,59,57 (100), 44 and 41. 
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EthyI3-pyrrolidinobut-2-enoate (2.18) 
• 
Ethyl acetoacetate (1O.21g, 78.45mmol) and pyrrolidine (5.62g, 79.02mmol) were 
dissolved in toluene (15Ocm3) and heated at reflux under Dean and Stark conditions for 4h. 
The solvent was removed under reduced pressure to give the title compound (14.37g, 
100%) as a brown solid with a melting point below ambient temperature that was used 
without further purification; Umax (neat)/cm,1 3583, 2975, 2870, 1679, 1577, 1433, 1365, 
1184 and 1059; ~H (3OOMHz; CDCI3) 1.24 (3H, t, J 7.1Hz, CH3CHz), 1.93 (4H, m, 
NCH2CHz), 2.46 (3H, s, CH3CN=CH), 3.30 (4H, br., NCHz), 4.08 (2H, q, J 7.1Hz, 
CHzCH3) and 4.45 (lH, s, CH=CN); Dc (75MHz; CDCh) 14.76 (CH3), 16.67 (CH3), 25.18 
(NCH2CHz), 47.89 (NCH2), 58.09 (ClhCH3), 83.269 (CH=CN), 159.58 (CN=CH) and 
169.24 (C=O). 
leTt-Butyl hypochlorite 
.. 
In subdued light, a mixture of 2-methylpropan-2-01 (74cm3, 780mmol) and glacial acetic 
acid (49cm3, 860mmol) was added to an ice-cooled household bleach solution (l000cm3). 
After stirring for 3min, the organic layer was separated and washed with sodium carbonate 
solution (0. 1M; l00cm3) and water (loocm3). Drying (CaCh) realised the title compound 
as a yellow oil (45.3g, 54%). 
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(S)-EthyI3-(1-tert-butoxycarbonylaminoethyl)-S-methylisoxazole-4-carboxylate (2.10) 
• 
(S)-2-tert-Butoxycarbonylaminopropanaldoxime (1.00g, 5.31mmol) was dissolved in 
chloroform (200cm3) and cooled to O°c. tert-Butyl hypochlorite (0.63g, 5.82mmol) was 
added and the solution stirred for 45min. Ethyl 3-pyrrolidinobut-2-enoate (1.95g. 
1O.64mmol) was added and the solution heated to reflux. Triethylamine (0.60g, 
5.88mmol) was then added over a period of 4-5h and the solution heated at reflux. for 
another 16h. The solution was washed with citric acid solution (1M; 2x5OcmJ) and 
saturated brine (50cm3), then the organic layer dried (MgS04) and the solvent removed 
under reduced pressure. The crude product was purified by column chromatography on 
silica gel using hexane and ethyl acetate (2: 1 v/v) as eluant to give the isoxazole as a 
yellow oil (1.04g, 66%); [a]o26 -29.8° (c 1.13, CHCh); Found: C, 56.22; H, 7.42; N, 
9.21 %; MH+, 299.1617. Cl4H22N20S requires C, 56.36; H, 7.43; N, 9.39%; MH, 299.1607; 
Umax (CHCh)/cm-1 3443, 2983, 2935, 1713, 1607, 1505, 1456, 1369, 1306, 1240, 1166, 
1112,1050,1032 and 861; OH (400MHz; CDCh) 1.39 (3H, t. J7.1Hz, CH3CH2), 1.44 [9H, 
s, (CH3)3C], 1.48 (3H, d, J 6.8Hz, CH3CH), 2.66 (3H. s, 5-CH3), 4.35 (2H, m, CH2CHJ ), 
5.30 (lH, m, CHCH3) and 5.68 (lH, d, J 8.3Hz, NH); Be (lOOMHz; CDCh) 13.52 (5-CHJ), 
14.19 (CH3CH2), 21.18 (CfhCH), 28.38 [(CH3)3C], 43.84 (CHCH), 61.05 (ClhCH), 
79.50 [C(CH)h], 107.405 (C). 154.99 (CONH), 162.12 (C). 164.67 (C) and 176.04 (C): 
mlz (EI) 299 (MH+, 5%), 283, 225, 197, 183, 154. 137,57 (100) and 43. 
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(S)-EthyI3-(1-aminoethyl)-5-methylisoxazole-4-carboxylate hydrochloride (2.31) 
• 
(S)-Ethyl 3-( I-tert-butoxycarbonylarninoethyl)-5-methylisoxazole-4-carboxylate (1. 16g, 
3.89mmol) was dissolved in DCM (200cm3). Trifluoroacetic acid (20cm3) was added and 
the solution stirred for 2h. The solvent was removed under reduced pressure, then 
hydrochloric acid (2M; 30cm3) was added and the solution stirred for lh. The solvent was 
removed under reduced pressure. Water (30cm3) and ethyl acetate (30cm3) were added to 
the residue, the two phases separated and the aqueous layer was collected. The water was 
removed on a rotary evaporator, then the product was dissolved in toluene (lOcm3) which 
was removed under reduced pressure to yield the amine salt (0.86g, 94%) as a pale brown 
solid, m.p. 126°C (dec.); [a]D25 -29.9° (c 1.03, CH30H); Found: C, 44.60; H, 6.28; N, 
11.59%; M+-HCI 198.0999. C9HI5N203CI·0.5H20 requires C, 44.36; H, 6.62; N, 11.50%; 
C9Hl5N203CI requires M-HCl, 198.1004; 'Umax (KBr)/cm-1 2878, 2645, 2518, 2025, 1713, 
1600, 1522, 1475, 1381, 1349, 1281, 1134, 1042,837 and 791; B.i [4ooMHz; (CD3hSO] 
1.32 (3H, t, J 7.1Hz, CH3CH2), 1.57 (3H, d, J 6.8Hz, CH3CH), 2.70 (3H, s, 5-CH3), 4.30 
(2H, m, CH2CH3), 4.76 (lH, m, CHCH3) and 8.91 (3H, s, NH3 +); Be [lOOMHz; (CD3hSO] 
12.88 (5-CH3), 13.79 (CfhCH2), 17.94 (CH3CH), 43.07 (CHCH3), 60.94 (CH2CH3), 
107.06 (C), 160.79 (C), 161.25 (C) and 176.19 (C); mlz (FAB) 199 (M+-CI, 100%), 182, 
105,61 and 45 (100). 
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N-Iert-Butoxycarbonylglycine (2.32) 
Glycine (S.lOg, 67.94mmol) was dissolved in a mixture of l,4-dioxane, water and 1M 
sodium hydroxide solution (2: 1: 1 v/v/v) (280cm3) and cooled to O°C. Di-tert-butyl 
dicarbonate (l4.84g, 68.00mmol) was added and the solution stirred for 90min at O°C 
followed by 30min at room temperature. The solvent was evaporated under reduced 
pressure to approx. 70cm3, then cooled to O°C and covered with a layer of ethyl acetate 
(2Scm\ Citric acid (l3.4Sg, 70.0lmmol) was added, then the aqueous layer was 
separated and extracted with ethyl acetate (2xSOcm3). The combined organic layers were 
dried (MgS04) and the solvent was removed under reduced pressure. The crude product 
was recrystallised from hexane and ethyl acetate (1: 1 v/v) to give the title compound as a 
white solid (S.S6g, 47%), m.p. 87-89°C (lit.,146 88-89°C); Major rotational isomer: BH 
(400MHz; CDCh) 1.46 [9H, s, (CH3)3C], 3.97 (2H, br.s, CH2), 5.l4 (lH, br.s, NH) and 
11.11 (lH, br.s, OH); Oc (lOOMHz; CDCh) 28.29 [(CH3hc], 42.23 (CH2), 80.45 
[C(CH3h], 155.98 (CONH) and 174.93 (C02H); Minor rotational isomer: ~ (400MHz; 
CDCh) 1.46 [9H, s, (CH3hc], 3.91 (2H, br.s, CH2), 6.86 (1H, s, NH) and 11.11 (1H, br.s, 
OH); Oc (lOOMHz; CDCI3) 28.29 [(CH3hc], 43.40 (CH2), 81.78 [C(CH3)3], 157.30 
(CONH) and 173.99 (C02H); mlz (EI) 176 (MH+, 14%), 160, 120, 59 (l00), 57 (100),41 
and 29. 
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(S)-N-tert-Butoxycarbonylalanine (2.33) 
To a solution of (S)-alanine (6.36g, 71.39mmol) in 1,4-dioxane, water and 1M sodium 
hydroxide (2: 1: 1 v/v/v) (280cm3) at O°C was added di-tert-butyl dicarbonate (l7.53g, 
80.32mmol). The solution was stirred for 90min at O°C then allowed to warm to room 
temperature and stirred for a further 30min. Using a rotary evaporator, the mixture was 
reduced to approx. 70cm3 then cooled to O°e. Ethyl acetate (25cm3) was added and the 
biphasic mixture acidified to pH 3 with a solution of potassium hydrogen sulphate (2M). 
The aqueous layer was separated, then extracted with ethyl acetate (2x5Ocm3). The 
organic layers were combined, dried (MgS04) and the solvent was removed under reduced 
pressure. The crude product was recrystallised from hexane and ethyl acetate (1: 1 v/v) to 
yield a white solid (4.96g, 37%), m.p. 79-81°C (lit.,147 81-82°C); Major rotational isomer: 
~ (400MHz; CDCh) 1.45 [12H, m, CH3CH & (CH3)3C], 4.35 (lH, m, CHCH3), 5.15 (lH, 
m, NH) and 11.44 (lH, br.s, OH); Be (lOOMHz; CDCh) 18.45 (CH3CH), 28.31 [(CH3hc], 
49.12 (CH), 80.25 [C(CH3h], 155.45 (CONH) and 178.03 (C02H); Minor rotational 
isomer: OH (400MHz; CDCh) 1.45 [12H. m, CH3CH & (CH3hc], 4.17 (lH, m, CHCH3), 
6.88 (lH, br.s, NH) and 11.44 (lH, br.s, OH); Be (I00MHz; CDCh) 18.45 (CfhCH), 28.31 
[(CH3hC], 50.22 (CH), 81.62 [C(CH3)3], 156.87 (CONH) and 177.36 (C02H); mlz (EI) 
190 (MH+, 29%), 172, 144, 88, 59 and 57 (100). 
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(S)-Ethyl 3-[1-N-(tert-butoxycarbonylaminoacetYl)aminoethYI]_S_methyIisoxazole-4-
carboxylate (2.34) 
(S)-Ethyl 3-( l-aminoethyl)-5-methylisoxazole-4-carboxylate hydrochloride (0.98g, 
4.18mmol) was suspended in DCM (25Ocm\ Triethylamine (0.87g, 8.61mmol) was 
added and the mixture stirred for lOmin. Water (50cm3) was then added, the organic layer 
separated and dried (MgS04) and the solvent removed under reduced pressure to yield the 
free amine (0.68g, 82%) which was used immediately in the coupling reaction. 
N-tert-Butoxycarbonylglycine (0.79g, 4.51mmol) and 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (EDCI) (0.96g, 5.01mmol) were dissolved in anhydrous 
DCM ( 15Ocm3) and stirred at O°C for 10min. (S)-Ethyl 3-( 1-aminoethyl)-5-
methylisoxazole-4-carboxylate (0.68g, 3.43mmol) in anhydrous DCM (50cm3) was added, 
the solution allowed to reach room temperature and stirred for 16h. Water (50cm3) was 
added, the organic layer separated and dried (MgS04), and the solvent removed under 
reduced pressure. Purification by column chromatography using hexane and ethyl acetate 
(1: 1 v/v) as eluant yielded the title compound as a colourless gum (0.85g, 70%; 57% from 
hydrochloride salt); [aJD27 -31.3° (c 1.05, CHCh); Found: C, 53.64; H, 7.25; N. 11.67%; 
MH+, 356.1806. Ct6H2sN306·0.1H20 requires C, 53.80; H, 7.11; N, 11.76%; Ct6H25N30 6 
requires MH, 356.1821; Umax (CHCh)/cm-t 3428, 2984, 2935. 1713, 1607, 1500, 1456. 
1369, 1308, 1167 and 1112; OH (400MHz; CDCh) 1.40 (3H, t, J 7.1Hz, CH3CH2), 1.44 
[9H, s, (CH3hCJ, 1.49 (3H, d, J 6.8Hz, CH3CH), 2.66 (3H, s, 5-CH3), 3.83 (2H, m. 
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NHCH2), 4.36 (2H, In, CH2CH3), 5.52 (lH, br., NHCH2), 5.61 (lH, In, CHCH3) and 7.55 
(1H, d, J 8.3Hz, NHCH); Oc (looMHz; CDCI3) 13.53 (5-CH3), 14.19 (CH3CH2), 20.67 
(CH3CH), 28.29 [(CH3hc], 42.19 (NHCH2), 44.22 (CHCH3), 61.21 (CH2CH3), 79.86 
[CCCH3)3], 107.48 (C), 156.02 (NHC02), 162.20 (C), 164.01 (C), 168.78 (C) and 176.08 
(C); mlz (FAB) 356 (MH+, 40%),300,256, 199,57 (100), 44, 41 and 29. 
(S,S)-Ethyl 3-[1-N-(2-tert-butoxycarbonylaminopropanoyl)aminoethyl]_5_ 
methylisoxazole-4-carboxylate (2.35) 
(S)-Ethyl 3-( l-aminoethyl)-5-methylisoxazole-4-carboxylate hydrochloride (O.50g, 
2. 13mmol), (S)-N-tert-butoxycarbonylalanine (0.88g, 4.65mmol), and EDCI (0.96g, 
5.0Immol) were dissolved in anhydrous diethyl ether (80cm3) and cooled to O°c. 
Triethylamine (0.24g, 2.37mmol) was added over period of 4h, then the solution allowed 
to warm to 20°C and stirred for 16h. Water (50cm3) was added, then the organic layer was 
separated, dried (MgS04) and the solvent removed under reduced pressure. Purification by 
column chromatography using a solvent system of hexane and ethyl acetate (1: 1 v/v) 
yielded the title compound as a white solid (0.58g, 74%), m.p. 70-73°C; [a]D25 -49.0° (c 
requires C, 54.60; H, 7.41; N, 11.24%; Cl7H27N306 requires MH, 370.1978; Umax 
(KBr)/cm-1 3338, 2983, 2935, 1726, 1687, 1659, 1605, 1526, 1458, 1367, 1335, 1254, 
1168 and 1107; ~ (3OOMHz; CDCh) 1.34 (3H, d, J 7.0Hz, CH3CHCO), 1.39 (3H, t, J 
7.1Hz, CH3CH2), 1.43 [9H, s, (CH3hc], 1.49 (3H, d, J 7.0Hz, CH3CHC=N), 2.66 (3H, s, 
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5-CH3), 4.20 (lH, br., CHCONH), 4.35 (2H, m, CH2CH3) , 5.23 (lH, br.d, J 6.6Hz, 
NHC02), 5.60 (lH, m, CHC=N) and 7.36 (lH, br., NHCHC=N); &: (75MHz; CDCh) 
13.54 (5-CH3), 14.20 (CH3CH2), 18.67 (CH3CHCO), 20.77 (CH3CHC=N), 28.30 
[(CH3hc], 42.30 (CHC=N) , 50.16 (CHCO), 61.20 (CH2CH3), 79.81 [C(CH3h], 107.45 
(C), 155.34 (NHC02), 162.21 (C), 164.01 (C), 171.81 (C) and 176.10 (C); mlz (FAB) 370 
(MH+, 60%), 314 (loo), 270, 292, 199, 182 and 153. 
(S)-3-(1-tert-Butoxycarbonylaminoethyl)-5-methylisoxazole-4-carboxylic acid (2.36) 
• 
To a solution of (S)-ethyl 3-(l-tert-butoxycarbonylaminoethyl)-5-methylisoxazole-4-
carboxylate (0.49g, 1.64mmol) in water, THF and ethanol (1:1:1 v/v/v) (7cm3) was added 
lithium hydroxide monohydrate (0.07g, 1. 69mmol). The solution was stirred at 20°C for 
16h, then citric acid (0.33g, 1.72mmol) added. The resulting precipitate was filtered off 
and the solvent removed under reduced pressure. The residue was partitioned between 
water (25cm3) and DCM (25cm\ The organic layer was dried (MgS04) and the solvent 
removed to yield the carboxylic acid as a white solid (0.29g, 65%), m.p. 146-147°C; [a]o22 
-22.1° (c 1.08, CH30H); Found: C, 53.46; H, 6.88; N, 9.97%; MH+, 271.1299. 
CI2HIsN20s requires C, 53.33; H, 6.71; N, 10.36%; MH, 271.1294; 'Umax (KBr)/cm'l 3348, 
2983, 2588, 1692, 1597, 1530, 1479, 1368, 1335, 1248, 1164, 1137 and 1057; BH 
[400MHz; (CD3hSO] 1.33 (3H, d, J7.3Hz, CH3CH), 1.36 [9H, s, (CH3hCl, 2.61 (3H, s, 5-
CH3), 5.07 (lH, m, CHCH3) and 7.26 (lH, d, J 8.3Hz, NH); &: [100MHz; (CD3)2S0] 
12.86 (5-CH3), 19.99 (Gl3CH), 28.09 [(C1I3)3Cl, 43.31 (CHCH3), 77.89 [C(CH3h], 
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107.44 (C), 154.64 (CONH), 162.98 (C), 165.53 (C) and 175.24 (C); m/z (FAB) 271 
(MH+, 8%),215, 171,75,61,57,49,43 and 29. 
(S)-3-(1-tert-Butoxycarbonylaminoethyl)-4-( ethoxycarbonylmethy Iaminocarbony I)-S-
methylisoxazole (2.39) 
.. 
(S)-3-( I-tert-Butoxycarbonylaminoethyl)-5-methylisoxazole-4-carboxylic acid (0.43g, 
1.45mmol), glycine ethyl ester hydrochloride (0.25g, 1. 79mmol) and EDCI (0. 39g, 
2.03mmol) were dissolved in anhydrous diethyl ether (80cm\ cooled to O°C and stirred 
for 45min. The mixture was allowed to warm to room temperature and stirred for Ih, then 
cooled to O°C and triethylamine (0. 18g, 1. 79mmol) was added over 3.5h. When addition 
was complete, the suspension was warmed to room temperature and stirred for a further 
16h. Water (25cm3) was then added to dissolve any precipitated material, the ether layer 
separated and the aqueous layer extracted with ethyl acetate (2xlOcm3). The combined 
organic extracts were dried (MgS04) and the solvent removed under reduced pressure. 
The crude product was purified by column chromatography on silica gel using hexane and 
ethyl acetate (1: 1 v/v) as eluant to give the title compound as a white solid (0.20g, 39%), 
m.p. 132-133°C; [a]D22 -24.0° (c 0.51, CH30H); Found: C, 54.07; H, 7.15; N, 11.66%; 
MH+, 356.1871. CI6H2sN306 requires C, 54.07; H, 7.09; N, 11.82%; MH, 356.1821; 'Umax 
(KBr)/cm-1 3318, 2984, 2934, 1755, 1733, 1685, 1654, 1610, 1531, 1450, 1370, 1338, 
1243,1175,1061 and 864; ~ (400MHz; CDCh) 1.30 (3H, t, 17.1Hz, CH3CH2), 1.41 [9H, 
s, (CH3)3C], 1.54 (3H, d, I 7.3Hz, CH3CH), 2.62 (3H, s, 5-CH3), 4.06 (tH, d, I 5.4Hz, 
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CHHC02) (major rotational isomer), 4.11 (lH, d, J 5.4Hz, CHHC02) (minor rotational 
isomer), 4.24 (3H, m, CHHC02 & CH2CH3), 5.13 (lH, m, CHCH3), 5.44 (lH, d, J 8.3Hz, 
NHCH) and 8.08 (lH, br., NHCH2); Oc (lOOMHz; CDCh) 12.69 (5-CH3), 14.16 
(CH3CH2), 20.78 (G-hCH), 28.29 [(CH3hc], 41.44 (NHCH2), 42.81 (CHCH3), 61.47 
(CH2CH3), 80.49 [C(CH3h], 111.28 (C), 155.87 (CONH), 162.14 (C), 162.89 (C), 169.71 
(C) and 172.42 (C); mlz (FAB) 356 (MH+, 16%),300,256, 155,85, 75, 65, 61, 57, 43,35 
and 29. 
(S,S)-3-(I-tert-Butoxycarbonylaminoethyl)-4-[ (1-
methoxycarbonyl)ethylaminocarbonyl]-S-methylisoxazole (2.40) 
.. 
An experimental procedure analogous to that used for the synthesis of (S)-ethyl 3-[I-N-
(tert-butoxycarbonylaminoacetyl)aminoethyl]-5-methylisoxazole-4-carboxylate was 
adopted with the following reagents: (S)-alanine methyl ester hydrochloride CO. 109, 
0.74mmol) and triethylamine (0.16g, 1.58mmol). On generating the free base it was 
dissolved in anhydrous DCM (25cm3) and added to (S)-3-( I-tert-
butoxycarbonylaminoethyl)-5-methylisoxazole-4-carboxylic acid (0.09g, 0.35mmol) and 
EDCI (0.08g, 0.42mmol) dissolved in anhydrous DCM (l5cm3). On purification, the title 
compound was isolated as a sticky white solid (0.03g, 24%); [a]025 14.2° (c 1.37, CHCh); 
Found: MH+, 356.1836. CI6H25N306 requires MH, 356.1821; 'Umax (CHCh)/cm,1 3443, 
3263, 2980, 1743, 1695, 1657, 1504, 1456, 1370, 1240, 1169 and 1054; aH (300MHz; 
CDCh) 1.41 [9H, s, (CH3)3C], 1.52 (3H, d, J 7.3Hz, CH3CHC02) , 1.56 (3H, d, J 7.0Hz, 
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CH3CHC=N), 2.60 (3H, s, 5-CH3), 3.77 (3H, s, C02CH3), 4.69 (IH, m, CHC02), 5.16 (IH, 
m, CHC=N), 5.38 (lH, d, J 8.3Hz, NHC02) and 8.43 (lH, br., NHCHC02); Be (75MHz; 
CDCh) 12.58 (5-CH3), 17.31 (CH3CHC02), 20.90 (CH3CHC=N), 28.30 [(CH3hC], 42.63 
(CHC=N), 48.41 (GIC02), 52.45 (C02GI3), 80.55 [C(CH3h], 111.48 (C), 155.95 
(NHC02), 161.68 (C), 162.96 (C), 172.30 (C) and 173.48 (C); mlz (FAB) 356 (MH+, 
30%),300,256,239, 179, 154,136,105,91,57 (100), 44, 41 and 29. 
(S)-3-[1-N-(tert-Butoxycarbonylaminoacetyl)aminoethyl]_4_ 
(ethoxycarbonylmethylaminocarbonyl)-S-methylisoxazole (2.41) 
Route A: 
~NH 
BocHN " 0 
o 
(S)-Ethyl 3-[ I-N-(tert-butoxycarbonylaminoacetyl)aminoethyl]-5-methylisoxazole-4-
carboxylate was converted to the carboxylic acid using the procedure described for (S)-3-
(l-tert-butoxycarbony laminoethyl)-5-methylisoxazole-4-carboxy lic acid. This was 
accomplished using the following quantities of reagents: (S)-ethyl 3-[1-N-(tert-
butoxycarbonylaminoacetyl)aminoethyl]-5-methylisoxazole-4-carboxylate (0. 15g, 
0.42mmol), lithium hydroxide monohydrate (0.02g, 0.48mmol), water, THF and ethanol 
(1: 1: 1 v/v/v) (7cm3) to give (S)-3-[ I-N-(tert-butoxycarbonylaminoacetyl)aminoethyl]-5-
methylisoxazole-4-carboxylic acid (0.06g, 43%) as a colourless gum that was used 
directly; OH (3OOMHz; CDCh) 1.37 [12H, m. CH3CH & (CH3)3], 2.61 (3H, S, 5-CH3), 
3.42-3.62 (2H, m., CH2NH), 5.38 (2H, m. CHCH3 & NHCH2) and 6.94 (NHCH). 
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The acid was then converted to the desired product using the conditions employed for the 
synthesis of (S)-ethyl 3-[1-N-( tert-butoxycarbony laminoacetyl)aminoethy 1]-5-
methylisoxazole-4-carboxylate using the following quantities of reagents: (S)-3-[ I-N-(tert-
butoxycarbonylaminoacetyl)aminoethyl]-5-methylisoxazole-4-carboxylic acid (0.29g, 
0.89mmol) and EDCI (O.44g, 2.30mmol) in anhydrous DCM (40cm\ The free base, 
formed by reaction between glycine ethyl ester hydrochloride (4.98g, 35.68mmol) and 
triethylamine (7.26g, 71.75mmol), was added as a solution in anhydrous DCM (4Ocm3). 
The title compound was obtained as a white solid (0. 109, 27%), m.p. 96-99°C; [<X]028 7.2° 
(c 1.31, CHCh); Found MH+, 413.2068. Cl8H28N407 requires MH, 413.2036; '\)max 
(KBr)/cm-1 3323, 3116, 2972, 2935, 1723, 1667, 1632, 1578, 1539, 1455, 1408, 1282 and 
1168; OH (3OOMHz; CDCh) 1.31 (3H, t, J 7. 1Hz, CH3CH2), 1.45 [9H, s, (CH3hC], 1.58 
(3H, d, J 7.1Hz, CH3CH), 2.61 (3H, s, 5-CH3), 3.68-3.89 (2H, m, CH2C02), 4.08-4.28 (4H, 
m, CH2CONH & CH2CH3), 5.07 (lH, br., NHC02), 5.41 (lH, m, CHCH3), 7.18 (lH, d, J 
7.9Hz, NHCH) and 8.09 (lH, m, NHCH2C02); Oc (75MHz; CDCh) 12.53 (5-CH3), 14.15 
(CH3CH2), 20.35 (CH3CH), 28.26 [(CH3hCl, 41.45 (CH2CONH), 41.76 (CHCH3), 44.07 
(CH2C02), 61.60 (CH2CH3), 80.37 [C(CH3)3], 111.46 (C), 155.93 (NHC02), 162.35 (C), 
162.41 (C), 170.00 (C), 170.15 (C) and 172.17 (C); mlz (FAB) 413 (MH+, 100%),385, 
357, 313, 282, 256, 210, 153 and 107. 
Route B: 
~NH 
BocHN II 0 
o 
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(S)-3-(I-tert-Butoxycarbonylaminoethyl)-4-(ethoxycarbonylmethylaminocarbonyl)-5-
methylisoxazole (O.IIg, O.3Immol) was dissolved in anhydrous ethanol (25cm3) and 
cooled to O°e. Acetyl chloride (O.I2g, 1.58mmol) was added drop wise and the solution 
stirred for 6h. After this time, TLC analysis [eluted with hexane and ethyl acetate (1: I 
v/v)] showed all of the starting material to have reacted, whereupon the solvent was 
removed under reduced pressure to give the free amine salt (O.09g, 100%) which was used 
without further purification. The reaction conditions used for the synthesis of (S)-ethyl 3-
[I-N-( tert-butoxycarbony laminoacetyl)aminoethy 1] -5-methylisoxazole-4-carboxylate were 
again adopted using the following quantities: (S)-3-( I-aminoethyl)-4-
(ethoxycarbonylmethylaminocarbonyl)-5-methylisoxazole hydrochloride (O.09g, 
0.3 Immol), N-tert-butoxycarbonylglycine (O.I2g, O.68mmol), EDC! (O.I4g, O.73mmol) 
and triethylamine (O.04g, 0.36mmol). The acid and coupling reagent were dissolved in 
anhydrous DCM (15cm3) and the free amine was added as a solution in the same solvent 
(l5cm\ Purification led to the isolation of the title compound as a colourless gum (O.OIg, 
10%); data as for sample from Route A. 
1,1-Dibromo-3-(tert -butoxycarbony laminG )but-l-ene (2.47) 
ytH 
NHBoc 
,~Br 
T Br 
NHBoc 
Carbon tetrabromide (4.3Ig, 13.oommol), zinc (O.86g, 13.15mmol) and 
triphenylphosphine (3.45g, 13.15mmol) were all dissolved/suspended in anhydrous DCM 
(50cm3) and the mixture stirred vigorously at O°e. A solution of (S)-N-tert-
butoxycarbonylalaninal (O.68g, 3.93mmol) in dry DCM (IOcm3) was added and the 
mixture stirred for 24h at 20°e. Pentane (50cm3) was added to the resultant dark brown 
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solution and the precipitate that formed was filtered off. This was then dissolved in DCM 
(75cm\ pentane (75cm3) was again added and the precipitate removed by filtration. This 
precipitate was again treated with pentane and DCM, filtered, and the organic extracts 
were combined and the solvent removed under reduced pressure. Purification of the crude 
material by column chromatography eluting with hexane and ethyl acetate (2: 1 v/v) gave 
the alkene (O.65g, 50%) as a white solid, m.p. 85-86°C; OH (400MHz; CDCh) 1.24 (3H, d, 
J 6.8Hz, CH3CH), 1.45 [9H, s, (CH3hC], 4.34 (lH, Ill, CHCH3), 4.55 (lH, br., NH) and 
6.34 (lH, d, J 8.4Hz, CH=C); Oc (lOOMHz; CDCh) 19.81 (CH3CH), 28.37 [(CH3hc], 
49.38 (CHCH3), 79.77 [C(CH3)3], 90.14 (CBr2), 140.43 (CH=CBr2) and 154.77 (C=O). 
Ethyl 4-(tert-butoxycarbonylamino )pent-2-ynoate (2.46) 
,~Br 
T Br 
NHBoc 
• 
1,1-Dibromo-3-(tert-butoxycarbonylamino)but-l-ene (0. 109, 0.30mmol) was dissolved in 
anhydrous THF (Wcm3) and cooled to -78°C. n-BuLi (O.84cm3 of a LIM solution in 
hexanes, 0.92mrnol) was added and after stirring the solution for 45min, it was allowed to 
warm to 20°C and stirred for another 45min. On cooling to -60°C, ethyl chloroforrnate 
(O.05g, 0.42mrnol) was also added and the solution again allowed to warm to 20°C where 
it was stirred for 16h. The reaction mixture was treated with water (5cm3) then extracted 
with ether (3xlOcm\ The organic extracts were dried (MgS04) and the solvent was 
removed under reduced pressure to give the alkyne (O.05g, 74%) as a yellow oil; ~ 
(400MHz; CDCh) 1.34 (3H, t, J 7.2Hz, CH3CH2), 1.53 [9H, s, (CH3hc], 1.57 (3H, d, J 
6.8Hz, CH3CH), 4.28 (2H, q, J 7.2Hz, CH2CH3) and 5.27 (lH, dq, J 2.4 & 6.8Hz, 
CHCH3), NH not observed; Oc (lOOMHz; CDCh) 14.09 (CH3CH2), 20.51 (CH3CH), 27.93 
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[(CH3hC], 43.68 (CHCH3), 63.03 (CH2CH3), 70.58 (C=C), 82.69 (C), 83.35 (C), 151.32 
(C=O) and 153.44 (C=O). 
Ethyl 4-(tert-butoxycarbonylamino )-3-oxo-pentanoate (2.51) 
(S)-N-tert-Butoxycarbonylalanine (1.75g, 9.25mmol) and 1,1 '-carbonyldiimidazole (1.50g, 
9.25mmol) were dissolved in anhydrous THF (35cm3) and stirred at 20°C for 24h. 
To magnesium turnings (O.44g, 18.lOmmol) in anhydrous THF (35cm3) heated to reflux 
was slowly added 2-bromopropane (1.99g, 16. 18mmol). The mixture was heated at reflux 
for a further 2h. 
A solution of ethyl hydrogen malonate (1.34g, 1O.14mmoI) in dry THF (4Ocm3) was 
cooled to O°C and the solution of iso-propylmagnesium bromide added over 40 minutes. 
After stirring the reaction mixture for 90min at 20°C, it was warmed to 40°C and stirred 
for another 30min. On cooling to O°C, the imidazolide solution was added and the solution 
allowed to warm to 20°C, whereupon it was stirred for 16h. Ethyl acetate (75cm3) was 
added and then the solution was washed with a citric acid solution (1M; 125cm\ It was 
then extracted with ethyl acetate (3x50cm3), the organic layers were combined, dried 
(MgS04) and the solvent was removed. The crude product was purified by column 
chromatography eluting with hexane and ethyl acetate (7:3 v/v) to give the title compound 
(1.36g, 57%); OH (400MHz; CDCh) 1.21 (3H, t, J 7.2Hz, CH3CH2), 1.29 (3H, d, J 7.2Hz, 
CH3CH), 1.38 (9H, S, [CH3)3C], 3.55 (2H, m, CH2C02), 4.12 (2H, q, J 7.2Hz, CH2CH3), 
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4.30 (lH, m, CRCH3) and 5.28 (lH, d, J 8.0Hz, NH); Be (lOOMHz; CDCh) 14.35 
(CH3CH2), 17.03 (CH3CH), 28.70 [(CH3hC], 45.97 (CH2C02), 55.57 (CHCH), 61.84 
(CH2CH3), 80.18 [C(CH3h], 155.09 (NHC02), 167.22 (C02CH2) and 202.69 (C=O); mlz 
(EI) 260 (MH+, 18%),231,204, 186, 144, 115,88,57 (100), 44 (100), 41 and 29. 
N1-Acetyl_N2 -methylhydrazine (3.10) 
HC 
3 'N-NH H 2 • 
o 
HC 1/ 
3 'N-N./'...CH 
H H 3 
Methylhydrazine (3.52g, 76.41mmol) and ethyl acetate (6.77g, 76.78mmol) were dissolved 
in ethanol (6cm3) and heated at reflux under an atmosphere of nitrogen for 96h. The 
solvent was removed under reduced pressure (1 OmmHg) and the crude reaction mixture 
then distilled under vacuum, b.p. 68°C/0.3mmHg (lit.,119 I40°CI12mmHg). After allowing 
the product to solidify in a freezer for I-2h, it was filtered under a nitrogen atmosphere to 
give the desired product (3.29g, 49%) as a white solid, m.p. 40-43°C (lit.,119 38-42°C); 
Found: C, 36.99; H, 9.15; N, 29.23%; MH+, 89.0714. C3HgN20·0.5H20 requires C, 37.10; 
H, 9.34; N, 28.85%; C3HSN20 requires MH, 89.0715; Umax (KBr)/cm·1 3445, 3274, 1657, 
1443 and 1375; ~ (300MHz; CDCl]) 1.96 (3H, s, CH3CO) and 2.62 (3H, s, CH3N); Be 
(75MHz; CDCh) 21.21 (CH3CO), 39.36 (CH3N) and 169.54 (C=O); mlz (EI) 89 (MH+, 
7%), 88, 60, 46, 45 and 43. 
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l-Acetyl-4-methoxycarbonyl-2-methyl-3-(2-propYl)tetrahydropyrazole (3.16 & 3.17) 
o 
He" 
3 'N-N~CH 
H H 3 
• 
N1-Acetyl-N2-methylhydrazine (0.50g, 5.67mmol) and 2-methylpropanal (0. 24g, 
3.30mmol) were dissolved in toluene (5Ocm3) and placed in a round-bottomed flask fitted 
with a Dean and Stark trap. The solution was heated at reflux under a nitrogen atmosphere 
for 2h. Heating was then stopped and methyl propenoate (l.OOg, 11.66mmol) added 
whereupon the solution was heated at reflux for a further 16h under nitrogen. The solvent 
and excess dipolarophile were removed under reduced pressure and the crude material 
purified by column chromatography using hexane and ethyl acetate (1: 1 v/v) as the solvent. 
This yielded one stereoisomer (Isomer A) of the title compound as a yellow oil (0.19g, 
25%) Purification by normal-phase preparative HPLC using a solvent system of CH3CN in 
water (30% v/v) resulted in isolation of the other diastereoisomer (Isomer B) (0.09g, 11 %) 
along with the 5-methoxycarbonyl isomer (0.03g, 1%), both as yellow oils. N1-(2-
Methoxycarbonylethyl)-N1-methyl-N2-acetylhydrazine, the product of Michael addition 
between the hydrazine and methyl propenoate, was also isolated (0.45g, 46%) as a mixture 
of rotational isomers. Isomer A: Found: M+, 228.1474. C11H2oN20 3 requires M, 
228.1474; Umax (CHCh)/cm-1 3670,3441,3013,2925,1740,1647,1439,1373,1245,1185 
and 1124; ~ (300MHz; CDCh) 0.83 (3H, d, J 6.6Hz, CH3CH), 0.94 (3H, d, J 6.6Hz, 
CH3CH) , 1.70 [IH, m, CH(CH3h], 2.20 (3H, s, CH3CON), 2.59 (3H, s, CH3N), 3.02 [IH, 
m, CHCH(CH3)z], 3.67 (lH, m, 5-CHH), 3.72 (lH, s, C02CH3), 3.76 (lH, m, CHC0 2) and 
4.20 (lH, m, 5-CHH); Be (lOOMHz; CDCh) 18.02 (CH3CH), 20.75 (CH3CON), 21.09 
(CH3CH), 29.23 [CH(CH3h], 44.80 (5-CHz), 44.98 (CHC02), 46.57 (CH3N), 52.00 
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(C02CH3), 73.69 [CHCH(CH3h], 170.51 (C=O) and 171.06 (C=O); mlz (EI) 228 (M+, 
13%), 197, 185 (100), 143, 125,83 and 43. Isomer B: Found: M+, 228.1474. CII H20N20 3 
requires M, 228.1474; Umax (CHCI3)/cm-1 2963, 1734, 1637, 1498, 1369, 1257 and 1185; 
&i (400MHz; CDCl) 0.93 (3H, d, J 6.4Hz, CH3CH), 0.99 (3H, d, J 6.8Hz, CH3CH), 1.50 
[IH, m, CH(CH3h], 2.16 (3H, s, CH3CON), 2.60 (3H, s, CH3N), 2.94 [IH, dd, J 3.9 & 
8.8Hz, CHCH(CH3h], 3.05 (tH, m, CHC02), 3.68 (tH, m, 5-CHH), 3.75 (IH, s, C02CH3) 
and 4.37 (1H, m, 5-CHH); Be (looMHz; CDCl) 19.11 (CFhCH), 19.81 (CH3CH), 20.57 
(CH3CON), 32.61 [CH(CH3h], 44.22 (5-CH2), 45.79 (CH3N), 47.46 (CHC02), 52.49 
(C02CH3), 77.07 [CHCH(CH3h], 170.88 (C=O) and 173.99 (C=O); mlz (EI) 228 (M+, 
24%), 197, 185 (100), 169, 143, 125,83 and 43. 5-Substituted isomer: Found: C, 56.73; H, 
8.74; N, 12.00%; M+, 228.1474. CIIH2oN20300.25H20 requires C, 56.75; H, 8.87; N, 
12.03%; CIIH20N203 requires M, 228.1474; Umax (CHCh)/cm-1 2960, 1749, 1646, 1438, 
1420 and 1370; Major rotational isomer: OH (4ooMHz; CDCl) 0.92 (3H, d, J 6.4Hz, 
CH3CH) , 1.05 (3H, d, J 6.3Hz, CH3CH), 1.73 [IH, m, CH(CH3)2] , 2.06 (lH, m, 4-CHH), 
2.18 (3H, s, CH3CON), 2.50 (3H, s, CH3N), 2.53 (lH, m, 4-CHH) , 2.66 [IH, m, 
CHCH(CH3h], 3.74 (tH, s, C02CH3) and 4.61 (lH, m, CHC02); Oc (looMHz; CDCh) 
20.28 (CH3CH), 20.87 (CH3CON), 20.96 (CH3CH), 28.73 [CH(CH3h], 32.61 (4-CH2), 
46.25 (CH3N), 52.40 (C02CH3), 57.63 (CHC02), 72.33 or 73.52 [CHCH(CH3)2], 170.55 
(C=O) and 172.36 (C=O); Minor rotational isomer: &i (4ooMHz; CDCh) 0.88 (3H. d, J 
6.8Hz, CH3CH), 0.96 (3H, d, J 6.8Hz, CH3CH), 1.33 [IH, m, CH(CH3h], 2.06 (lH, m, 4-
CHH), 2.20 (3H, s, CH3CON), 2.50 (3H, s, CH3N), 2.53 (IH, m, 4-CHH), 2.66 [IH, m, 
CHCH(CH3)z] , 3.76 (lH. s, C02CH3) and 4.61 (lH, m, CHC02); Be (looMHz; CDCh) 
19.44 (CH3CH). 20.87 (CH3CON), 20.96 (CH3CH), 30.36 [CH(CH3h], 31.27 (4-CH2), 
46.25 (CH3N), 52.40 (C0 2CH3), 58.16 (CHC02), 72.33 or 73.52 [CHCH(CH3h], 171.18 
(C=O) and 172.86 (C=O); mlz (EI) 228 (M+, 24%), 197, 185 (100), 169, 143, 125, 83 and 
43 (100). Michael addition product: Major rotational isomer: &i (300MHz; CDCh) 2.06 
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(3R, s, CR3CO), 2.48-2.61 (2H, In, CH2), 2.59 (3R, s, CH3N), 2.86-3.07 (2R, In, CR2), 
3.69 (3R, s, C02CH3) and 6.50 (IR, br.s, NR); Be (75MHz; CDCh) 19.63 (CH3CO), 32.34 
(CH2) , 47.37 (CH3N), 51.84 (CH2), 55.53 (C02CH3), 172.36 (C=O) and 174.84 (C=O); 
Minor rotational isomer: ~ (3OOMHz; CDCh) 1.90 (3H, s, CH3CO), 2.48-2.61 (2H, m, 
CR2), 2.66 (3H, s, CH3N), 2.86-3.07 (2H, m, CH2), 3.69 (3H, s, C02CH3) and 6.54 (IH, 
br.s, NH); Oc (75MHz; CDCh) 21.48 (CH3CO), 32.40 (CH2), 46.17 (CH3N), 51.81 (CHz), 
54.01 (C02CH3), 168.62 (C=O) and 173.20 (C=O); mlz (En 174 (M+, 1%), 143, 131, 116, 
101,59 (100) and 43. 
N1-Acetyl-N2 -(2-tert-butoxy-4-methyl-2-oxazolin-5-yl)-N1-methylhydrazine (3.31) 
ytH 
NHBoc 
The procedure for the synthesis of l-acetyl-4-methoxycarbonyl-2-methyl-3-(2-
propyl)tetrahydropyrazole was adopted using the following reagents: (S)-N-tert-
butoxycarbonylalaninal (0.50g, 2.89mmol), NI-acetyl-N2 -methylhydrazine (0.38g, 
4.31mmol) and methyl propenoate (0.75g, 8.66mmol) in toluene (50cm3). Purification by 
column chromatography eluting with hexane and ethyl acetate (1: 1 v/v), followed by 
further purification by normal phase HPLC using a solvent system of 30% (v/v) CH3CN in 
water gave the oxazoline (0. 199, 27%); ~ (4ooMHz; CDCh) 1.36 (3H, d, J 7. 3Hz, 
CH3CH), 1.46 [9H, S, (CH3hC), 2.32 (3H, s, CH3CO), 3.19 (3H, s, CR3N), 4.45 (1H, br., 
CHCH
3
) , 5.39 (lH, br., CHNCH3) and 7.03 (tH, br.s, NH); Be (I00MHz; CDCh) 18.86 
(CH3CH), 21.43 (CH3CO), 27.32 (CH3N), 28.57 [(CH3)3C], 47.93 (CHCH3), 79.55 
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[C(CH3h], 141.97 (CHNCH3), 155.32 (C=N) and 172.60 (C=O); mlz (EI) 244 (MH+, 
75%),204,201, 144, 128,99 (100),59,57,43 and 41. 
(S)-N,N-Dibenzylalanine benzyl ester (3.34) 
o 
----. YOBn 
NBn2 
S-Alanine (8.16g, 91.59mmol) and benzyl bromide (48.31g, 282.45mmol) were dissolved 
in ethanol (1500cm\ A solution of potassium carbonate (50.66g, 366.54mmol) in water 
(35Ocm3) was added, and the solution stirred at 20°C for 48h. Water (300cm3) was added 
and the aqueous layer extracted with ethyl acetate (3x250cm3). The combined organic 
extracts were washed with sodium hydroxide solution (2M; 300cm3) and then water 
(3x300cm3). Following drying (MgS04) and removal of the solvent under reduced 
pressure, the crude product was purified by column chromatography using a solvent 
system of hexane and ethyl acetate (8: 1 v/v) to give the product as a colourless oil (l2.50g, 
38%); ~ (3OOMHz; CDCh) 1.34 (3H, d, J 7. 1Hz, CH3CH), 3.55 (lH, q, J 7.1 Hz, CHCH3), 
3.62 (2H, d, J 14.0Hz, NCHH), 3.82 (2H, d, J 14.0Hz, NCHH), 5.14 (IH, d, J 12.4Hz, 
C02CHH), 5.22 (1H, d, J 12.4Hz, C02CHH) and 7.17-7.40 (I5H, m, Ar-CH); Be (75MHz; 
CDCI3) 14.92 (OhCH), 54.38 (C6HsGh), 56.17 (CHCH3), 65.98 (C6HSCH2), 126.89 (Ar-
CH), 128.19 (Ar-CH), 128.22 (Ar-CH), 128.28 (Ar-CH), 128.55 (Ar-CH), 128.60 (Ar-
CH), 136.11 (Ar-C), 139.79 (Ar-C) and 173.50 (C=O); mlz (EI) 359 (M+, 5%), 268, 224, 
181, 132,91 (100) and 65. 
175 
(S)·2-(DibenzyIamino )propanol (3.35) 
• 
(S)-N,N-Dibenzylalanine benzyl ester (0.50g, 1.39mmol) was dissolved in anhydrous THF 
(4Ocm3) and cooled to -60°C. LiAIH4 (0.79g, 20.82mmol) was carefully added and the 
mixture stirred for 1 h. The reaction was quenched with a saturated solution of ammonium 
chloride (1.58g, 29.54mmol) in water and THF (20cm3). and the resulting mixture 
extracted with DCM (3x5Ocm3). The organic extracts were combined. dried (MgS04) and 
the solvent removed under reduced pressure. Purification by column chromatography 
eluting with hexane and ethyl acetate (4: 1 v/v) gave the title compound as a colourless oil 
(0.23g. 65%); ~ (400MHz; CDCh) 0.97 (3H, d. J 6.9Hz, CH3CH), 2.99 (lH, m, 
CHHOH). 3.14 (lH, m, CHHOH), 3.34 (2H, d, J 13.7Hz, NCHH), 3.44 (lH. m, CHCH3), 
3.81 (2H. d. J 13.7Hz. NCHH) and 7.15-7.33 (lOH, m, Ar-CH); &: (lOOMHz; CDCh) 8.67 
(CH3CH). 52.58 (CH2), 54.15 (aICH3). 62.71 (CH2). 126.90 (Ar-CH), 128.09 (Ar-CH). 
129.22 (Ar-CH) and 139.26 (Ar-C); mlz (EI) 255 (M+, 13%).240.224 (100). 181. 132. 91 
(100).65 and 28. 
(S).N,N.Dibenzylalaninal (3.32) 
Oxalyl chloride (0.17g, 1.38mmol) was dissolved in dry DCM (2Ocm3). The solution was 
cooled to -60°C and DMSO (0.22g, 2.82mmol) was added and the solution then stirred for 
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2min. After this time, (S)-2-(dibenzylamino)propanol (O.l7g, 0.67mmol) was added to the 
mixture, which was then stirred for 15min. The solution was treated with triethylamine 
(0.41g, 4.02mmol), stirred for 5min and allowed to warm to 20°C. Water (5cm3) was 
added and the aqueous layer extracted with DCM (3xI5cm\ The organic extracts were 
washed with hydrochloric acid (0.3M; 20cm\ water (20cm3), saturated brine (20cm3) and 
water (20cm3) again. Drying the organic layer (MgS04) and removing the solvent under 
reduced pressure yielded the aldehyde (0. 14g, 83%) as a yellow oil; aH (400MHz; CDCh) 
1.17 (3H, d, J 6.9Hz, CH3CH) , 3.32 (lH, q, J 6.9Hz, CHCH3), 3.56 (2H, d, J 14.2Hz, 
NCHH), 3.72 (2H, d, J 14.2Hz, NCHH), 7.21-7.43 (lOH, m, Ar-CH) and 9.72 (CHO); &: 
(lOOMHz; CDCh) 6.79 (CH3CH), 54.94 (CHCH3), 62.87 (CH2), 127.49 (Ar-CH), 128.62 
(Ar-CH), 129.28 (Ar-CH), 139.01 (Ar-C) and 202.42 (C=O). 
(S)-3-(1-Dibenzylaminoethyl)-2,5-dimethyl-4-oxo-l-pyrazoline (3.38) 
(S)-N,N-Dibenzylalaninal (0. 12g, 0.47mmol), N1-acetyl-N2 -methylhydrazine (0.05g, 
0.56mmol) and methyl propenoate (0.33g, 3.89mmol) were dissolved in toluene (5Ocm3) 
and heated at reflux in the presence of 4A molecular sieves for 16h. Following removal of 
the solvent under reduced pressure and purification by column chromatography eluting 
with hexane and ethyl acetate (1: 1 v/v) , the only pure product isolated was the title 
compound as a yellow oil (O.01g, 7%), aH (400MHz; CDCI3) 1.29 (3H, d, J 7.4Hz, 
CH
3
CH), 2.30 (3H, s, CH3C=N), 3.07 (3H, s, CH3N), 3.63 (2H, d, J IO.3Hz, C6HsCHH), 
3.67 (lH, m, CHCH3) , 3.71 (2H, d, J IO.3Hz, C6HSCHH), 6.94 (tH, d, J 5.0Hz, NCHO) 
and 7.22-7.40 (WH, m, Ar-CH). 
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2.Benzyloxypropanal (3.41) 
.. ~H 
OBn 
Methyl 2-benzyloxypropionate (1.98g, 1O.19mmol) was dissolved in anhydrous toluene 
(40cm3) and cooled to -50°C. DIBAL (lO.l6cm3 of a 1.2M solution in toluene, 
12.40mmol) was added dropwise then the solution stirred for 2.5h. A saturated solution of 
sodium metabisulfite (60cm3) was added and the mixture was allowed to warm to 20°C. 
The layers were separated and the organic phase further extracted with saturated sodium 
metabisulfite solution (3x80cm3). The combined aqueous layers were washed with ether 
(3x60cm3) then cooled to O°C and the pH raised to 11 with sodium hydroxide solution 
(8M). The solution was then extracted with ether (3x50cm3), washed with saturated brine 
(75cm3), dried (MgS04) and the solvent removed under reduced pressure. Purification by 
column chromatography using 9: 1 (v/v) hexane:ethyl acetate as eluant gave the aldehyde 
as a colourless oil (0.41g, 25%); Found: MNH/, 182.1183. CIOHI20 2 requires MNH.t, 
182.1181; 'Umax (neat)!cm- I 3465,3032,2982,2869,2361, 1736, 1497, 1455, 1375 and 
1094; OH (300MHz; CDCh) 1.31 (3H, d, J 7.0Hz, CH3CH), 3.87 (tH, dq, J 1.7 & 7.0Hz, 
CHCH3), 4.57 (lH, d, J 11.7Hz, CHH), 4.64 (lH, d, J 11.7Hz, CHH), 7.28-7.36 (SH, m, 
Ar-CH) and 9.65 (lH, d, J 1.7Hz, CHO); Oc (75MHz; CDCh) 15.26 (CH3), 71.96 (CH2), 
79.41 (CHCH3), 127.91 (Ar-CH), 128.04 (Ar-CH), 128.54 (Ar-CH), 137.37 (Ar-C) and 
203.32 (CHO); mlz (CI) 182 (MNH.t +, 100%), 125, 108, 106,91 and 61. 
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3-(1-Benzyloxyethyl)-2,5-dimethyl-4-oxo-l-pyrazoline (Fig. 3.9) 
o YH 
OBn 
2-Benzyloxypropanal (0.37g, 2.25mmol), N'-Acetyl-N2-methylhydrazine (0.20g, 
2.27mmol) and methyl propenoate (0.40g, 4.66mmol) in toluene (25cm3) were placed in a 
round-bottomed flask fitted with a Dean and Stark trap and heated at reflux for 24h. The 
solvent was removed under reduced pressure and the residue purified by column 
chromatography eluting with hexane and ethyl acetate (l: 1 v/v). The only pure product 
isolated was the title compound as a yellow oil (0.06g, 11 %), 8H (300MHz; CDCh) 1.40 
(3H, d, J 6.4Hz, CH3CH), 2.32 (3H, s, CH3C=N), 3.13 (3H, s, CH3N), 4.18 (lH, quintet, J 
6.4Hz, CHCH3), 4.55 (2H, s, C6H5CH2), 6.84 (lH, d, J 6.4Hz, NCHO) and 7.19-7.37 (5H, 
Ill. Ar-CH). 
2-Methylpropanal Acetylhydrazone (3.45) 
o 
A 
. y-~ CH3 
2-Methylpropanal (1.99g, 27.53mmol), acetylhydrazine (1.99g, 26.86mmol) and toluene 
(60cm3) were placed in a flask fitted with a Dean and Stark trap. After heating at reflux for 
2h, the solvent was removed under reduced pressure to yield the title compound (3.43g, 
100%) as a colourless viscous oil; 8H (400MHz; CDCh) 1.10 [6H, d, J 6.8Hz, (CH3hCH], 
2.24 (3H, s, CH3CO), 2.50 [lH, Ill. CH(CH3h] , 7.17 (lH, d, J 5.5Hz, CH=N) and 10.34 
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(lH, br.s, NH); 8c (lOOMHz; CDCh) 19.55 [(CfhhCH], 19.93 (CH3CO), 31.36 
[CH(CH3h], 152.74 (CH=N) and 174.19 (C=O). 
2-Methylpropanal tert-Butoxycarbonylhydrazone (3.51) 
The procedure for the synthesis of 2-methylpropanal acetylhydrazone was used with the 
following reagents: 2-methylpropanal (2.94g, 40.74mmol) and tert-butyl carbazate (4.98g, 
37.68mmol). The product was isolated (3.44g, 49%) following column chromatography 
eluting with hexane and ethyl acetate (4:1 v/v); 3H (400MHz; CDCh) 1.09 [6H, d, J 6.8Hz, 
(CH3hCH], 1.50 [9H, s, (CH3)3C], 2.58 [IH, m, CH(CH3h], 7.04 (lH, d, J 5.4Hz, CH=N) 
and 7.69 (lH, br.s, NH); 3c (lOOMHz; CDCh) 19.90 [(CH3hCH], 28.29 [(CH3hc], 31.35 
[CH(CH3)2], 80.92 [C(CH3)3], 152.27 and 152.60. 
l-Acetyl-4-methoxycarbonyl-2-methyl-3-phenyitetrahydropyrazole (3.58 & 3.59) 
o 
Hell 
3 'N-N/'....,CH 
H H 3 
Benzaldehyde (1.20g, 11.31mmol), NI-acetyl-N2-methylhydrazine (1.05g, 11.92mmol) and 
methyl propenoate (1.53g, 17.77mmol) in toluene (70cm3) were placed in a flask fitted 
with a Dean and Stark trap. After heating at reflux for 72h, the solvent was removed using 
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a rotary evaporator and the crude product purified by column chromatography eluting with 
hexane:ethyl acetate (2: 1 v/v) to give the syn diastereoisomer (0.50g, 17%) as a white 
solid, mp. 47-50°C. The other diastereoisomer was also isolated (0.63g, 21 %) but 
contained traces of an impurity. This was removed by further purification using normal-
phase preparative HPLC with a solvent system of 0.375% methanol in DCM (v/v) to give 
the anti diastereoisomer (0. 17g, 6%) as a white solid, m.p. 79-81°C. Also isolated from 
the reaction mixture was 1,4-diacetyl-2,5-dimethyl-3,6-diphenylhexahydrotetraZine (0.53g, 
27%), formed by dimerisation of the dipole, as a white solid, m.p. 80-82°C. Syn isomer: 
Found: C, 63.99; H, 6.96; N, 10.68%; M+, 262.1318. CI4HIsN203 requires C, 64.11; H, 
6.92; N, 10.67%; M, 262.1317; Urnax (KBr)/cm-1 2955, 2380, 1728, 1646, 1437, 1382, 
1316, 1213, 1134, 1094, 732 and 697; ~ (300MHz; CDCh) 2.16 (3H, s, CH3CO), 2.74 
(3H, s, CH3N), 3.35 (3H, s, C02CH3), 3.76 (lH, dd, J 9.7 & 1 1. 6Hz, 5-CHH), 3.94 (1H, m, 
CHC02), 4.35 (1H, d, J 7.7Hz, C6H5CH), 4.45 (IH, dd, J 7.5 & 11.6Hz, 5-CHH), 7.05-
7.14 (2H, m, Ar-CH) and 7.23-7.33 (3H, m, Ar-CH); Be (75MHz; CDCI]) 21.08 (CH3CO), 
44.45 (5-CH2)' 46.17 (CH3N), 47.84 (CHC02), 51.77 (C02CH3), 72.36 (C6H5CH), 126.70 
(Ar-CH), 127.95 (Ar-CH), 128.48 (Ar-CH), 137.90 (Ar-C) , 170.06 (C=O) and 171.45 
(C=O); mlz (EI) 262 (M+, 7%), 219 (100), 187, 159, 115,91, 77, 57 and 43. Anti isomer: 
Found: C, 64.12; H, 6.94; N, 10.61%; MH+, 263.1396. CI4HIsN203 requires C, 64.11; H, 
6.92; N, 10.67%; MH, 263.1396; Umax (KBr)/cm-1 3456, 2956, 2889, 1738, 1656, 1464, 
1412, 1382, 1208, 1053, 726 and 701; ~ (300MHz; CDCh) 2.17 (3H, s, CH3CO), 2.63 
(3H, s, CH3N), 3.45 (1H, m, CHC02), 3.76 (3H, s, C02CH3), 3.86 (lH, m, 5-CHH), 4.43 
(1H, m, 5-CHH), 4.47 (lH, d, J 5.9Hz, C6H5CH) and 7.27-7.37 (5H, m, Ar-CH); Oc 
(75MHz; CDCh) 20.83 (CfhCO), 44.51 (CH3N), 45.02 (5-CH2), 50.87 (CHC0 2), 52.62 
(C02ffi3), 73.51 (C6H5CH), 126.68 (Ar-CH), 127.90 (Ar-CH), 128.77 (Ar-CH), 139.86 
(Ar-C), 171.05 (C=O) and 172.72 (C=O); mlz (EI) 263 (MH+, 10%), 219, 187, 159, 131, 
117, 115,91, 77,57 and 43 (100). Tetrazine: Found: C, 68.18; H, 6.87; N, 15.86%; MH+, 
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353.1986. C2oH24N402 requires C, 68.16; H, 6.86; N, 15.89; MH, 353.1977; UlTla~ 
(KBr)/cm- J 3020, 2975, 1682, 1602, 1573, 1462, 1411, 1398, 1142, 995, 762 and 698; ~ 
(300MHz; CDCh) 2.46 (6H, s, CH3CO), 3.34 (6H, s, CH3N), 7.34-7.44 (6H, m, Ar-CH) 
and 7.59-7.72 (6H, m, Ar-CH and NCHN); (75MHz; CDCh) 21.59 (CH3CO), 27.47 
(CH3N), 126.951 (Ar-CH), 128.74 (Ar-CH), 129.62 (Ar-CH), 134.81 (Ar-C), 138.72 
(NCHN) and 172.88 (C=O); mlz (EI) 176 (Ml2+, 5%), 133,90,89,77,63,51 and 43 (loo). 
l-Acetyl-4-cyano-2-methyl-3-phenyltetrahydropyrazole (3.67 & 3.68) 
o 
Hell 
3 'N-N....x....CH H H 3 
The procedure for the synthesis of l-acetyl-4-methoxycarbonyl-2-methyl-3-
phenyltetrahydropyrazole was used with the following reagents: benzaldehyde (0. 94g, 
8.85mmol), N I-acetyl-N2-methylhydrazine (O.76g, 8.63mmol), propenonitrile (O.93g, 
17.47mmol) and toluene (40cm\ Purification yielded one pure diastereoisomer of the title 
compound (0.29g, 15%), assumed to have syn relative stereochemistry, as a pale yellow 
solid, m.p. 150-153°C. The other diastereoisomer (O.20g, 10%), presumed to be anti, 
contained traces of an impurity (which appeared to be the 5-cyano isomer) and was 
obtained as a yellow solid. Syn isomer: Found: C, 68.09; H, 6.64; N, 18.06%; M+, 
229.1216. C13HJ5N30 requires C, 68.10; H, 6.59; N, 18.32%; M, 229.1215; U/1lIU 
(KBr)lcm-1 2998,2964,2895, 2246, 1656, 1470, 1453, 1444, 1414, 1373, 758 and 7]2; 5.J 
(300MHz; CDCh) 2.21 (3H, s, CH3CO), 2.72 (3H, s, CH3N), 3.78 (1H, ddd, J 5.6, 6.6 & 
8.2Hz, CHCN), 3.87 (lH, dd, J 8.2 & 11.4Hz, 5-CHH), 4.32 (IH, d, J 6.6Hz, C6Hj CH), 
4.41 (1H, dd, J 5.6 & 11.4Hz, 5-CHH), 7.25-7.27 (2H, m, Ar-CH) and 7.31-7.43 (3H, m. 
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Ar-CH); 8c (75MHz; CDCh) 20.90 (CH3CO), 34.90 (CHCN), 45.83 (CH3N), 46.50 (5-
CH2), 72.29 (C6H5CH), 117.07 (CN), 127.00 (Ar-CH), 128.88 (Ar-CH), 128.94 (Ar-CH), 
135.85 (Ar-C) and 172.09 (C=O); mlz (EI) 229 (M+, 5%), 186 (100), 159, 142, 133, 115, 
91, 77, 57 and 43. Anti isomer: Found: C, 67.90; H, 6.57; N, 18.26%; M+, 229.1226. 
C13H15N30 requires C, 68.10; H, 6.59; N, 18.32%; M, 229.1215; Umax (KBr)/cm-1 3035, 
2994, 2963, 2922, 2883, 2802, 2247, 1662, 1496, 1398, 1344, 1319, 1216, 1110, 768, 738 
and 702; OH (3OOMHz; CDCh) 2.14 (3H, s, CH3CO), 2.75 (3H, s, CH3N), 3.44 (1H, In, 
CHCN), 3.84 (1H, dd, J 7.1 & 1 1. 9Hz, 5-CHH), 4.46 (IH, d, J 6.0Hz, C6HsCH), 4.49 (1H, 
m, 5-CHH), 7.26-7.32 (2H, m, Ar-CH) and 7.34-7.42 (3H, In, Ar-CH); &: (75MHz; 
CDCh) 20.82 (CH3CO), 34.96 (CHCN), 44.48 (CH3N), 46.04 (5-CH2), 74.21 (C6HsCH), 
119.38 (CN), 126.52 (Ar-CH), 128.74 (Ar-CH), 129.11 (Ar-CH), 137.26 (Ar-C) and 
171.55 (C=O); mlz (EI) 229 (M+, 1%), 186, 143, 133,115,91,77,57 and 43 (100). 
l-Acetyl-4,S-dimethoxycarbonyl-2-methyl-3-phenyltetrahydropyrazole (all-syn) (3.70) 
o 
Hell 
3 'N-N~CH H H 3 
• 
The procedure for the synthesis of l-acetyl-4-methoxycarbonyl-2-methyl-3-
phenyltetrahydropyrazole was used with the following reagents: benzaldehyde (0.56g, 
5.31mmol), NI-acetyl-N2-methylhydrazine (0.47g, 5.33mmol), dimethyl maleate (1.66g. 
11.52mmol) and toluene (40cm\ Analysis of the products following purification revealed 
the presence of the tetrazine from dipole dimerisation (not isolated) and an inseparable 
mixture of stereoisomeric tetrahydropyrazoles (0.43g, 25%). The only pure product to be 
isolated was the all-syn tetrahydropyrazole (0.18g, 11 %), a white solid m.p. I55-1S8°C; 
183 
Found: C, 59.78; H, 6.32; N, 8.58%; M+, 320.1372. C'6H2oN20s requires C, 59.99; H, 
6.29; N, 8.74%; M, 320.1372; Umax (KBr)lcm-1 3007,2953,1765,1747,1641, 1494, 1455, 
1433, 1377, 1356, 1342, 1198, 1168, 1110, 741 and 700; OH (3OOMHz; CDCh) 2.33 (3H, s, 
CH3CO), 2.78 (3H, S, CH3N), 3.53 (3H, S, C02CH3), 3.66 (3H, s, C02CH3), 4.23 (tH, dd, J 
7.9 & 1O.1Hz, 4-CHC02), 4.50 (tH, d, J 7.9Hz, C6HsCH), 4.85 (lH, d, J 1O.1Hz, 5-
CHC02) and 7.24-7.38 (5H, m, Ar-CH); Oc (75MHz; CDCh) 21.18 (CH3CO), 45.23 
(CH3N), 51.18 (4-CHC02), 51.98 (C02CH3), 52.24 (C02CH3), 59.00 (5-CHC02), 71.65 
(C6H5CH), 127.97 (Ar-CH), 128.01 (Ar-CH), 128.09 (Ar-CH), 136.08 (Ar-C), 167.93 
(C=O), 168.74 (C=O) and 169.57 (C=O); m/z (EI) 321 (MH+, 2%), 278, 219, 159, 133, 
115,91, 77, 59 and 43 (100). 
l-Acetyl-4,S-dimethoxycarbonyl-2-methyl-3-phenyltetrahydropyrazoJe 
(3.71) 
o 
Hell 
3 'N-N~CH 
H H 3 
(anti-anti) 
The procedure for the synthesis of l-acetyl-4-methoxycarbonyl-2-methyl-3-
phenyltetrahydropyrazole was used with the following reagents: benzaldehyde (O.61g, 
5.71mmol), N I -acetyl-N2-methylhydrazine (0.51g, 5.79mmol), dimethyl fumarate (1.68g, 
11.66mmol) and toluene (40cm\ Along with an 18:5 mixture of the title compound and 
the syn-anti diastereoisomer (0.49g, 27%), the title compound was isolated (0.69g, 38%) as 
a white solid, m.p. 152-154°C; Found: C, 59.89; H, 6.27; N, 8.71%; M+, 320.1368. 
CI6H2oN20s requires C, 59.99; H, 6.29; N, 8.74%; M, 320.1372; Umax (KBr)lcm-1 2991, 
2963, 2361, 1765, 1732, 1654, 1435, 1409, 1215, 764 and 708; ~ (3OOMHz; CDCh) 2.27 
184 
(6H, S, CH3CO & CH3N), 3.71 (3H, s, C02CH3), 3.81 (3H, s. C02CH3), 4.03 (lH, dd, J 8.3 
& 1O.8Hz. 4-CHC02), 4.58 (lH. d, J 1O.8Hz, C6HsCH), 5.16 OH, d, J 8.3Hz, 5-CHC02) 
and 7.33-7.43 (5H, m, Ar-CH); Be (75MHz; CDCh) 20.95 (CH3CO), 39.75 (CH3N), 49.79 
(4-CHC02), 52.84 (C02CH3), 52.97 (C02CH3), 62.33 (5-CHC02), 71.90 (C6HSCH), 
128.82 (Ar-CH), 128.83 (Ar-CH), 128.85 (Ar-CH), 132.85 (Ar-C), 170.93 (C=O), 171.00 
(C=O) and 171.18 (C=O); mlz (EI) 320 (M+, 12%),278,245,217, 185, 159, 115,91,77, 
59 and 43 (100). 
2-Acetyl-3-methyl-6,8-dioxo-4, 7 -diphenyl-2,3, 7 -triazabicyclo[3.3.0]octane (anti-syn) 
(3.74) 
o 
He " 3 'N-N~CH H H 3 
o 
Hell 
3 'N-N~CH3 
Ph~"'rO 
r NPh o 
The procedure for the synthesis of l-acetyl-4-methoxycarbonyl-2-methyl-3-
phenyltetrahydropyrazole was used with the following reagents: benzaldehyde (0.63g, 
5.90mmol), N I-acetyl-N2-methylhydrazine (0.55g, 6.24mmol), N-phenylmaleirnide (2.05g, 
11.84mmol) and toluene (40cm3). Purification by column chromatography, eluting with 
hexane:ethyl acetate (3:2 v/v) yielded the product (0.08g, 4%) as a yellow solid, mp. 239-
241°C; Found: C, 68.43; H, 5.44; N, 11.58%; M+, 349.1422. C20HI9N30 3 requires C, 
68.75; H, 5.44; N, 12.02%; M, 349.1426; 'Umax (KBr)/cm-1 1719, 1653, 1499, 1386, 1199, 
1158, 746 and 696; ~ (300MHz; CDCh) 2.03 (3H, s, CH3CO), 2.87 (3H, s, CH3N), 4.02 
(lH, d, J 8.6Hz, C6HsCHCHCO), 4.73 (lH, s, C6HsClf). 5.80 (lH, d, J 8.6Hz. NCHCO) 
and 7.18-7.53 (IOH, m, Ar-CH); Be (75MHz; CDCh) 20.88 (CH3CO), 47.55 (CH3N), 
53.11 (C
6
H
s
CHaICO) 58.42 (NCHCO), 73.07 (C6HsCH). 125.82 (Ar-CH), 125.99 (Ar-
185 
CH), 128.28 (Ar-CH), 129.07 (Ar-CH), 129.12 (Ar-CH), 129.39 (Ar-CH), 131.51 (Ar-C), 
139.67 (Ar-C), 172.99 (C=O) and 175.80 (C=O); m/z (EI) 350 (MH+, 82%), 349 (100), 
307, 159, 133, 115,91, 77 and 43. 
t-Acetyl-S-methoxycarbonyl-2-methyl-4-methylaminocarbonyl-3-
phenyltetrahydropyrazole (3.75) & l-Acetyl-2-methyl-4,5-bis(methylaminocarbonyl)_ 
3-phenyltetrahydropyrazole (3.76) 
---------~ + 
l-Acetyl-4,5-dimethoxycarbonyl-2-methyl-3-phenyltetrahydropyrazole (0.14g, 0.43mmol) 
was placed in a screw-cap vial along with sodium cyanide (2.7mg, 0.06mmol) and a 
solution of methylamine in methanol (2M; 0.22cm3, 0.44mmol). The mixture was heated 
in an oil bath at 50-55°C for 16h. The solvent was then removed under reduced pressure 
and the crude material purified by column chromatography using ethyl acetate as eluant to 
give the mono-amide product (0.05g, 38%) as a colourless oil and the di-amide product 
(O.04g, 33%) as a white solid, m.p. 208-21O°C; Mono-amide: Found: MH+, 320.1614. 
C16H21N304 requires MH, 320.1610; 'Umax (CHCl)/cm,l 3680, 3341, 2956, 1734, 1681. 
1636, 1556, 1438, 1416 and 1247; BH (300MHz; CDCh) 2.14 (3H, S, CH3CO), 2.28 (3H, s, 
CH3NN), 2.85 (3H, d, J 5.0Hz, CH3NHCO), 3.66 (3H, s, C02CH3), 4.54 (tH, d, J 1105Hz, 
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C6HsCH), 4.78 OH, dd, J 7.5 & 11.5Hz, CHCONH), 5.08 (1H, d, J 7.5Hz, CHC02), 7.33-
7.44 (4H, m, Ar-CH & NH) and 7.46-7.50 (2H, m, Ar-CH); Be (75MHz; CDCI]) 20.99 
(CH3CO), 26.56 (CH3NHCO), 39.37 (CH3NN), 46.15 (CHCONH), 52.63 (C02CH3), 63.29 
(CHC02), 71.46 (C6HsCH), 128.74 (Ar-CH), 128.79 (Ar-CH), 129.27 (Ar-CH), 132.95 
(Ar-C), 169.80 (C=O), 172.04 (C=O) and 173.03 (C=O); mlz (EI) 320 (MH+, 2%), 277, 
219, 185, 159, 115, 91, 77, 58 and 43 (100). Di-amide: Found: C, 59.34; H, 6.97; N, 
16.61%; MH+, 319.1768. CI6H22N403·0.5H20 requires C, 59.62; H, 7.28; N, 16.86%; 
Cl6H22N403 requires MH, 319.1770; Umax (CHCh)lcm-1 3323, 3125,2970, 1668, 1631, 
1580, 1536, 1408 and 765; bH (300MHz; CDCh) 2.13 (3H, s, CH3CO), 2.30 (3H, s, 
CH3NN), 2.76 (3H, d, J 4.7Hz, CH3NHCO), 2.84 (3H, d, J 5.0Hz, CH3NHCO), 4.38 (1H, 
dd, J 8.3 & 11.6Hz, 4-CH), 4.75 (1H, d, J 11.6Hz, C6HsCH), 4.86 (1H, d, J 8.3Hz, 5-CH), 
7.04 (1H, br.d, J 4.7Hz, NH), 7.30-7.41 (5H, m, Ar-CH) and 7.65 (1H, br.d, J 5.0Hz, NH); 
Be (75MHz; CDCh) 21.16 (CH3CO), 26.43 (CH3NHCO), 26.58 (CH3NHCO), 39.69 
(CH3NN), 46.57 (4-CHCONH), 63.96 (5-CHCONH), 69.58 (C6HsCH), 128.56 (Ar-CH), 
128.74 (Ar-CH), 128.98 (Ar-CH), 133.65 (Ar-C), 170.16 (C=O), 171.56 (C=O) and 174.05 
(C=O); mlz (CI) 319 (MH+, 100%),275, 191, 145, 131, 120, 106,91 and 77. 
Benzaldehyde Acetylhydrazone (3.81) 
o )l V 'N-N CH3 I H ~ 
Benzaldehyde (26.22g, 0.25mol) and acetylhydrazine (18.30g, 0.25mol) in toluene 
(300cm3) were placed in a flask fitted with a Dean and Stark trap. After heating at reflux 
for 16h, the solvent was removed under reduced pressure and the crude product purified by 
column chromatography on silica gel using ethyl acetate as eluant to give the product as a 
187 
h't }' 148 W Ie so Id, (25.72g, 64%) m.p. 136.5-138.0°C (liL, 137-140°C); 'Umax (KBr)/cm-1 3187, 
3084, 2979, 2868, 1675, 1608, 1400, 1343, 1139, 1023 and 952; &J (400MHz; CDCh) 
2.42 (3H, s, CH3), 7.40 (3H, m, Ar-CH), 7.68 (2H, m, Ar-CH), 7.89 (lH, s, CH=N) and 
10.56 (lh, br.s, NH); Oc (lOOMHz; CDCI3) 20.39 (CH3), 127.14 (Ar-CH), 128.71 (Ar-CH), 
130.06 (Ar-CH), 133.92 (Ar-C), 144.05 (CH=N) and 177.52 (C=O). 
N
2 
-Acetyl-N1-benzylhydrazine-cyanoborate (3.82) 
.. 
To benzaldehyde acetylhydrazone (4.62g, 28.48mmol) and sodium cyanoborohydride 
(7.18g, 114.26mmol) in anhydrous THF (250cm3) was added a few drops of bromocresol 
green indicator. para-Toluenesulfonic acid monohydrate (21.98g, 114.35mmol) in 
anhydrous THF (50cm3) was slowly added to maintain a pH of around 3.5, indicated by a 
light brown colour. After addition was complete, the suspension was stirred for Ih, then 
the sodium para-toluenesulfonate that had precipitated was filtered off. The solution was 
diluted with ethyl acetate (200cm3) and washed with saturated brine (150cm\ saturated 
sodium bicarbonate solution (150cm3), and a second portion of saturated brine (15Ocm\ 
After drying (MgS04), the solvent was removed under reduced pressure to give the crude 
product which was purified by column chromatography on silica gel using toluene and 
THF (1: 1 v/v) as eluant to give the pure hydrazine salt (4.02g, 70%) as a white solid, m.p. 
130-131°C; Found: [M-Hr. 202.1155. CIOHI4BN30 requires M-H, 202.1152; 'Umax 
(KBr)/cm-1 3205, 3111, 3067, 2965, 2816, 2450, 2421, 1663, 1560, 1416, 1373, 1290, 
1222 and 1134; OH [300MHz; (CD3hSO] 1.71 (3H, s, CH3CO), 3.79 (lH, dd, J 4.6 & 
13.0Hz, C6HsCHH), 4.20 (lH, d, J 13.0Hz, C6HsCHH), 7.30 (3H, m, Ar-CH), 7.42 (2H, m, 
188 
Ar-CH) , 9.72 (lH, br., NH) and 10.40 (IH, br., NH); Oc [75MHz; (CD3hSO] 19.61 
(CH3CO), 59.17 (C6HsCH2), 127.79 (Ar-CH), 128.55 (Ar-CH), 131.05 (Ar-CH), 131.51 
(C), 138.70 (C) and 166.36 (C=O); mlz (ES) 202 ([M-Hr, 100), 175, 161, 132 and 83. 
N1-Acetyl_N2 -benzylhydrazine (3.25) 
N-Aeetyl-N -benzylhydrazinium eyanoborate (0.15g, 0.74mmol) was dissolved in water 
(2em3), sodium hydroxide solution (lM; 0.82cm3, 0.82mmol) added, and the solution 
heated at 60°C for Ih. Ethyl acetate (5cm3) was added, the organic layer separated and 
dried (MgS04), then the solvent removed under reduced pressure to yield the free 
hydrazine as a white solid (O.llg, 91%), a mixture of rotational isomers, m.p. 77-78°C 
(lit.!49 78°C); Found: MH+, 165.1031. C9HI2N20 requires MH, 165.1028; Umax (KBr)/cm-1 
3311, 3228, 3027, 1641, 1537, 1496 and 1372; Major isomer: ~ (400MHz; CDCh) 1.89 
(3H, s, CH3CO), 3.94 (2H, s, C6HsCH2), 4.75 (lH, br., NH), 7.32 (5H, m, Ar-CH) and 7.57 
(lH, hr., NH); Oc (lOOMHz; CDCh) 21.10 (CH3CO), 55.72 (C6HSCH2), 127.56 (Ar-CH), 
128.49 (Ar-CH), 128.91 (Ar-CH), 137.58 (Ar-C) and 169.77 (C=O); Minor isomer: ~ 
(400MHz; CDCh) 2.01 (3H, s, CH3CO), 3.86 (2H, s, C6HSCH2), 4.75 (IH. br., NH). 7.32 
(5H, m, Ar-CH) and 7.57 (lH, br., NH); Oc (looMHz; CDCh) 19.46 (CH3CO), 56.93 
(C6HsCH2), 127.96 (Ar-CH), 128.60 (Ar-CH), 128.71 (Ar-CH), 136.50 (Ar-C) and 176.00 
(C=O); mlz (FAB) 165 (MH+, 61%),106,91 (100) and 43. 
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l-Acetyl-2-benzyl-4-methoxycarbonyl-3-(2-propyl)-tetrahydropyrazole (3.29) 
N
1
-Acetyl-N2-benzylhydrazine (0.32g, 1. 95mmol), 2-methylpropanal (0. 15g, 2.09mmol) 
and methyl propenoate (0.52g, 6.00mmol) were placed in a glass tube with a screw-cap. 
Toluene (lOcm3) and 4A molecular sieves were also placed in the tube, which was then 
sealed. The solution was heated for 72h, after which the solvent was removed under 
reduced pressure. The crude product was purified by column chromatography eluting with 
hexane and ethyl acetate (2: 1 v/v) to give the product (0.03g, 4%) as a yellow oil; Found: 
MH+, 305.1863. C17H24N203 requires MH, 305.1865; Umax (CHCh)lcm-1 3021, 2963, 
1733, 1641, 1437, 1369, 1216 and 700; ~ (300MHz, CDCh) 0.83 (3H, d, J 6.9Hz, 
CH3CH), 0.85 (3H, d, J 7. 1Hz, CH3CH), 1.39 [IH, m, CH(CH3h], 1.92 (3H, s, CH3CON), 
3.06-3.12 [2H, m, CHCH(CH3h & CHC02], 3.75 (lH, m, 5-CHH), 3.79 (3H, s, C02CH3), 
3.83 (lH, d, J 11.9Hz, C6HSCHH), 3.90 (lH, d, J 11.9Hz, C6HSCHH), 4.52 (lH, dd, J 9.8 
&12Hz, 5-CHH) and 7.26-7.38 (5H, rn, Ar-CH); Be (75MHz, CDCh) 18.99 (CH3CH), 
20.09 (CH3CH), 20.72 (CH3CON), 32.51 [CH(CH3)2], 44.65 (5-CH2), 47.56 (CHC02), 
52.54 (C02CH3), 61.84 (C6HSCH2), 74.86 [CHCH(CH3)2], 127.93 (Ar-CH), 128.45 (Ar-
CH), 130.29 (Ar-CH), 136.29 (Ar-C), 171.59 (C=O) and 174.37 (C=O); mlz (EI) 305 
(MH+, 2%), 261, 171, 111,91 (100),69,65 and 43. 
190 
N1-Benzyloxycarbonyl-N1-methylhydrazine (3.85) 
He 
3 'N-NH H 2 
Triethylamine (4.21g, 41.61mmol) was added to methylhydrazine (1.84g, 39.85mmol) in 
chloroform (30cm3). The solution was cooled to O°C and benzyl chloroformate (5.81g, 
34.04mmol) was added over a period of 30min. The solution was stirred at 20°C for 16h, 
then washed with water (10cm\ The organic layer was separated, dried (MgS04) and the 
solvent evaporated. The residue was distilled under reduced pressure to give the required 
hydrazine (3.49g, 57%) as a colourless liquid, b.p. 120°CIO.6nunHg (liL,136 98-
102°C/0.3mmHg); Found: C, 60.00; H, 6.84; N, 15.09%; MH+, 181.0975. C9HI2N202 
requires C, 59.99; H, 6.71; N, 15.54%; MH, 181.0977; Umax (neat)/cm-1 3334,2953, 1703, 
1627,1455, 1394, 1352, 1213, 1165 and 1002; ~ (300MHz; CDCh) 3.10 (3H, s, CH3N), 
4.15 (2H, br.s, NH2), 5.13 (2H, s, C6HsCH2) and 7.31-7.36 (5H, m, Ar-CH); Be (75MHz; 
CDCI3) 38.38 (CH3N), 67.59 (C6HsCI-{z), 128.00 (Ar-CH), 128.14 (Ar-CH), 128.51 (Ar-
CH), 136.47 (Ar-C) and 157.50 (C=O): mlz (CI) 198 (MNH/, 54%), 183, 181 (MH+, 100), 
137, 135, 122, 120, 108, 106, 91, 64 and 61. 
Nt_ Benzyloxycarbonyl-N2 -tert-butoxycarbony I-Nl-methylhydrazine (3.86) 
• 
N1-Benzyloxycarbonyl-NI-methylhydrazine (5.73g, 31.80mmol) was dissolved in propan-
2-01 (4Ocm3) and cooled to O°C. A solution of Boc20 (7.71g, 35.33mmol) in DCM 
191 
(15cm3) was added dropwise, then the reaction mixture allowed to warm to 20°C and 
stirred for 16h. The solvent was removed under reduced pressure and the crude product 
purified by column chromatography eluting with hexane and ethyl acetate (3: 1 v/v). 
Recrystallisation from hexane and ether (10: 1 v/v) gave the tri-substituted hydrazine 
(4.75g, 53%) as a white solid, m.p. 58-59°C (lit.,150 61-62°C); Found: C, 60.08; H, 7.22; N, 
10.03%; MH+, 281.1502. Cl4H20N204 requires C, 59.99; H, 7.19; N, 9.99%; MH. 
281.1501; Umax (KBr)/cm- 1 3271, 3150, 2966, 1697, 1462, 1422, 1368 and 1154; B.J 
(300MHz; CDCh) 1.43 [9H, br.s, (CH3hc], 3.19 (3H, s, CH3N), 5.15 (2H, s, C6H5CH2), 
6.52 (lH, br.s, NH) and 7.32-7.34 (5H, m, Ar-CH); &: (75MHz; CDC!) 28.13 [(CH3hc), 
37.99 & 38.42 (CH3N), 67.95 (C6H5CH2), 81.61 [C(CH3)3], 127.99 (Ar-CH), 128.18 (Ar-
CH), 128.47 (Ar-CH), 136.03 (Ar-C), 154.69 & 155.25 (C=O) and 156.38 & 156.76 
(C=O); mlz (CI) 298 (MNH/, 21%), 281 (MH+, 2%), 242,198,183,181,147,108 (100), 
106 and 91. 
N1-tert_ Butoxycarbonyl-N2 -methylhydrazine (3.83) 
N1-Benzyloxycarbonyl-N2 _tert_butoxycarbonyl-N1-methylhydrazine (2.00g, 7.14mmol) 
was dissolved in methanol (4Ocm\ A catalyst of 10% palladium on charcoal (0.12g, 
11.28mmol) was added and the solution was stirred at 20°C under an atmosphere of 
hydrogen for 16h. The catalyst was filtered off and washed with methanol (3x2Ocm3). 
The solvent was removed under reduced pressure and the product purified by column 
chromatography using a solvent of hexane and ethyl acetate (4:1 v/v) to give the title 
Compound (O.36g, 35%) as a white solid m.p. 42-45°C (lit.,141 46-49°C); \)max (KBr)/cm·
1 
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3321, 3260, 2983, 1699, 1559, 1489, 1368, 1274, 1253, 1175 and 1143; ~ (300MHz; 
CDCh) 1.47 [9H, s, (CH3)3C), 2.62 (3H, s, CH3N), 3.89 (lH, br.s, NHCH3) and 6.14 (IH, 
br.s, NHC=O); Oc (75MHz; CDC}3) 28.38 [CH3)3C], 39.36 (CH3N), 80.46 [C(CH3hJ and 
156.66 (C=O). 
I-tert-Butoxycarbonyl-4-methoxycarbonyl-2_methyl_3_phenyltetrahydropyrazole 
(3.87) 
.. 
The procedure for the synthesis of 1-acetyl-4-methoxycarbonyl-2-methyl-3-
phenyltetrahydropyrazole was used with the following reagents: benzaldehyde (0. 26g, 
2.46mmol), N I-tert-butoxycarbonyl-N2-methylhydrazine (0.35g, 2.39mmol), methyl 
propenoate (0.42g, 4.89mmol) and toluene (25cm3). Purification by column 
chromatography eluting with hexane and ethyl acetate (2: 1 v/v) led to isolation of the N-
Boc tetrahydropyrazole (0. 14g, 18%) as a colourless oil; Found: M+, 320.1735. 
CI7H24N204 requires M, 320.1736; 'Umax (CHCh)/cm-1 2982, 1739, 1710, 1390, 1369, 1312, 
1169 and 1121; OH (300MHz, CDCh) 1.54 [3H, s, (CH3)3C], 2.72 (3H, s, CH3N), 3.42 (3H, 
s, C02CH3), 3.72 (2H, m, CHC02 & 5-C/lH) , 4.00 (lR, dd, J 10.8 & 14.3Hz, 5-CHH) , 
4.32 (lH, d, J 6.4Hz, C6H5CH) and 7.17-7.30 (5H, m, Ar-CH); &: (75MHz, CDCh) 28.52 
[(CH3hC], 45.54 (CH3N), 46.36 (5-CH2), 48.33 (CHC02) , 51.65 (C02CH3), 71.61 
(C6H5CH), 80.39 [C(CH3hJ, 126.70 (Ar-CH), 127.69 (Ar-CH), 128.27 (Ar-CH), 137.85 
(Ar-C), 154.79 (CON) and 170.19 (C02CH3); mlz (EI) 320 (M+, 3%), 265, 219,187,159, 
133, 115,91, 77, 57 (100) and 41. 
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